<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'><collection><source>PubTator</source><date></date><key>BioC.key</key><document><id>11850164</id><passage><infon key="name_3">surname:Soldovieri;given-names:Laura</infon><infon key="name_2">surname:Moffa;given-names:Simona</infon><infon key="name_1">surname:Ciccarelli;given-names:Gea</infon><infon key="name_0">surname:Sonnino;given-names:Rebecca</infon><infon key="year">2025</infon><infon key="article-id_pmc">PMC11850164</infon><infon key="article-id_publisher-id">111848</infon><infon key="article-id_doi">10.1016/j.isci.2025.111848</infon><infon key="title">Subject areas</infon><infon key="type">front</infon><infon key="section_type">TITLE</infon><infon key="issue">2</infon><infon key="elocation-id">111848</infon><infon key="volume">28</infon><infon key="license">This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</infon><infon key="name_10">surname:Pontecorvi;given-names:Alfredo</infon><infon key="name_11">surname:Giaccari;given-names:Andrea</infon><infon key="name_12">surname:Mezza;given-names:Teresa</infon><infon key="kwd">Cognitive neuroscience Human metabolism</infon><infon key="name_9">surname:Nista;given-names:Enrico C.</infon><infon key="name_8">surname:Gasbarrini;given-names:Antonio</infon><infon key="name_7">surname:Di Piazza;given-names:Eleonora</infon><infon key="article-id_pii">S2589-0042(25)00108-7</infon><infon key="name_6">surname:Cinti;given-names:Francesca</infon><infon key="name_5">surname:Brunetti;given-names:Michela</infon><infon key="name_4">surname:Di Giuseppe;given-names:Gianfranco</infon><infon key="article-id_pmc">11850164</infon><infon key="article-id_pmid">40008362</infon><offset>0</offset><text>Exploring nutraceutical approaches linking metabolic syndrome and cognitive impairment</text><annotation id="0"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="43" length="18" /><text>metabolic syndrome</text></annotation><annotation id="1"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="66" length="20" /><text>cognitive impairment</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>87</offset><text>Summary</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>95</offset><text>Metabolic syndrome (MetS) and mild cognitive impairment (MCI) are interconnected conditions sharing common pathological pathways, such as inflammation and oxidative stress, leading to the concept of "metabolic-cognitive syndrome." This highlights their mutual influence and potential overlapping therapeutic strategies. Although lifestyle modifications remain essential, nutraceutical supplementation has emerged as a promising adjunct for the prevention and management of these preclinical conditions. This review examines clinical and translational evidence on commonly used nutraceuticals targeting shared pathophysiological mechanisms of MetS and MCI. By addressing inflammation, oxidative stress, and metabolic dysfunction, these supplements may offer a valuable approach to mitigating the progression and consequences of both conditions. Understanding their efficacy could provide practical tools to complement lifestyle changes, offering a more comprehensive strategy for managing metabolic-cognitive syndrome.</text><annotation id="2"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="95" length="18" /><text>Metabolic syndrome</text></annotation><annotation id="3"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="115" length="4" /><text>MetS</text></annotation><annotation id="4"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="130" length="20" /><text>cognitive impairment</text></annotation><annotation id="5"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="152" length="3" /><text>MCI</text></annotation><annotation id="6"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="233" length="12" /><text>inflammation</text></annotation><annotation id="7"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="295" length="28" /><text>metabolic-cognitive syndrome</text></annotation><annotation id="8"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="737" length="4" /><text>MetS</text></annotation><annotation id="9"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="746" length="3" /><text>MCI</text></annotation><annotation id="10"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="765" length="12" /><text>inflammation</text></annotation><annotation id="11"><infon key="identifier">MESH:D008659</infon><infon key="type">Disease</infon><location offset="801" length="21" /><text>metabolic dysfunction</text></annotation><annotation id="12"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="1083" length="28" /><text>metabolic-cognitive syndrome</text></annotation></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1117</offset><text>Graphical abstract</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1136</offset><text>Cognitive neuroscience; Human metabolism</text><annotation id="13"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="1160" length="5" /><text>Human</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1177</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1190</offset><text>Morbidity and mortality due to metabolic syndrome (MetS) make it a global health concern since it is well known that, if left untreated, MetS is strongly associated with increased risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVDs).</text><annotation id="14"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="1221" length="18" /><text>metabolic syndrome</text></annotation><annotation id="15"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="1241" length="4" /><text>MetS</text></annotation><annotation id="16"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="1327" length="4" /><text>MetS</text></annotation><annotation id="17"><infon key="identifier">MESH:D003924</infon><infon key="type">Disease</infon><location offset="1389" length="24" /><text>type 2 diabetes mellitus</text></annotation><annotation id="18"><infon key="identifier">MESH:D003924</infon><infon key="type">Disease</infon><location offset="1415" length="4" /><text>T2DM</text></annotation><annotation id="19"><infon key="identifier">MESH:D002318</infon><infon key="type">Disease</infon><location offset="1425" length="23" /><text>cardiovascular diseases</text></annotation><annotation id="20"><infon key="identifier">MESH:D002318</infon><infon key="type">Disease</infon><location offset="1450" length="4" /><text>CVDs</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1457</offset><text>Poor cognitive function is one of the many adverse health outcomes deriving from MetS. MetS is in fact associated with a higher risk of mild cognitive impairment (MCI) and the progression from MCI to dementia, particularly vascular dementia as evidenced by many cross sectional studies and systematic reviews. Not surprisingly, an inverse correlation between the presence of MetS and global cognitive performance has often been highlighted, and of all MetS components, high blood pressure and hyperglycaemia seem to be the strongest predictors of impaired cognitive function.</text><annotation id="21"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="1457" length="23" /><text>Poor cognitive function</text></annotation><annotation id="22"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="1538" length="5" /><text>MetS.</text></annotation><annotation id="23"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="1544" length="4" /><text>MetS</text></annotation><annotation id="24"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="1598" length="20" /><text>cognitive impairment</text></annotation><annotation id="25"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="1620" length="3" /><text>MCI</text></annotation><annotation id="26"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="1650" length="3" /><text>MCI</text></annotation><annotation id="27"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="1657" length="8" /><text>dementia</text></annotation><annotation id="28"><infon key="identifier">MESH:D015140</infon><infon key="type">Disease</infon><location offset="1680" length="17" /><text>vascular dementia</text></annotation><annotation id="29"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="1832" length="4" /><text>MetS</text></annotation><annotation id="30"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="1909" length="4" /><text>MetS</text></annotation><annotation id="31"><infon key="type">Disease</infon><location offset="1950" length="14" /><text>hyperglycaemia</text></annotation><annotation id="32"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="2004" length="27" /><text>impaired cognitive function</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2033</offset><text>One of the most investigated pathogenetic features of MetS is systemic inflammation also known as "chronic low-grade inflammation," primarily resulting from adipose tissue dysfunction in the context of a high-calorie diet. This persistent inflammatory state is believed to impact brain function, representing a shared pathological substrate between MetS and MCI. Notably, obesity has been linked to neuroinflammation, initially observed in the hypothalamus and later identified in other brain regions such as the hippocampus, cortex, brainstem, and amygdala. This phenomenon, termed "obesity-derived neuroinflammation," is associated with mood alterations and cognitive decline. In parallel with adipose tissue dysfunction, neuroinflammation in the brain has been linked to insulin resistance (IR), defined as reduced cellular sensitivity to insulin. More than two decades ago, research demonstrated that the brain is highly responsive to insulin, as evidenced by the presence of insulin receptors on both neurons and glial cells, circulating insulin within the brain, and localized insulin synthesis. Subsequent studies revealed a decline in the quantity and activity of insulin receptors in the brain, particularly in aging and Alzheimer's disease (AD) models. This finding has fueled the hypothesis that neuronal IR may significantly contribute to memory impairment in these conditions.</text><annotation id="33"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="2875" length="7" /><text>insulin</text></annotation><annotation id="34"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="2972" length="7" /><text>insulin</text></annotation><annotation id="35"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="3076" length="7" /><text>insulin</text></annotation><annotation id="36"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="3116" length="7" /><text>insulin</text></annotation><annotation id="38"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="2087" length="4" /><text>MetS</text></annotation><annotation id="39"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="2104" length="12" /><text>inflammation</text></annotation><annotation id="40"><infon key="identifier">MESH:D009800</infon><infon key="type">Disease</infon><location offset="2140" length="4" /><text>low-</text></annotation><annotation id="41"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="2150" length="12" /><text>inflammation</text></annotation><annotation id="42"><infon key="identifier">MESH:D018205</infon><infon key="type">Disease</infon><location offset="2190" length="26" /><text>adipose tissue dysfunction</text></annotation><annotation id="43"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="2272" length="12" /><text>inflammatory</text></annotation><annotation id="44"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="2382" length="4" /><text>MetS</text></annotation><annotation id="45"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="2391" length="3" /><text>MCI</text></annotation><annotation id="46"><infon key="identifier">MESH:D009765</infon><infon key="type">Disease</infon><location offset="2405" length="7" /><text>obesity</text></annotation><annotation id="47"><infon key="identifier">MESH:D000090862</infon><infon key="type">Disease</infon><location offset="2432" length="17" /><text>neuroinflammation</text></annotation><annotation id="48"><infon key="identifier">MESH:D009765</infon><infon key="type">Disease</infon><location offset="2617" length="7" /><text>obesity</text></annotation><annotation id="49"><infon key="identifier">MESH:D000090862</infon><infon key="type">Disease</infon><location offset="2633" length="17" /><text>neuroinflammation</text></annotation><annotation id="50"><infon key="identifier">MESH:D019964</infon><infon key="type">Disease</infon><location offset="2672" length="16" /><text>mood alterations</text></annotation><annotation id="51"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="2693" length="17" /><text>cognitive decline</text></annotation><annotation id="52"><infon key="identifier">MESH:D018205</infon><infon key="type">Disease</infon><location offset="2729" length="26" /><text>adipose tissue dysfunction</text></annotation><annotation id="53"><infon key="identifier">MESH:D000090862</infon><infon key="type">Disease</infon><location offset="2757" length="17" /><text>neuroinflammation</text></annotation><annotation id="54"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="2807" length="18" /><text>insulin resistance</text></annotation><annotation id="55"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="2827" length="2" /><text>IR</text></annotation><annotation id="56"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="3263" length="19" /><text>Alzheimer's disease</text></annotation><annotation id="57"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="3284" length="2" /><text>AD</text></annotation><annotation id="58"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="3349" length="2" /><text>IR</text></annotation><annotation id="59"><infon key="identifier">MESH:D008569</infon><infon key="type">Disease</infon><location offset="3384" length="17" /><text>memory impairment</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3433</offset><text>Some authors propose that AD and MCI could be conceptualized as an "insulin resistance brain state." Impaired insulin signaling disrupts critical pathways essential for neuronal health and cognitive function. For example, IR diminishes the activity of the PI3K/Akt pathway, leading to aberrant activation of glycogen synthase kinase-3 beta (GSK3beta). This upregulation promotes tau protein hyperphosphorylation, a hallmark of AD. Furthermore, IR interferes with O-GlcNAcylation, a modification inversely related to phosphorylation, exacerbating tau pathology. Normal insulin signaling also supports the transcription of anti-amyloidogenic proteins such as the insulin-degrading enzyme (IDE) and alpha-secretase, which reduce amyloid-beta (Abeta) production. When IR occurs, Abeta production and aggregation increase, triggering synaptic toxicity. Elevated Abeta levels further impair insulin signaling, creating a vicious cycle that accelerates cognitive decline.</text><annotation id="60"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="3543" length="7" /><text>insulin</text></annotation><annotation id="61"><infon key="identifier">5294</infon><infon key="type">Gene</infon><location offset="3689" length="4" /><text>PI3K</text></annotation><annotation id="62"><infon key="identifier">207</infon><infon key="type">Gene</infon><location offset="3694" length="3" /><text>Akt</text></annotation><annotation id="63"><infon key="identifier">2932</infon><infon key="type">Gene</infon><location offset="3741" length="31" /><text>glycogen synthase kinase-3 beta</text></annotation><annotation id="64"><infon key="identifier">2932</infon><infon key="type">Gene</infon><location offset="3774" length="8" /><text>GSK3beta</text></annotation><annotation id="65"><infon key="identifier">4137</infon><infon key="type">Gene</infon><location offset="3812" length="3" /><text>tau</text></annotation><annotation id="66"><infon key="identifier">4137</infon><infon key="type">Gene</infon><location offset="3979" length="3" /><text>tau</text></annotation><annotation id="67"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="4001" length="7" /><text>insulin</text></annotation><annotation id="68"><infon key="identifier">3416</infon><infon key="type">Gene</infon><location offset="4094" length="24" /><text>insulin-degrading enzyme</text></annotation><annotation id="69"><infon key="identifier">3416</infon><infon key="type">Gene</infon><location offset="4120" length="3" /><text>IDE</text></annotation><annotation id="70"><infon key="identifier">351</infon><infon key="type">Gene</infon><location offset="4159" length="12" /><text>amyloid-beta</text></annotation><annotation id="71"><infon key="identifier">351</infon><infon key="type">Gene</infon><location offset="4173" length="5" /><text>Abeta</text></annotation><annotation id="72"><infon key="identifier">351</infon><infon key="type">Gene</infon><location offset="4208" length="5" /><text>Abeta</text></annotation><annotation id="73"><infon key="identifier">351</infon><infon key="type">Gene</infon><location offset="4290" length="5" /><text>Abeta</text></annotation><annotation id="74"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="4318" length="7" /><text>insulin</text></annotation><annotation id="76"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="3459" length="2" /><text>AD</text></annotation><annotation id="77"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="3466" length="3" /><text>MCI</text></annotation><annotation id="78"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="3501" length="18" /><text>insulin resistance</text></annotation><annotation id="79"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="3655" length="2" /><text>IR</text></annotation><annotation id="80"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="3860" length="2" /><text>AD</text></annotation><annotation id="81"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="3877" length="2" /><text>IR</text></annotation><annotation id="82"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="4197" length="2" /><text>IR</text></annotation><annotation id="83"><infon key="identifier">MESH:D012183</infon><infon key="type">Disease</infon><location offset="4262" length="17" /><text>synaptic toxicity</text></annotation><annotation id="84"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="4379" length="17" /><text>cognitive decline</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4398</offset><text>Given the strong correlation between cognitive performance and brain IR, antidiabetic drugs aimed at enhancing insulin signaling have been explored as therapeutic interventions, yielding promising results. Clinical guidelines for diabetes management have increasingly recognized cognitive impairment as a chronic complication of T2DM, with its incidence being approximately twice as high in individuals with T2DM compared to those without.</text><annotation id="85"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="4509" length="7" /><text>insulin</text></annotation><annotation id="86"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="4467" length="2" /><text>IR</text></annotation><annotation id="87"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="4628" length="8" /><text>diabetes</text></annotation><annotation id="88"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="4677" length="20" /><text>cognitive impairment</text></annotation><annotation id="89"><infon key="identifier">MESH:D003924</infon><infon key="type">Disease</infon><location offset="4727" length="4" /><text>T2DM</text></annotation><annotation id="90"><infon key="identifier">MESH:D003924</infon><infon key="type">Disease</infon><location offset="4806" length="4" /><text>T2DM</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4838</offset><text>The primary cause of the interesting overlap between MetS and neurodegenerative disorders is still a matter of debate. However, due to the emerging awareness of this intricate link between metabolic features and cognitive decline, the concept of "metabolic-cognitive syndrome" has recently been introduced indicating a cross-talk between the pathological mechanisms involved in both conditions and their propensity to occur together.</text><annotation id="91"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="4891" length="4" /><text>MetS</text></annotation><annotation id="92"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="4900" length="27" /><text>neurodegenerative disorders</text></annotation><annotation id="93"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="5050" length="17" /><text>cognitive decline</text></annotation><annotation id="94"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="5085" length="28" /><text>metabolic-cognitive syndrome</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5276</offset><text>Hyperglycemia and IR are known to drive the overproduction of reactive oxygen species (ROS), neuroinflammation, and the disruption of key signaling pathways such as the PI3K/Akt pathway. These changes lead to cellular damage in critical brain regions like the hippocampus and hypothalamus, which play essential roles in cognitive processes, learning, and memory. Alterations in the hippocampus are also linked to deficits in executive functions, such as reduced cognitive flexibility and increased impulsivity. These impairments can hinder effective weight management and adherence to dietary regimens, thus perpetuating the interdependence of MCI and MetS within a complex and self-reinforcing vicious cycle.</text><annotation id="95"><infon key="identifier">5294</infon><infon key="type">Gene</infon><location offset="5445" length="4" /><text>PI3K</text></annotation><annotation id="96"><infon key="identifier">207</infon><infon key="type">Gene</infon><location offset="5450" length="3" /><text>Akt</text></annotation><annotation id="97"><infon key="identifier">MESH:D006943</infon><infon key="type">Disease</infon><location offset="5276" length="13" /><text>Hyperglycemia</text></annotation><annotation id="98"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="5294" length="2" /><text>IR</text></annotation><annotation id="99"><infon key="identifier">MESH:D000090862</infon><infon key="type">Disease</infon><location offset="5369" length="17" /><text>neuroinflammation</text></annotation><annotation id="100"><infon key="identifier">MESH:D001289</infon><infon key="type">Disease</infon><location offset="5689" length="31" /><text>deficits in executive functions</text></annotation><annotation id="101"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="5730" length="29" /><text>reduced cognitive flexibility</text></annotation><annotation id="102"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="5920" length="3" /><text>MCI</text></annotation><annotation id="103"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="5928" length="4" /><text>MetS</text></annotation><annotation id="104"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="5338" length="23" /><text>reactive oxygen species</text></annotation><annotation id="105"><infon key="identifier">MESH:D017382</infon><infon key="type">Chemical</infon><location offset="5363" length="3" /><text>ROS</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5986</offset><text>Conversely, weight loss has been consistently associated with improvements in cognitive functions, including memory and executive control. Supporting this connection, several studies have explored dietary interventions using functional food products, such as Opuntia ficus-indica (prickly pear cactus), in animal models of MetS. These studies reported enhanced behavioral performance and overall cognitive improvements. At the biochemical level, such interventions were shown to improve lipid profiles and reduce oxidative stress markers, with concurrent modulation of circulating leptin levels. Further evidence from mouse models of MetS-associated cognitive decline highlights the benefits of dietary changes. Specifically, transitioning from a high-fat diet (HFD) to a low-fat diet and administering repeated infusions of plasma from healthy mice to HFD-fed mice have demonstrated notable memory improvements. These findings emphasize the potential of dietary strategies in mitigating cognitive decline linked to MetS.</text><annotation id="106"><infon key="identifier">16846</infon><infon key="type">Gene</infon><location offset="6567" length="6" /><text>leptin</text></annotation><annotation id="107"><infon key="identifier">MESH:D015431</infon><infon key="type">Disease</infon><location offset="5998" length="11" /><text>weight loss</text></annotation><annotation id="108"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="6309" length="5" /><text>MetS.</text></annotation><annotation id="109"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="6620" length="4" /><text>MetS</text></annotation><annotation id="110"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="6636" length="17" /><text>cognitive decline</text></annotation><annotation id="111"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="6974" length="17" /><text>cognitive decline</text></annotation><annotation id="112"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="7002" length="5" /><text>MetS.</text></annotation><annotation id="113"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="6473" length="5" /><text>lipid</text></annotation><annotation id="114"><infon key="identifier">MESH:D005223</infon><infon key="type">Chemical</infon><location offset="6738" length="3" /><text>fat</text></annotation><annotation id="115"><infon key="identifier">MESH:D005223</infon><infon key="type">Chemical</infon><location offset="6762" length="3" /><text>fat</text></annotation><annotation id="116"><infon key="identifier">371859</infon><infon key="type">Species</infon><location offset="6245" length="20" /><text>Opuntia ficus-indica</text></annotation><annotation id="117"><infon key="type">Species</infon><location offset="6267" length="19" /><text>prickly pear cactus</text></annotation><annotation id="118"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="6604" length="5" /><text>mouse</text></annotation><annotation id="119"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="6831" length="4" /><text>mice</text></annotation><annotation id="120"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="6847" length="4" /><text>mice</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7008</offset><text>As both MetS and MCI are characterized by a slow and discontinuous progression, they represent an intermediate clinical phenotype between a healthy condition and the fully manifest disease. Therefore, both disorders can be seen as a time interval in which it may be possible to intervene and delay progression to dementia or T2DM and cardiovascular outcomes. Unfortunately, this silent evolution makes the diagnostic work up slower. Moreover, given the inconclusive data available regarding the exact mechanism behind them, there are currently no codified therapies available for treatment or prevention.</text><annotation id="121"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="7016" length="4" /><text>MetS</text></annotation><annotation id="122"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="7025" length="3" /><text>MCI</text></annotation><annotation id="123"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="7321" length="8" /><text>dementia</text></annotation><annotation id="124"><infon key="identifier">MESH:D003924</infon><infon key="type">Disease</infon><location offset="7333" length="4" /><text>T2DM</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7613</offset><text>Certainly though, MetS and MCI are both multifactorial conditions, with environmental and genetic factors contributing to their development. In addition, lifestyle factors, especially lack of physical activity and excessive nutritional intake, have been identified as major contributors. Consequently, multidomain lifestyle modifications have been proposed as a valid therapeutical strategy. Cardio metabolic risk factors usually develop in middle age, suggesting the importance of preventive approaches for target population in their 40s and 50s. Also, it has been demonstrated that young adulthood and middle age are crucial periods for determining cognitive health in old age. Modifiable lifestyle factors in the prevention of MCI and dementia are diet, physical activity, cognitive and social engagement, smoking and alcohol consumption. Similarly well-known modifiable lifestyle factors in the prevention of MetS and then T2DM are diet and physical activity. Based on the importance of diet for both conditions and on the urgency of prevention, great interest has risen in the non-pharmacological approach through the use of nutraceuticals. Nutraceuticals are a food or part of food capable of providing beneficial health effects, including the prevention and the treatment of diseases. These products have risen interest in different fields for the fewer side effects and long-term safety along with a broad therapeutic effect. Indeed, the same nutraceutical can address different diseases with common pathways and risk factors, as MCI and MetS.</text><annotation id="125"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="7631" length="4" /><text>MetS</text></annotation><annotation id="126"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="7640" length="3" /><text>MCI</text></annotation><annotation id="127"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="8343" length="3" /><text>MCI</text></annotation><annotation id="128"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="8351" length="8" /><text>dementia</text></annotation><annotation id="129"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="8526" length="4" /><text>MetS</text></annotation><annotation id="130"><infon key="identifier">MESH:D003924</infon><infon key="type">Disease</infon><location offset="8540" length="4" /><text>T2DM</text></annotation><annotation id="131"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="9151" length="3" /><text>MCI</text></annotation><annotation id="132"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="9159" length="5" /><text>MetS.</text></annotation><annotation id="133"><infon key="identifier">MESH:D000438</infon><infon key="type">Chemical</infon><location offset="8434" length="7" /><text>alcohol</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tbl1.xml</infon><infon key="id">tbl1</infon><infon key="type">table_caption</infon><offset>9165</offset><text>Classification of the studied compounds according to their properties</text></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tbl1.xml</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt; &lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;th&gt;Active ingredient&lt;/th&gt;&lt;th&gt;Mostly anti-inflammatory&lt;/th&gt;&lt;th&gt;Mostly antioxidant&lt;/th&gt;&lt;th&gt;Both properties&lt;/th&gt;&lt;th&gt;Actions&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;Resveratrol&lt;/td&gt;&lt;td&gt;-&lt;/td&gt;&lt;td&gt;-&lt;/td&gt;&lt;td&gt;x&lt;/td&gt;&lt;td&gt;Upregulating AMP-activated protein kinase. Increase endothelial nitric oxide bioavailability. Inhibition of COX-2, 5-lipoxygenase, and nuclear factor-kappaB. Upregulation of IL-10 and the downregulation of interferon-gamma and IL-17.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Tocotrienols (T3) and tocopherols (TF)&lt;/td&gt;&lt;td&gt;x&lt;/td&gt;&lt;td&gt;-&lt;/td&gt;&lt;td&gt;x&lt;/td&gt;&lt;td&gt;Suppressing M1 macrophage differentiation.&lt;break/&gt;Increase NGF levels.   of the glutathione redox ratio and plasma lipid peroxidation. Vasorelaxation by stimulation of K-Ca channel&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;PUFAs&lt;/td&gt;&lt;td&gt;x&lt;/td&gt;&lt;td&gt;-&lt;/td&gt;&lt;td&gt;-&lt;/td&gt;&lt;td&gt;Downregulation of IL-6, tumor necrosis factor alpha (TNF- alpha), CRP, and IL-1 levels. Converting the phenotype of microglial cells from macrophage M1 state to an M2 state.&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Probiotics&lt;/td&gt;&lt;td&gt;x&lt;/td&gt;&lt;td&gt;-&lt;/td&gt;&lt;td&gt;-&lt;/td&gt;&lt;td&gt;High IL-10-inducing activity in immune cells. Downregulation of hs-CRP and TNF-alpha levels&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </infon><infon key="id">tbl1</infon><infon key="type">table</infon><offset>9235</offset><text>Active ingredient	Mostly anti-inflammatory	Mostly antioxidant	Both properties	Actions	 	Resveratrol	-	-	x	Upregulating AMP-activated protein kinase. Increase endothelial nitric oxide bioavailability. Inhibition of COX-2, 5-lipoxygenase, and nuclear factor-kappaB. Upregulation of IL-10 and the downregulation of interferon-gamma and IL-17.	 	Tocotrienols (T3) and tocopherols (TF)	x	-	x	Suppressing M1 macrophage differentiation.Increase NGF levels.   of the glutathione redox ratio and plasma lipid peroxidation. Vasorelaxation by stimulation of K-Ca channel	 	PUFAs	x	-	-	Downregulation of IL-6, tumor necrosis factor alpha (TNF- alpha), CRP, and IL-1 levels. Converting the phenotype of microglial cells from macrophage M1 state to an M2 state.	 	Probiotics	x	-	-	High IL-10-inducing activity in immune cells. Downregulation of hs-CRP and TNF-alpha levels	 	</text><annotation id="134"><infon key="identifier">4513</infon><infon key="type">Gene</infon><location offset="9449" length="5" /><text>COX-2</text></annotation><annotation id="135"><infon key="identifier">240</infon><infon key="type">Gene</infon><location offset="9456" length="14" /><text>5-lipoxygenase</text></annotation><annotation id="136"><infon key="identifier">3586</infon><infon key="type">Gene</infon><location offset="9515" length="5" /><text>IL-10</text></annotation><annotation id="137"><infon key="identifier">3458</infon><infon key="type">Gene</infon><location offset="9547" length="16" /><text>interferon-gamma</text></annotation><annotation id="138"><infon key="identifier">3605</infon><infon key="type">Gene</infon><location offset="9568" length="5" /><text>IL-17</text></annotation><annotation id="139"><infon key="identifier">310738</infon><infon key="type">Gene</infon><location offset="9673" length="3" /><text>NGF</text></annotation><annotation id="140"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="9875" length="3" /><text>CRP</text></annotation><annotation id="141"><infon key="identifier">3586</infon><infon key="type">Gene</infon><location offset="10007" length="5" /><text>IL-10</text></annotation><annotation id="142"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="10069" length="3" /><text>CRP</text></annotation><annotation id="143"><infon key="identifier">24835</infon><infon key="type">Gene</infon><location offset="10077" length="9" /><text>TNF-alpha</text></annotation><annotation id="144"><infon key="identifier">7124</infon><infon key="type">Gene</infon><location offset="9833" length="27" /><text>tumor necrosis factor alpha</text></annotation><annotation id="145"><infon key="identifier">3552</infon><infon key="type">Gene</infon><location offset="9884" length="4" /><text>IL-1</text></annotation><annotation id="146"><infon key="identifier">3569</infon><infon key="type">Gene</infon><location offset="9827" length="4" /><text>IL-6</text></annotation><annotation id="147"><infon key="identifier">MESH:D009569</infon><infon key="type">Chemical</infon><location offset="9405" length="12" /><text>nitric oxide</text></annotation><annotation id="148"><infon key="identifier">MESH:D005978</infon><infon key="type">Chemical</infon><location offset="9694" length="11" /><text>glutathione</text></annotation><annotation id="149"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="9729" length="5" /><text>lipid</text></annotation><annotation id="150"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="9782" length="4" /><text>K-Ca</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>10101</offset><text>Since MCI and MetS are conditions at risk of evolution in overt non-communicable diseases:T2DM and dementia:and since a recognized pharmaceutical strategy has not been found for any of the two conditions, in this review, we aim to explore data on the nutraceutical approach to MCI and MetS, as a possible alternative to medical treatment and/or as an useful add-on to diet and physical activity. Specifically, we explore the role of different type of nutraceuticals, as vitamins, botanicals, dietary supplements and probiotics, known for their anti-inflammatory and antioxidant properties, that may exert a role in MCI and/or MetS. There is a considerable body of literature on the subject and our selection was guided mostly by the potential role of these compounds in clinical practice. Also, we did not reported literature about well-known and recognized nutraceuticals in the context of MCI and MetS, such as B group vitamins and iron, and, in contrast, we did not reported nutraceuticals that have not been studies in these two conditions so far. We rather focused on elements presenting heterogeneous results in randomized clinical trials (RCTs), highlighting gaps in the literature and possible critical explanations for any controversial finding. In Table 1, we listed the compounds that we have selected, classified according to their properties, i.e., mostly anti-inflammatory, mostly antioxidant or both.</text><annotation id="151"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="10107" length="3" /><text>MCI</text></annotation><annotation id="152"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="10115" length="4" /><text>MetS</text></annotation><annotation id="153"><infon key="identifier">MESH:D003924</infon><infon key="type">Disease</infon><location offset="10191" length="4" /><text>T2DM</text></annotation><annotation id="154"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="10200" length="8" /><text>dementia</text></annotation><annotation id="155"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="10378" length="3" /><text>MCI</text></annotation><annotation id="156"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="10386" length="4" /><text>MetS</text></annotation><annotation id="157"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="10650" length="12" /><text>inflammatory</text></annotation><annotation id="158"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="10716" length="3" /><text>MCI</text></annotation><annotation id="159"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="10727" length="5" /><text>MetS.</text></annotation><annotation id="160"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="10992" length="3" /><text>MCI</text></annotation><annotation id="161"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="11000" length="4" /><text>MetS</text></annotation><annotation id="162"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="11475" length="12" /><text>inflammatory</text></annotation><annotation id="163"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="11014" length="16" /><text>B group vitamins</text></annotation><annotation id="164"><infon key="identifier">MESH:D007501</infon><infon key="type">Chemical</infon><location offset="11035" length="4" /><text>iron</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>11522</offset><text>The role of vitamin E in MetS</text><annotation id="165"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="11547" length="4" /><text>MetS</text></annotation><annotation id="166"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="11534" length="9" /><text>vitamin E</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>11552</offset><text>Vitamin E is a fat-soluble vitamin found in seeds, nuts and seed oils. Its components, particularly tocotrienols (T3) and tocopherols (TF), are antioxidants, due to their ability to utilize the free hydroxyl group on the chromanol ring to capture free radicals, resulting in a reduction of the glutathione (GSH) redox ratio and plasma lipid peroxidation. Due to the latter properties the effects of vitamin E, particularly T3 and TF, on MetS have been investigated in both animal models and human studies with contradictory results.</text><annotation id="167"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="11989" length="4" /><text>MetS</text></annotation><annotation id="168"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="11552" length="9" /><text>Vitamin E</text></annotation><annotation id="169"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="11612" length="9" /><text>seed oils</text></annotation><annotation id="170"><infon key="identifier">MESH:D024508</infon><infon key="type">Chemical</infon><location offset="11652" length="12" /><text>tocotrienols</text></annotation><annotation id="171"><infon key="identifier">MESH:D014284</infon><infon key="type">Chemical</infon><location offset="11666" length="2" /><text>T3</text></annotation><annotation id="172"><infon key="identifier">MESH:D024505</infon><infon key="type">Chemical</infon><location offset="11674" length="11" /><text>tocopherols</text></annotation><annotation id="173"><infon key="identifier">MESH:C029141</infon><infon key="type">Chemical</infon><location offset="11773" length="9" /><text>chromanol</text></annotation><annotation id="174"><infon key="identifier">MESH:D005609</infon><infon key="type">Chemical</infon><location offset="11799" length="13" /><text>free radicals</text></annotation><annotation id="175"><infon key="identifier">MESH:D005978</infon><infon key="type">Chemical</infon><location offset="11846" length="11" /><text>glutathione</text></annotation><annotation id="176"><infon key="identifier">MESH:D005978</infon><infon key="type">Chemical</infon><location offset="11859" length="3" /><text>GSH</text></annotation><annotation id="177"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="11887" length="5" /><text>lipid</text></annotation><annotation id="178"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="11951" length="9" /><text>vitamin E</text></annotation><annotation id="179"><infon key="identifier">MESH:D014284</infon><infon key="type">Chemical</infon><location offset="11975" length="2" /><text>T3</text></annotation><annotation id="180"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="12043" length="5" /><text>human</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>12085</offset><text>In obese mouse models, Zhao et al. have shown that T3 supplementation leads to accumulation of this vitamin in adipose tissue (AT). Mice were fed a HFD supplemented with 0.05% gammaT3 for 4 weeks and showed a lower accumulation of fat depots in liver, epididymis, and mesentery than MetS-mice without vitamin E supplementation. Concomitantly, mice supplemented with gammaT3 also showed lower levels of fasting glucose, insulin and proinflammatory cytokines, improved glucose tolerance and insulin sensitivity. Zhao et al. also demonstrated in vitro that T3 may exert a positive role in impaired AT by suppressing M1 macrophage differentiation, reducing inflammation and ultimately improving insulin signaling. This evidence has been recently confirmed by Kato Y, who demonstrated that treatment with T3 inhibited white adipose tissue accumulation and elevation of serum cholesterol concentrations in HFD mice.</text><annotation id="181"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="12504" length="7" /><text>insulin</text></annotation><annotation id="182"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="12574" length="7" /><text>insulin</text></annotation><annotation id="183"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="12776" length="7" /><text>insulin</text></annotation><annotation id="184"><infon key="identifier">MESH:D009765</infon><infon key="type">Disease</infon><location offset="12088" length="5" /><text>obese</text></annotation><annotation id="185"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="12368" length="4" /><text>MetS</text></annotation><annotation id="186"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="12738" length="12" /><text>inflammation</text></annotation><annotation id="187"><infon key="identifier">MESH:D014284</infon><infon key="type">Chemical</infon><location offset="12136" length="2" /><text>T3</text></annotation><annotation id="188"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="12261" length="7" /><text>gammaT3</text></annotation><annotation id="189"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="12386" length="9" /><text>vitamin E</text></annotation><annotation id="190"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="12495" length="7" /><text>glucose</text></annotation><annotation id="191"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="12552" length="7" /><text>glucose</text></annotation><annotation id="192"><infon key="identifier">MESH:D014284</infon><infon key="type">Chemical</infon><location offset="12639" length="2" /><text>T3</text></annotation><annotation id="193"><infon key="identifier">MESH:D014284</infon><infon key="type">Chemical</infon><location offset="12885" length="2" /><text>T3</text></annotation><annotation id="194"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="12955" length="11" /><text>cholesterol</text></annotation><annotation id="195"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="12094" length="5" /><text>mouse</text></annotation><annotation id="196"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="12217" length="4" /><text>Mice</text></annotation><annotation id="197"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="12373" length="4" /><text>mice</text></annotation><annotation id="198"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="12428" length="4" /><text>mice</text></annotation><annotation id="199"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="12989" length="4" /><text>mice</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>12995</offset><text>Studies in humans have yielded similar positive results: Manzella et al. observed a positive effect of vitamin E (all-rac-alpha-tocopheryl acetate, 600 mg die for 4 months) supplementation on the cardiac autonomic nervous system in subjects with diabetes, showing an increased antioxidant capacity, significantly decreased plasma catecholamine concentrations, Homeostasis Model Assessment (HOMA) index and HbA1c values. The 4 months length of time was specifically chose by the authors as they considered it the minimum length of time necessary to observe effects of vitamin E supplementation, based on previous groups' studies. Considering oxidative stress as a main effector of the unbalanced sympathetic-parasympathetic tone typically expressed in subjects with diabetes, these results may indicate that vitamin E, which lowers oxidative stress, could exert beneficial effects by improving metabolism, downregulating inflammatory mediators and rebalancing autonomic activity. These results in diabetic models appear to be congruent with an effect of vitamin E on oxidative stress induced by glucotoxicity. Interestingly, there is also indirect evidence that this nutrient plays a role in the preservation of beta-cells. Indeed, Asayama et al. found that rats deficient in vitamin E had diminished insulin secretory reserves, implying that vitamin E level can directly influence pancreatic islet function.</text><annotation id="200"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="14295" length="7" /><text>insulin</text></annotation><annotation id="201"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="13241" length="8" /><text>diabetes</text></annotation><annotation id="202"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="13760" length="8" /><text>diabetes</text></annotation><annotation id="203"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="13915" length="12" /><text>inflammatory</text></annotation><annotation id="204"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="13991" length="8" /><text>diabetic</text></annotation><annotation id="205"><infon key="type">Disease</infon><location offset="14089" length="13" /><text>glucotoxicity</text></annotation><annotation id="206"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="13098" length="9" /><text>vitamin E</text></annotation><annotation id="207"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="13109" length="32" /><text>all-rac-alpha-tocopheryl acetate</text></annotation><annotation id="208"><infon key="identifier">MESH:D002395</infon><infon key="type">Chemical</infon><location offset="13325" length="13" /><text>catecholamine</text></annotation><annotation id="209"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="13562" length="9" /><text>vitamin E</text></annotation><annotation id="210"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="13802" length="9" /><text>vitamin E</text></annotation><annotation id="211"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="14048" length="9" /><text>vitamin E</text></annotation><annotation id="212"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="14270" length="9" /><text>vitamin E</text></annotation><annotation id="213"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="14337" length="9" /><text>vitamin E</text></annotation><annotation id="214"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="13006" length="6" /><text>humans</text></annotation><annotation id="215"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="14252" length="4" /><text>rats</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tbl2.xml</infon><infon key="id">tbl2</infon><infon key="type">table_caption</infon><offset>14410</offset><text>Offers a view of the proposed mechanism by which some nutraceuticals may have a positive impact on MetS and MCI. It summarizes the nutraceuticals selected in this review and offers a schematic representation of possible implications for clinical practice</text><annotation id="216"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="14509" length="4" /><text>MetS</text></annotation><annotation id="217"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="14518" length="3" /><text>MCI</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tbl2.xml</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt; &lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;th&gt;Efficacy&lt;/th&gt;&lt;th&gt;Action&lt;/th&gt;&lt;th&gt;References&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;bold&gt;Vitamin E on MetS&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Reduces levels of proinflammatory cytokines. Reduces M1 macrophage differentiation. Improves glucose tolerance and insulin sensitivity&lt;/td&gt;&lt;td&gt;Zhao et al.&lt;xref rid="bib38" ref-type="bibr"&gt;&lt;sup&gt;38&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Decreases plasma catecholamine concentrations, HOMA index and HbA1c values&lt;/td&gt;&lt;td&gt;Manzella et al.&lt;xref rid="bib40" ref-type="bibr"&gt;&lt;sup&gt;40&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Influences pancreatic islet function&lt;/td&gt;&lt;td&gt;Asayama et al.&lt;xref rid="bib45" ref-type="bibr"&gt;&lt;sup&gt;45&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Positive impact on body weight&lt;/td&gt;&lt;td&gt;Wong et al.&lt;xref rid="bib37" ref-type="bibr"&gt;&lt;sup&gt;37&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Lowering total cholesterol, LDL-C, apoB, TG, FBG, and glucagon levels&lt;/td&gt;&lt;td&gt;Qureshi et al.&lt;xref rid="bib66" ref-type="bibr"&gt;&lt;sup&gt;48&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Anti-hypertensive effect&lt;/td&gt;&lt;td&gt;Aminuddin et al.&lt;xref rid="bib47" ref-type="bibr"&gt;&lt;sup&gt;47&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;Anti-hypertensive effect&lt;/td&gt;&lt;td&gt;Palumbo et al.&lt;xref rid="bib50" ref-type="bibr"&gt;&lt;sup&gt;49&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;bold&gt;Vitamin E on MCI&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Up- or downregulating some genes involved in the pathogenesis of neurodegeneration&lt;/td&gt;&lt;td&gt;Gugliandolo et al.&lt;xref rid="bib54" ref-type="bibr"&gt;&lt;sup&gt;50&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Increases expression of NGF&lt;/td&gt;&lt;td&gt;Rota et al.&lt;xref rid="bib57" ref-type="bibr"&gt;&lt;sup&gt;51&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Delay loss of cognition&lt;/td&gt;&lt;td&gt;Maxwell et al.&lt;xref rid="bib61" ref-type="bibr"&gt;&lt;sup&gt;52&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;Delay loss of cognition&lt;/td&gt;&lt;td&gt;Lloret et al.&lt;xref rid="bib35" ref-type="bibr"&gt;&lt;sup&gt;35&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;Delay loss of cognition&lt;/td&gt;&lt;td&gt;Morris et al.&lt;xref rid="bib62" ref-type="bibr"&gt;&lt;sup&gt;53&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;Delay loss of cognition&lt;/td&gt;&lt;td&gt;Jae et al.&lt;xref rid="bib63" ref-type="bibr"&gt;&lt;sup&gt;54&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;bold&gt;RVS on MetS&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Positive impact on insulin resistance and pancreatic beta-cells by the upregulation of AMP-activated protein kinase&lt;/td&gt;&lt;td&gt;Szkudelski and Szkudelska&lt;xref rid="bib74" ref-type="bibr"&gt;&lt;sup&gt;55&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Upregulation of lipolysis and reduction of lipogenesis in mature adipocytes&lt;/td&gt;&lt;td&gt;Baile et al.&lt;xref rid="bib75" ref-type="bibr"&gt;&lt;sup&gt;56&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Increase endothelial NO bioavailability, modulation of the renin-angiotensin system&lt;/td&gt;&lt;td&gt;Kim et al.&lt;xref rid="bib77" ref-type="bibr"&gt;&lt;sup&gt;57&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Glycemic control and insulin sensitivity, along with a reduction in serum levels of inflammatory markers&lt;/td&gt;&lt;td&gt;Timmers et al.&lt;xref rid="bib90" ref-type="bibr"&gt;&lt;sup&gt;58&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;Increasing HDL-C level, decreasing BMI, TG, and FBG&lt;/td&gt;&lt;td&gt;Asgary et al.&lt;xref rid="bib79" ref-type="bibr"&gt;&lt;sup&gt;59&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;bold&gt;RVS on MCI&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Neuroprotective effect by upregulation of neurogenesis and microvasculature, downregulation of astrocyte hypertrophy and microglial activation in the hippocampus&lt;/td&gt;&lt;td&gt;Zhou et al.&lt;xref rid="bib81" ref-type="bibr"&gt;&lt;sup&gt;60&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;improvement in spatial and emotional learning memory&lt;/td&gt;&lt;td&gt;Gocmez et al.&lt;xref rid="bib92" ref-type="bibr"&gt;&lt;sup&gt;61&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Vasorelaxation by stimulation of K-Ca channel&lt;/td&gt;&lt;td&gt;Li et al.&lt;xref rid="bib84" ref-type="bibr"&gt;&lt;sup&gt;62&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Improvement in verbal memory performance by increasing functional connectivity of the hippocampus and reduction of glucotoxicity in brain tissue&lt;/td&gt;&lt;td&gt;Veronica Witte et al.&lt;xref rid="bib85" ref-type="bibr"&gt;&lt;sup&gt;63&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;bold&gt;PUFAs on MetS&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Effect on BP and inflammatory markers such as IL-6, TNF-alpha, CRP, and IL-1 levels&lt;/td&gt;&lt;td&gt;Wang et al.&lt;xref rid="bib97" ref-type="bibr"&gt;&lt;sup&gt;64&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;FBG control by insulin sensitivity, BP&lt;/td&gt;&lt;td&gt;Liu et al.&lt;xref rid="bib103" ref-type="bibr"&gt;&lt;sup&gt;65&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;FBG control&lt;/td&gt;&lt;td&gt;Belchior et al.&lt;xref rid="bib96" ref-type="bibr"&gt;&lt;sup&gt;66&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Reduction the levels of brain receptor for advanced 14 glycation end-product and plasma TNF-alpha&lt;/td&gt;&lt;td&gt;Y. R. Guo et al.&lt;xref rid="bib119" ref-type="bibr"&gt;&lt;sup&gt;67&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;FBG control&lt;/td&gt;&lt;td&gt;Simao et al.&lt;xref rid="bib99" ref-type="bibr"&gt;&lt;sup&gt;68&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;FBG control&lt;/td&gt;&lt;td&gt;Mori et al.&lt;xref rid="bib100" ref-type="bibr"&gt;&lt;sup&gt;69&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;bold&gt;PUFAs on MCI&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Modulation of the production of inflammatory cytokines. Upregulation of antioxidant proteins, conversion of microglia cell phenotype from macrophage M1 state to an M2 state&lt;/td&gt;&lt;td&gt;Serini and Calviello&lt;xref rid="bib109" ref-type="bibr"&gt;&lt;sup&gt;70&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Impact on MMSE&lt;/td&gt;&lt;td&gt;Freund-Levi et al.&lt;xref rid="bib110" ref-type="bibr"&gt;&lt;sup&gt;71&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Impact on MMSE&lt;/td&gt;&lt;td&gt;Lee, Shahar, Rajab et al.&lt;xref rid="bib112" ref-type="bibr"&gt;&lt;sup&gt;72&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Impact on MMSE&lt;/td&gt;&lt;td&gt;Sinn et al.&lt;xref rid="bib113" ref-type="bibr"&gt;&lt;sup&gt;73&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Impact on MMSE&lt;/td&gt;&lt;td&gt;Mazereeuw et al.&lt;xref rid="bib115" ref-type="bibr"&gt;&lt;sup&gt;74&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;Impact on MMSE&lt;/td&gt;&lt;td&gt;Solfrizzi et al.&lt;xref rid="bib114" ref-type="bibr"&gt;&lt;sup&gt;75&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;bold&gt;Probiotics on MetS&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Improvement in waist circumference and in fasting plasma FBI, lipidic profile&lt;/td&gt;&lt;td&gt;Cicero et al.&lt;xref rid="bib128" ref-type="bibr"&gt;&lt;sup&gt;76&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Significantly lower total cholesterol and LDL-C&lt;/td&gt;&lt;td&gt;Z. Guo et al.&lt;xref rid="bib129" ref-type="bibr"&gt;&lt;sup&gt;77&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;Impact on HDL-C and triglycerides&lt;/td&gt;&lt;td&gt;Z. Guo et al.&lt;xref rid="bib129" ref-type="bibr"&gt;&lt;sup&gt;77&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;bold&gt;Probiotics on MCI&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Improvement in cognitive function associated with lower level of MDA and hs-CRP&lt;/td&gt;&lt;td&gt;Den H et al.&lt;xref rid="bib124" ref-type="bibr"&gt;&lt;sup&gt;78&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Suppressed brain atrophy progression&lt;/td&gt;&lt;td&gt;Asaoka et al.&lt;xref rid="bib137" ref-type="bibr"&gt;&lt;sup&gt;79&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Suppressed the hippocampal expressions of inflammation&lt;/td&gt;&lt;td&gt;Xiao et al.&lt;xref rid="bib138" ref-type="bibr"&gt;&lt;sup&gt;80&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Improvement of cognitive functions as measured with RBANS total score associated with HbA1c reduction&lt;/td&gt;&lt;td&gt;Bernier et al.&lt;xref rid="bib139" ref-type="bibr"&gt;&lt;sup&gt;81&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Potentially useful&lt;/td&gt;&lt;td&gt;Visual memory: gut microbiota, supposed correlation with blood ammonia levels and IL-1 activity&lt;/td&gt;&lt;td&gt;Sakurai et al.&lt;xref rid="bib133" ref-type="bibr"&gt;&lt;sup&gt;82&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Not useful&lt;/td&gt;&lt;td&gt;No differences observed in "immediate memory"&lt;/td&gt;&lt;td&gt;Kobayashi et al.&lt;xref rid="bib141" ref-type="bibr"&gt;&lt;sup&gt;83&lt;/sup&gt;&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt; </infon><infon key="id">tbl2</infon><infon key="type">table</infon><offset>14665</offset><text>Efficacy	Action	References	 	Vitamin E on MetS	 		 	Potentially useful	Reduces levels of proinflammatory cytokines. Reduces M1 macrophage differentiation. Improves glucose tolerance and insulin sensitivity	Zhao et al.	 	Potentially useful	Decreases plasma catecholamine concentrations, HOMA index and HbA1c values	Manzella et al.	 	Potentially useful	Influences pancreatic islet function	Asayama et al.	 	Potentially useful	Positive impact on body weight	Wong et al.	 	Potentially useful	Lowering total cholesterol, LDL-C, apoB, TG, FBG, and glucagon levels	Qureshi et al.	 	Potentially useful	Anti-hypertensive effect	Aminuddin et al.	 	Not useful	Anti-hypertensive effect	Palumbo et al.	 		 	Vitamin E on MCI	 		 	Potentially useful	Up- or downregulating some genes involved in the pathogenesis of neurodegeneration	Gugliandolo et al.	 	Potentially useful	Increases expression of NGF	Rota et al.	 	Potentially useful	Delay loss of cognition	Maxwell et al.	 	Not useful	Delay loss of cognition	Lloret et al.	 	Not useful	Delay loss of cognition	Morris et al.	 	Not useful	Delay loss of cognition	Jae et al.	 		 	RVS on MetS	 		 	Potentially useful	Positive impact on insulin resistance and pancreatic beta-cells by the upregulation of AMP-activated protein kinase	Szkudelski and Szkudelska	 	Potentially useful	Upregulation of lipolysis and reduction of lipogenesis in mature adipocytes	Baile et al.	 	Potentially useful	Increase endothelial NO bioavailability, modulation of the renin-angiotensin system	Kim et al.	 	Potentially useful	Glycemic control and insulin sensitivity, along with a reduction in serum levels of inflammatory markers	Timmers et al.	 	Not useful	Increasing HDL-C level, decreasing BMI, TG, and FBG	Asgary et al.	 		 	RVS on MCI	 		 	Potentially useful	Neuroprotective effect by upregulation of neurogenesis and microvasculature, downregulation of astrocyte hypertrophy and microglial activation in the hippocampus	Zhou et al.	 	Potentially useful	improvement in spatial and emotional learning memory	Gocmez et al.	 	Potentially useful	Vasorelaxation by stimulation of K-Ca channel	Li et al.	 	Potentially useful	Improvement in verbal memory performance by increasing functional connectivity of the hippocampus and reduction of glucotoxicity in brain tissue	Veronica Witte et al.	 		 	PUFAs on MetS	 		 	Potentially useful	Effect on BP and inflammatory markers such as IL-6, TNF-alpha, CRP, and IL-1 levels	Wang et al.	 	Potentially useful	FBG control by insulin sensitivity, BP	Liu et al.	 	Potentially useful	FBG control	Belchior et al.	 	Potentially useful	Reduction the levels of brain receptor for advanced 14 glycation end-product and plasma TNF-alpha	Y. R. Guo et al.	 	Not useful	FBG control	Simao et al.	 	Not useful	FBG control	Mori et al.	 		 	PUFAs on MCI	 		 	Potentially useful	Modulation of the production of inflammatory cytokines. Upregulation of antioxidant proteins, conversion of microglia cell phenotype from macrophage M1 state to an M2 state	Serini and Calviello	 	Potentially useful	Impact on MMSE	Freund-Levi et al.	 	Potentially useful	Impact on MMSE	Lee, Shahar, Rajab et al.	 	Potentially useful	Impact on MMSE	Sinn et al.	 	Potentially useful	Impact on MMSE	Mazereeuw et al.	 	Not useful	Impact on MMSE	Solfrizzi et al.	 		 	Probiotics on MetS	 		 	Potentially useful	Improvement in waist circumference and in fasting plasma FBI, lipidic profile	Cicero et al.	 	Potentially useful	Significantly lower total cholesterol and LDL-C	Z. Guo et al.	 	Not useful	Impact on HDL-C and triglycerides	Z. Guo et al.	 		 	Probiotics on MCI	 		 	Potentially useful	Improvement in cognitive function associated with lower level of MDA and hs-CRP	Den H et al.	 	Potentially useful	Suppressed brain atrophy progression	Asaoka et al.	 	Potentially useful	Suppressed the hippocampal expressions of inflammation	Xiao et al.	 	Potentially useful	Improvement of cognitive functions as measured with RBANS total score associated with HbA1c reduction	Bernier et al.	 	Potentially useful	Visual memory: gut microbiota, supposed correlation with blood ammonia levels and IL-1 activity	Sakurai et al.	 	Not useful	No differences observed in "immediate memory"	Kobayashi et al.	 	</text><annotation id="218"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="14851" length="7" /><text>insulin</text></annotation><annotation id="219"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="15833" length="7" /><text>insulin</text></annotation><annotation id="220"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="16224" length="7" /><text>insulin</text></annotation><annotation id="221"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="17144" length="7" /><text>insulin</text></annotation><annotation id="222"><infon key="identifier">310738</infon><infon key="type">Gene</infon><location offset="15547" length="3" /><text>NGF</text></annotation><annotation id="223"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="18345" length="3" /><text>CRP</text></annotation><annotation id="224"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="17075" length="3" /><text>CRP</text></annotation><annotation id="225"><infon key="identifier">24835</infon><infon key="type">Gene</infon><location offset="17337" length="9" /><text>TNF-alpha</text></annotation><annotation id="226"><infon key="identifier">24835</infon><infon key="type">Gene</infon><location offset="17064" length="9" /><text>TNF-alpha</text></annotation><annotation id="227"><infon key="identifier">100523371</infon><infon key="type">Gene</infon><location offset="15188" length="4" /><text>apoB</text></annotation><annotation id="228"><infon key="identifier">3552</infon><infon key="type">Gene</infon><location offset="18763" length="4" /><text>IL-1</text></annotation><annotation id="229"><infon key="identifier">3552</infon><infon key="type">Gene</infon><location offset="17084" length="4" /><text>IL-1</text></annotation><annotation id="230"><infon key="identifier">5972</infon><infon key="type">Gene</infon><location offset="16146" length="5" /><text>renin</text></annotation><annotation id="231"><infon key="identifier">397595</infon><infon key="type">Gene</infon><location offset="15207" length="8" /><text>glucagon</text></annotation><annotation id="232"><infon key="identifier">3569</infon><infon key="type">Gene</infon><location offset="17058" length="4" /><text>IL-6</text></annotation><annotation id="233"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="14829" length="7" /><text>glucose</text></annotation></passage><passage><infon key="section_type">TABLE</infon><infon key="file">tbl2.xml</infon><infon key="id">tbl2</infon><infon key="type">table_footnote</infon><offset>18911</offset><text>BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; FBG, fasting blood glucose; FBI, fasting blood insulin; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; IL-1, interleukin 1; IL-6, interleukin 6; LDL-C, low-density lipoprotein; NGF, the nerve growth factor; NO, nitric oxide; TNF-alpha, tumor necrosis factor alpha.</text><annotation id="234"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="18953" length="3" /><text>CRP</text></annotation><annotation id="235"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="18958" length="18" /><text>C-reactive protein</text></annotation><annotation id="236"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="19025" length="7" /><text>insulin</text></annotation><annotation id="237"><infon key="identifier">3552</infon><infon key="type">Gene</infon><location offset="19168" length="4" /><text>IL-1</text></annotation><annotation id="238"><infon key="identifier">3552</infon><infon key="type">Gene</infon><location offset="19174" length="13" /><text>interleukin 1</text></annotation><annotation id="239"><infon key="identifier">3569</infon><infon key="type">Gene</infon><location offset="19189" length="4" /><text>IL-6</text></annotation><annotation id="240"><infon key="identifier">3569</infon><infon key="type">Gene</infon><location offset="19195" length="13" /><text>interleukin 6</text></annotation><annotation id="241"><infon key="identifier">310738</infon><infon key="type">Gene</infon><location offset="19242" length="3" /><text>NGF</text></annotation><annotation id="242"><infon key="identifier">310738</infon><infon key="type">Gene</infon><location offset="19251" length="19" /><text>nerve growth factor</text></annotation><annotation id="243"><infon key="identifier">24835</infon><infon key="type">Gene</infon><location offset="19290" length="9" /><text>TNF-alpha</text></annotation><annotation id="244"><infon key="identifier">7124</infon><infon key="type">Gene</infon><location offset="19301" length="27" /><text>tumor necrosis factor alpha</text></annotation><annotation id="246"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="19148" length="18" /><text>insulin resistance</text></annotation><annotation id="247"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="18997" length="7" /><text>glucose</text></annotation><annotation id="248"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="19062" length="5" /><text>HDL-C</text></annotation><annotation id="249"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="19210" length="5" /><text>LDL-C</text></annotation><annotation id="250"><infon key="identifier">MESH:D009569</infon><infon key="type">Chemical</infon><location offset="19272" length="2" /><text>NO</text></annotation><annotation id="251"><infon key="identifier">MESH:D009569</infon><infon key="type">Chemical</infon><location offset="19276" length="12" /><text>nitric oxide</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>19330</offset><text>Vitamin E has also been investigate-d in hypertension. Supplementation with tocotrienol-rich fraction (TRF) was found to reduce the incidence of pregnancy-induced hypertension. In particular, Aminuddin et al. showed an association between vitamin E (TRF 100 mg daily in super olein for a six month period minimum, beginning from 12 to 16 gestational weeks until delivery) supplementation and a reduction in the incidence of preeclampsia and maternal hypertension, after controlling for other confounders such as age and maternal weight (Table 2).</text><annotation id="252"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="19371" length="12" /><text>hypertension</text></annotation><annotation id="253"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="19493" length="12" /><text>hypertension</text></annotation><annotation id="254"><infon key="identifier">MESH:D011225</infon><infon key="type">Disease</infon><location offset="19754" length="12" /><text>preeclampsia</text></annotation><annotation id="255"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="19780" length="12" /><text>hypertension</text></annotation><annotation id="256"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="19330" length="9" /><text>Vitamin E</text></annotation><annotation id="257"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="19354" length="13" /><text>investigate-d</text></annotation><annotation id="258"><infon key="identifier">MESH:D024508</infon><infon key="type">Chemical</infon><location offset="19406" length="11" /><text>tocotrienol</text></annotation><annotation id="259"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="19569" length="9" /><text>vitamin E</text></annotation><annotation id="260"><infon key="identifier">MESH:C005953</infon><infon key="type">Chemical</infon><location offset="19606" length="5" /><text>olein</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>19880</offset><text>Other studies aiming to assess the effect of antioxidant supplementation on hypertension, have found a hypotensive effect. Following the same rationale, many RCTs have tried to demonstrate a beneficial effect of vitamin E on hypertension, with conflicting results. Palumbo et al. explored the effect of vitamin E (300 mg once a day for 12 weeks), on systolic and diastolic blood pressure in treated hypertensive patients. The authors found no clinically relevant effect on blood pressure in hypertensive patients already in treatment. The same results were obtained in a study on 89 randomized patients treated with vitamin E 1,800 international units (IU) daily or placebo for a 12 month-period (Table 2).</text><annotation id="261"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="19956" length="12" /><text>hypertension</text></annotation><annotation id="262"><infon key="identifier">MESH:D007022</infon><infon key="type">Disease</infon><location offset="19983" length="11" /><text>hypotensive</text></annotation><annotation id="263"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="20105" length="12" /><text>hypertension</text></annotation><annotation id="264"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="20279" length="12" /><text>hypertensive</text></annotation><annotation id="265"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="20371" length="12" /><text>hypertensive</text></annotation><annotation id="266"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="20092" length="9" /><text>vitamin E</text></annotation><annotation id="267"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="20183" length="9" /><text>vitamin E</text></annotation><annotation id="268"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="20496" length="9" /><text>vitamin E</text></annotation><annotation id="269"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="20292" length="8" /><text>patients</text></annotation><annotation id="270"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="20384" length="8" /><text>patients</text></annotation><annotation id="271"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="20474" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>20592</offset><text>Despite these contradictory results, vitamin E has proven overall to have a positive impact on the oxidative stress and systemic inflammation generated by metabolic conditions such as MetS. However, more research is required to assess the exact target of this nutraceutical, in order to standardize it as a useful tool for MetS treatment.</text><annotation id="272"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="20721" length="12" /><text>inflammation</text></annotation><annotation id="273"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="20776" length="5" /><text>MetS.</text></annotation><annotation id="274"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="20915" length="4" /><text>MetS</text></annotation><annotation id="275"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="20629" length="9" /><text>vitamin E</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>20931</offset><text>The role of vitamin E in MCI</text><annotation id="276"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="20956" length="3" /><text>MCI</text></annotation><annotation id="277"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="20943" length="9" /><text>vitamin E</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>20960</offset><text>As a correlation has been reported between AD and MCI and lower levels of tocopherol, many studies have investigated the antioxidant properties of vitamin E and its major elements for a possible role in lowering or delaying the process of intellectual deterioration in MCI with conflicting results.</text><annotation id="278"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="21003" length="2" /><text>AD</text></annotation><annotation id="279"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="21010" length="3" /><text>MCI</text></annotation><annotation id="280"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="21199" length="26" /><text>intellectual deterioration</text></annotation><annotation id="281"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="21229" length="3" /><text>MCI</text></annotation><annotation id="282"><infon key="identifier">MESH:D024505</infon><infon key="type">Chemical</infon><location offset="21034" length="10" /><text>tocopherol</text></annotation><annotation id="283"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="21107" length="9" /><text>vitamin E</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>21259</offset><text>Studies exploring the role of vitamin E on cognitive impairment in both animal models and human patients found it useful not only for its antioxidant capacity, but also because it has an up- or downregulating effect on some genes involved in the pathogenesis of neurodegeneration in AD. Indeed, vitamin E deficiency has been shown to induce an increase in cerebellar oxidative stress, as suggested by the high levels of protein nitrosylation found in a Ttpa-/- knock-out mouse model. The Ttpa gene encodes for a protein responsible for the selective excretion of RRR-alpha-tocopherol from hepatocytes to circulating lipoproteins that transfer the vitamin to non-hepatic tissues, such as neurological tissue. Subjects carrying loss-of-function mutations in the Ttpa gene develop ataxia associated with extremely low vitamin E levels (less than 2 muM) compared with the normal range of 18-36 muM. Furthermore, a significant expression of Ttp was demonstrated in the brain as well as in the placenta, suggesting that this protein provides additional protection to vulnerable tissues.</text><annotation id="284"><infon key="identifier">50500</infon><infon key="type">Gene</infon><location offset="21712" length="4" /><text>Ttpa</text></annotation><annotation id="285"><infon key="identifier">7274</infon><infon key="type">Gene</infon><location offset="21747" length="4" /><text>Ttpa</text></annotation><annotation id="286"><infon key="identifier">7274</infon><infon key="type">Gene</infon><location offset="22019" length="4" /><text>Ttpa</text></annotation><annotation id="287"><infon key="identifier">23677</infon><infon key="type">Gene</infon><location offset="22195" length="3" /><text>Ttp</text></annotation><annotation id="288"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="21302" length="20" /><text>cognitive impairment</text></annotation><annotation id="289"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="21521" length="17" /><text>neurodegeneration</text></annotation><annotation id="290"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="21542" length="2" /><text>AD</text></annotation><annotation id="291"><infon key="identifier">MESH:D001259</infon><infon key="type">Disease</infon><location offset="22037" length="6" /><text>ataxia</text></annotation><annotation id="292"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="21289" length="9" /><text>vitamin E</text></annotation><annotation id="293"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="21554" length="9" /><text>vitamin E</text></annotation><annotation id="294"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="21822" length="20" /><text>RRR-alpha-tocopherol</text></annotation><annotation id="295"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="22074" length="9" /><text>vitamin E</text></annotation><annotation id="296"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21349" length="5" /><text>human</text></annotation><annotation id="297"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="21355" length="8" /><text>patients</text></annotation><annotation id="298"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="21730" length="5" /><text>mouse</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>22345</offset><text>Moreover, comparing rats receiving a diet without vitamin E with rats fed a standard diet, Rota et al. found that the nerve growth factor (NGF), a neurotrophin that promotes neuron survival, is less expressed in rats without vitamin E supplementation, compared with models supplemented with 60 mg/kg for a period of 9 months. In contrast, studies investigating the efficacy of vitamin E supplements to treat MCI and AD have found no evidence that this intervention prevents progression of dementia or improves overall cognitive function.</text><annotation id="299"><infon key="identifier">310738</infon><infon key="type">Gene</infon><location offset="22463" length="19" /><text>nerve growth factor</text></annotation><annotation id="300"><infon key="identifier">310738</infon><infon key="type">Gene</infon><location offset="22484" length="3" /><text>NGF</text></annotation><annotation id="301"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="22753" length="3" /><text>MCI</text></annotation><annotation id="302"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="22761" length="2" /><text>AD</text></annotation><annotation id="303"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="22834" length="8" /><text>dementia</text></annotation><annotation id="304"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="22395" length="9" /><text>vitamin E</text></annotation><annotation id="305"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="22570" length="9" /><text>vitamin E</text></annotation><annotation id="306"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="22722" length="9" /><text>vitamin E</text></annotation><annotation id="307"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="22365" length="4" /><text>rats</text></annotation><annotation id="308"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="22410" length="4" /><text>rats</text></annotation><annotation id="309"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="22557" length="4" /><text>rats</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>22886</offset><text>Some authors have explained the contradictory results on the efficacy of vitamin E in improving cognitive function with the interesting concept of "the vitamin E paradox": in a prospective, double blind, placebo-controlled study with 57 AD subjects, 800 IU of vitamin E supplementation per day for six months led to an acceleration in mental deterioration. Studies have found a possible explanation for these results in identifying two sub populations who react in opposite ways to vitamin E supplementation: subjects in whom vitamin E acts as an antioxidant, respond positively to treatment, especially in terms of prevention of functional decline, while in the other subset of patients, who do not respond to treatment with this vitamin, there is no improvement in oxidant level, with a worsening in cognitive function (Table 2). However, the clinical traits that distinguish the different phenotypes remain as yet unknown.</text><annotation id="310"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="23123" length="2" /><text>AD</text></annotation><annotation id="311"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="23221" length="20" /><text>mental deterioration</text></annotation><annotation id="312"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="22959" length="9" /><text>vitamin E</text></annotation><annotation id="313"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="23038" length="9" /><text>vitamin E</text></annotation><annotation id="314"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="23146" length="9" /><text>vitamin E</text></annotation><annotation id="315"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="23368" length="9" /><text>vitamin E</text></annotation><annotation id="316"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="23412" length="9" /><text>vitamin E</text></annotation><annotation id="317"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="23565" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>23817</offset><text>The role of vitamin E in the prevention of MCI/MetS</text><annotation id="318"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="23860" length="3" /><text>MCI</text></annotation><annotation id="319"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="23864" length="4" /><text>MetS</text></annotation><annotation id="320"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="23829" length="9" /><text>vitamin E</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>23869</offset><text>A limited number of studies have examined the effects of vitamin E on cognitive function in healthy populations, with inconclusive and conflicting results. Maxwell et al. using data from the Canadian Study of Health and Aging (CSHA), reported that supplemental use of antioxidant vitamins, including vitamin E, reduced the risk of significant cognitive decline and the incidence of vascular dementia.</text><annotation id="321"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="24212" length="17" /><text>cognitive decline</text></annotation><annotation id="322"><infon key="identifier">MESH:D015140</infon><infon key="type">Disease</infon><location offset="24251" length="17" /><text>vascular dementia</text></annotation><annotation id="323"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="23926" length="9" /><text>vitamin E</text></annotation><annotation id="324"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="24137" length="20" /><text>antioxidant vitamins</text></annotation><annotation id="325"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="24169" length="9" /><text>vitamin E</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>24271</offset><text>The prospective Rush Memory and Aging Project showed an inverse association between levels of gamma-tocopherol and amyloid loads along with neurofibrillary tangle pathology. However, the trial failed to provide evidence of a statistical interaction between clinical cognitive impairments and tocopherol levels. On the contrary, the Women's Health Study, with 6,377 women over 65 years, observed no significant effect of long term use of vitamin E on cognitive function. In a phenytoin-induced cognitive impairment rat model, Nagib MM and colleagues demonstrated that alpha tocopherol supplementation alleviates the cognitive impairment suppressing oxidative damage. Also, in old rats, vitamin E have proved to improve cognitive and motor abilities, through increasing the synthesis rate of monoaminergic neurotransmitters.</text><annotation id="326"><infon key="identifier">MESH:C000718787</infon><infon key="type">Disease</infon><location offset="24386" length="7" /><text>amyloid</text></annotation><annotation id="327"><infon key="identifier">MESH:D055956</infon><infon key="type">Disease</infon><location offset="24411" length="22" /><text>neurofibrillary tangle</text></annotation><annotation id="328"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="24537" length="21" /><text>cognitive impairments</text></annotation><annotation id="329"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="24764" length="20" /><text>cognitive impairment</text></annotation><annotation id="330"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="24886" length="20" /><text>cognitive impairment</text></annotation><annotation id="331"><infon key="identifier">MESH:D024504</infon><infon key="type">Chemical</infon><location offset="24365" length="16" /><text>gamma-tocopherol</text></annotation><annotation id="332"><infon key="identifier">MESH:D024505</infon><infon key="type">Chemical</infon><location offset="24563" length="10" /><text>tocopherol</text></annotation><annotation id="333"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="24708" length="9" /><text>vitamin E</text></annotation><annotation id="334"><infon key="identifier">MESH:D010672</infon><infon key="type">Chemical</infon><location offset="24746" length="9" /><text>phenytoin</text></annotation><annotation id="335"><infon key="identifier">MESH:D024502</infon><infon key="type">Chemical</infon><location offset="24838" length="16" /><text>alpha tocopherol</text></annotation><annotation id="336"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="24956" length="9" /><text>vitamin E</text></annotation><annotation id="337"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="25061" length="31" /><text>monoaminergic neurotransmitters</text></annotation><annotation id="338"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="24603" length="5" /><text>Women</text></annotation><annotation id="339"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="24636" length="5" /><text>women</text></annotation><annotation id="340"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="24785" length="3" /><text>rat</text></annotation><annotation id="341"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="24950" length="4" /><text>rats</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>25094</offset><text>This finding suggests the possible preventive function of vitamin E on cognitive impairment; however, more RCTs with selective use of vitamin E are required to confirm this.</text><annotation id="342"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="25165" length="20" /><text>cognitive impairment</text></annotation><annotation id="343"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="25152" length="9" /><text>vitamin E</text></annotation><annotation id="344"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="25228" length="9" /><text>vitamin E</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>25268</offset><text>Vitamin E has also been investigated for its anti-hyperlipidemic properties, through post-transcriptional mechanisms. In healthy animal models, studies have shown a reduction in cholesterol and a significant effect in decreasing body weight. Furthermore, Qureshi et al. showed efficacy of 50 mg alpha-tocopherol per day for 35 days (compared with lovastatin) in lowering total cholesterol, LDL-C, apoB, triglycerides (TG), glucose, and glucagon levels in a hereditary hypercholesterolemic swine model.</text><annotation id="345"><infon key="identifier">100523371</infon><infon key="type">Gene</infon><location offset="25665" length="4" /><text>apoB</text></annotation><annotation id="346"><infon key="identifier">397595</infon><infon key="type">Gene</infon><location offset="25704" length="8" /><text>glucagon</text></annotation><annotation id="347"><infon key="type">Disease</infon><location offset="25318" length="14" /><text>hyperlipidemic</text></annotation><annotation id="348"><infon key="identifier">MESH:D006938</infon><infon key="type">Disease</infon><location offset="25736" length="20" /><text>hypercholesterolemic</text></annotation><annotation id="349"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="25268" length="9" /><text>Vitamin E</text></annotation><annotation id="350"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="25446" length="11" /><text>cholesterol</text></annotation><annotation id="351"><infon key="identifier">MESH:D024502</infon><infon key="type">Chemical</infon><location offset="25563" length="16" /><text>alpha-tocopherol</text></annotation><annotation id="352"><infon key="identifier">MESH:D008148</infon><infon key="type">Chemical</infon><location offset="25615" length="10" /><text>lovastatin</text></annotation><annotation id="353"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="25645" length="11" /><text>cholesterol</text></annotation><annotation id="354"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="25658" length="5" /><text>LDL-C</text></annotation><annotation id="355"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="25671" length="13" /><text>triglycerides</text></annotation><annotation id="356"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="25686" length="2" /><text>TG</text></annotation><annotation id="357"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="25691" length="7" /><text>glucose</text></annotation><annotation id="358"><infon key="identifier">9823</infon><infon key="type">Species</infon><location offset="25757" length="5" /><text>swine</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>25775</offset><text>Vitamin E has also been reported to have an inverse association with non-alcoholic fatty liver disease (NAFLD) in humans. Qi et al. conducted a cross-sectional study with data from the National Health and Nutrition Examination Survey (2017-2020), and after adjusting results for confounders, observed that dietary intake of vitamin E had a protective role against NAFLD (Table 2).</text><annotation id="359"><infon key="identifier">MESH:D065626</infon><infon key="type">Disease</infon><location offset="25844" length="33" /><text>non-alcoholic fatty liver disease</text></annotation><annotation id="360"><infon key="identifier">MESH:D065626</infon><infon key="type">Disease</infon><location offset="25879" length="5" /><text>NAFLD</text></annotation><annotation id="361"><infon key="identifier">MESH:D065626</infon><infon key="type">Disease</infon><location offset="26139" length="5" /><text>NAFLD</text></annotation><annotation id="362"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="25775" length="9" /><text>Vitamin E</text></annotation><annotation id="363"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="26099" length="9" /><text>vitamin E</text></annotation><annotation id="364"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="25889" length="6" /><text>humans</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>26160</offset><text>Kato Y and colleagues have demonstrated:in HFD mice:that T3 treatment inhibits body weight gain and attenuates brain oxidation. It seems that vitamin E can delay but not arrest the body weight gain associated to a hypercaloric diet and it can prevent brain oxidation via antioxidative effect as well as by upregulating antioxidative defense system. Later, the same group has demonstrated that high fat high sucrose diet in mice decreases their learning ability and that T3 treatment prevents its change. All this evidence show how vitamin E could prevent first steps of obesity-related cognitive impairment.</text><annotation id="365"><infon key="identifier">MESH:D015430</infon><infon key="type">Disease</infon><location offset="26244" length="11" /><text>weight gain</text></annotation><annotation id="366"><infon key="identifier">MESH:D015430</infon><infon key="type">Disease</infon><location offset="26346" length="11" /><text>weight gain</text></annotation><annotation id="367"><infon key="identifier">MESH:D009765</infon><infon key="type">Disease</infon><location offset="26730" length="7" /><text>obesity</text></annotation><annotation id="368"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="26746" length="20" /><text>cognitive impairment</text></annotation><annotation id="369"><infon key="identifier">MESH:D014284</infon><infon key="type">Chemical</infon><location offset="26217" length="2" /><text>T3</text></annotation><annotation id="370"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="26302" length="9" /><text>vitamin E</text></annotation><annotation id="371"><infon key="identifier">MESH:D013395</infon><infon key="type">Chemical</infon><location offset="26567" length="7" /><text>sucrose</text></annotation><annotation id="372"><infon key="identifier">MESH:D014284</infon><infon key="type">Chemical</infon><location offset="26630" length="2" /><text>T3</text></annotation><annotation id="373"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="26691" length="9" /><text>vitamin E</text></annotation><annotation id="374"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="26207" length="4" /><text>mice</text></annotation><annotation id="375"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="26583" length="4" /><text>mice</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>26772</offset><text>These findings could suggest a potential role of vitamin E in the prevention of MetS, as some studies have highlighted the impact of this nutrient on all syndrome-related comorbidities.</text><annotation id="376"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="26852" length="4" /><text>MetS</text></annotation><annotation id="377"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="26821" length="9" /><text>vitamin E</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>26958</offset><text>The role of resveratrol in MetS</text><annotation id="378"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="26985" length="4" /><text>MetS</text></annotation><annotation id="379"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="26970" length="11" /><text>resveratrol</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>26990</offset><text>Resveratrol (RSV), known also as 3,5,4V-hydroxystilbene, is a natural polyphenol produced by plants in response to environmental stress. As all polyphenols, it derives from phenylalanine and is composed of an aromatic ring with a reactive hydroxyl group. It is a popular nutraceutical, known especially for being responsible for the beneficial health effects of wine, and identified as the main player in the questionable "French paradox." Foods containing this extract, such as cocoa, green tea and wine, are derived from plant sources.</text><annotation id="380"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="26990" length="11" /><text>Resveratrol</text></annotation><annotation id="381"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="27003" length="3" /><text>RSV</text></annotation><annotation id="382"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="27023" length="22" /><text>3,5,4V-hydroxystilbene</text></annotation><annotation id="383"><infon key="identifier">MESH:D059808</infon><infon key="type">Chemical</infon><location offset="27060" length="10" /><text>polyphenol</text></annotation><annotation id="384"><infon key="identifier">MESH:D059808</infon><infon key="type">Chemical</infon><location offset="27134" length="11" /><text>polyphenols</text></annotation><annotation id="385"><infon key="identifier">MESH:D010649</infon><infon key="type">Chemical</infon><location offset="27163" length="13" /><text>phenylalanine</text></annotation><annotation id="386"><infon key="identifier">3641</infon><infon key="type">Species</infon><location offset="27469" length="5" /><text>cocoa</text></annotation><annotation id="387"><infon key="type">Species</infon><location offset="27476" length="9" /><text>green tea</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>27532</offset><text>Scientific research has investigated this element for its involvement in various pathways, and specifically for its ability in targeting antioxidant and anti-inflammatory mediators.</text><annotation id="388"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="27690" length="12" /><text>inflammatory</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>27714</offset><text>Due to its pleiotropic effect RSV has a substantial impact on metabolism, as evidenced in animal and human studies. It has been shown to improve glucose homeostasis and insulin secretion, playing a role in the modulation of IR, and protecting pancreatic beta-cells mainly by upregulating adenosine monophosphate (AMP)-activated protein kinase in various tissues of diabetic subjects.</text><annotation id="389"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="27883" length="7" /><text>insulin</text></annotation><annotation id="390"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="28079" length="8" /><text>diabetic</text></annotation><annotation id="391"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="27744" length="3" /><text>RSV</text></annotation><annotation id="392"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="27859" length="7" /><text>glucose</text></annotation><annotation id="393"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="27815" length="5" /><text>human</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>28098</offset><text>RSV has been shown to improve body fat accumulation and energy balance. In both white and brown adipose tissue it actively decreases lipid accumulation by modulating different pathways resulting in upregulation of lipolysis and reduction of lipogenesis in mature adipocytes.</text><annotation id="394"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="28098" length="3" /><text>RSV</text></annotation><annotation id="395"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="28231" length="5" /><text>lipid</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>28373</offset><text>Considering the crucial role played by oxidative stress in the development of vascular dysfunction triggered by hypertension, RSV has been shown to increase endothelial nitric oxide (NO) bioavailability by enhancing its transduction pathway. Kim et al. have shown a positive effect of a mixture of RSV 40 mg/kg for 6 months on vascular dynamics, and thus on hypertension, through the modulation of the renin-angiotensin system. However, whether RSV has an effect on lowering blood pressure or not, remains debatable.</text><annotation id="396"><infon key="identifier">5972</infon><infon key="type">Gene</infon><location offset="28775" length="5" /><text>renin</text></annotation><annotation id="397"><infon key="identifier">MESH:D002561</infon><infon key="type">Disease</infon><location offset="28451" length="20" /><text>vascular dysfunction</text></annotation><annotation id="398"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="28485" length="12" /><text>hypertension</text></annotation><annotation id="399"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="28731" length="12" /><text>hypertension</text></annotation><annotation id="400"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="28499" length="3" /><text>RSV</text></annotation><annotation id="401"><infon key="identifier">MESH:D009569</infon><infon key="type">Chemical</infon><location offset="28542" length="12" /><text>nitric oxide</text></annotation><annotation id="402"><infon key="identifier">MESH:D009569</infon><infon key="type">Chemical</infon><location offset="28556" length="2" /><text>NO</text></annotation><annotation id="403"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="28671" length="3" /><text>RSV</text></annotation><annotation id="404"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="28818" length="3" /><text>RSV</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>28894</offset><text>Asgary et al. carried out a meta-analysis to determine the association between resveratrol intake and metabolic parameters in patients with MetS. Results were encouraging and consistent with a positive impact of nutraceuticals on MetS. Out of 16 studies analyzed, (10 on humans and 6 on animal models), supplementation with RSV at the dosage of &gt;500 mg proved to be effective in increasing high-density lipoprotein (HDL) levels, and decreasing BMI, TG, and glucose levels (Table 2).</text><annotation id="405"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="29034" length="5" /><text>MetS.</text></annotation><annotation id="406"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="29124" length="5" /><text>MetS.</text></annotation><annotation id="407"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="28973" length="11" /><text>resveratrol</text></annotation><annotation id="408"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="29218" length="3" /><text>RSV</text></annotation><annotation id="409"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="29343" length="2" /><text>TG</text></annotation><annotation id="410"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="29351" length="7" /><text>glucose</text></annotation><annotation id="411"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="29020" length="8" /><text>patients</text></annotation><annotation id="412"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="29165" length="6" /><text>humans</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>29380</offset><text>Due to its impact on all MetS domains this nutrient is therefore an excellent candidate for MetS treatment and prevention.</text><annotation id="413"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="29405" length="4" /><text>MetS</text></annotation><annotation id="414"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="29472" length="4" /><text>MetS</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>29503</offset><text>The role of RSV on MCI</text><annotation id="415"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="29522" length="3" /><text>MCI</text></annotation><annotation id="416"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="29515" length="3" /><text>RSV</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>29526</offset><text>There is an ample body of literature documenting the beneficial effects of RSV on cognitive decline. In animal models, RSV treatment improved memory and learning ability compared with controls. Resveratrol also improved net neurogenesis and microvasculature, decreased astrocyte hypertrophy, and microglial activation in the hippocampus, demonstrating an effective neuroprotection. In vivo experiments conducted by Gocmez et al. on both normal aging and cognitively impaired animal models, showed that RSV 50 mg/kg/day for 12 weeks could reverse cognitive impairment via inhibition of the production of inflammatory cytokines resulting in an improvement in spatial and emotional learning memory.</text><annotation id="417"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="29608" length="17" /><text>cognitive decline</text></annotation><annotation id="418"><infon key="identifier">MESH:D006984</infon><infon key="type">Disease</infon><location offset="29805" length="11" /><text>hypertrophy</text></annotation><annotation id="419"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="29980" length="20" /><text>cognitively impaired</text></annotation><annotation id="420"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="30072" length="20" /><text>cognitive impairment</text></annotation><annotation id="421"><infon key="identifier">MESH:D000080424</infon><infon key="type">Disease</infon><location offset="30129" length="22" /><text>inflammatory cytokines</text></annotation><annotation id="422"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="29601" length="3" /><text>RSV</text></annotation><annotation id="423"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="29645" length="3" /><text>RSV</text></annotation><annotation id="424"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="29720" length="11" /><text>Resveratrol</text></annotation><annotation id="425"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="30028" length="3" /><text>RSV</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>30226</offset><text>The most studied mechanism through which RSV is believed to provide neuroprotection is its ability to reduce some proinflammation pathways, through the inhibition of the cyclooxygenase-2 (COX-2), 5-lipoxygenase, and nuclear factor-kappaB. It is also associated with the upregulation of interleukin (IL)-10 and the downregulation of interferon-gamma and IL-17. Both anti-inflammatory and antioxidant effects of this natural component represent an attractive alternative in the treatment of neurodegenerative diseases. Moreover, it has been shown that in human endothelial cells, resveratrol induced vasorelaxation by stimulation of K-Ca channel that could be the mechanism responsible for its preventive role in CVD and their consequences.</text><annotation id="426"><infon key="identifier">5743</infon><infon key="type">Gene</infon><location offset="30396" length="16" /><text>cyclooxygenase-2</text></annotation><annotation id="427"><infon key="identifier">4513</infon><infon key="type">Gene</infon><location offset="30414" length="5" /><text>COX-2</text></annotation><annotation id="428"><infon key="identifier">240</infon><infon key="type">Gene</infon><location offset="30422" length="14" /><text>5-lipoxygenase</text></annotation><annotation id="429"><infon key="identifier">3586</infon><infon key="type">Gene</infon><location offset="30512" length="19" /><text>interleukin (IL)-10</text></annotation><annotation id="430"><infon key="identifier">3458</infon><infon key="type">Gene</infon><location offset="30558" length="16" /><text>interferon-gamma</text></annotation><annotation id="431"><infon key="identifier">3605</infon><infon key="type">Gene</infon><location offset="30579" length="5" /><text>IL-17</text></annotation><annotation id="432"><infon key="type">Disease</infon><location offset="30340" length="15" /><text>proinflammation</text></annotation><annotation id="433"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="30596" length="12" /><text>inflammatory</text></annotation><annotation id="434"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="30715" length="26" /><text>neurodegenerative diseases</text></annotation><annotation id="435"><infon key="type">Disease</infon><location offset="30937" length="3" /><text>CVD</text></annotation><annotation id="436"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="30267" length="3" /><text>RSV</text></annotation><annotation id="437"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="30804" length="11" /><text>resveratrol</text></annotation><annotation id="438"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="30779" length="5" /><text>human</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>30965</offset><text>Experimentation with RSV supplementation in normal aging humans has shown ubiquitarian effects. Witte et al. reported that 26 weeks of resveratrol intake (200 mg/d) resulted in improvement of verbal memory performance through an increased functional connectivity of the hippocampus; moreover, subjects in the treatment group showed a significant reduction in HbA1c compared with placebo. This double-positive effect was confirmed in MCI human models: an RCT performed on 110 subjects diagnosed with MCI showed a moderate reduction of HbA1c concentration and preserved left anterior hippocampus volume. These results seem to be in line with the previously demonstrated effect of RSV on cerebral flow. The authors also describe the reduction of glucotoxicity in the brain tissue and the increase in the functional connectivity between the hippocampus and different brain regions as the potential mechanisms underlying the positive influence of RSV on neuroactivity. As reviewed by Buglio et al. literature offers many examples of RCTs showing the benefits of RSV in patients with MCI or AD. Moreover, RSV has been shown to have a preventive effect on AD, reducing amyloid plaques in animal models with AD (Table 2).</text><annotation id="439"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="31398" length="3" /><text>MCI</text></annotation><annotation id="440"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="31464" length="3" /><text>MCI</text></annotation><annotation id="441"><infon key="type">Disease</infon><location offset="31708" length="13" /><text>glucotoxicity</text></annotation><annotation id="442"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="32043" length="3" /><text>MCI</text></annotation><annotation id="443"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="32050" length="2" /><text>AD</text></annotation><annotation id="444"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="32114" length="2" /><text>AD</text></annotation><annotation id="445"><infon key="identifier">MESH:D058225</infon><infon key="type">Disease</infon><location offset="32127" length="15" /><text>amyloid plaques</text></annotation><annotation id="446"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="32165" length="2" /><text>AD</text></annotation><annotation id="447"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="30986" length="3" /><text>RSV</text></annotation><annotation id="448"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="31100" length="11" /><text>resveratrol</text></annotation><annotation id="449"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="31643" length="3" /><text>RSV</text></annotation><annotation id="450"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="31907" length="3" /><text>RSV</text></annotation><annotation id="451"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="32022" length="3" /><text>RSV</text></annotation><annotation id="452"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="32064" length="3" /><text>RSV</text></annotation><annotation id="453"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="31022" length="6" /><text>humans</text></annotation><annotation id="454"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="31402" length="5" /><text>human</text></annotation><annotation id="455"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="32029" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>32184</offset><text>These promising results highlight a possible therapeutic strategy for MCI, as there is currently no effective pharmacological intervention for this condition.</text><annotation id="456"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="32254" length="3" /><text>MCI</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>32343</offset><text>The role of RSV in the prevention of MCI/MetS</text><annotation id="457"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="32380" length="3" /><text>MCI</text></annotation><annotation id="458"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="32384" length="4" /><text>MetS</text></annotation><annotation id="459"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="32355" length="3" /><text>RSV</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>32389</offset><text>RSV has been reported to play a protective role in hypertension, dyslipidaemia, obesity, and IR. It also been shown to act as an antioxidant and to be neuroprotective by inhibiting the production of inflammatory cytokines. Therefore, given the possible benefits in a healthy population, including weight loss, rebalanced metabolic function and normal aging, RSV emerges as a promising tool for the prevention of MetS and MCI.</text><annotation id="460"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="32440" length="12" /><text>hypertension</text></annotation><annotation id="461"><infon key="type">Disease</infon><location offset="32454" length="13" /><text>dyslipidaemia</text></annotation><annotation id="462"><infon key="identifier">MESH:D009765</infon><infon key="type">Disease</infon><location offset="32469" length="7" /><text>obesity</text></annotation><annotation id="463"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="32482" length="2" /><text>IR</text></annotation><annotation id="464"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="32588" length="12" /><text>inflammatory</text></annotation><annotation id="465"><infon key="identifier">MESH:D015431</infon><infon key="type">Disease</infon><location offset="32686" length="11" /><text>weight loss</text></annotation><annotation id="466"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="32801" length="4" /><text>MetS</text></annotation><annotation id="467"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="32810" length="3" /><text>MCI</text></annotation><annotation id="468"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="32389" length="3" /><text>RSV</text></annotation><annotation id="469"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="32747" length="3" /><text>RSV</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>32815</offset><text>In female senescence accelerated mouse-prone mice, it has been demonstrated that a resveratrol-enriched diet, for two months prior to mating, prevent cognitive impairment in mice offspring through epigenetic changes and cell signaling pathways. Moreover, Wu Z and colleagues have demonstrated that a resveratrol and selenium rich milk supplementation ameliorates cognitive function in d-galactose-induced cognitive dysfunction model mice.</text><annotation id="470"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="32965" length="20" /><text>cognitive impairment</text></annotation><annotation id="471"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="33220" length="21" /><text>cognitive dysfunction</text></annotation><annotation id="472"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="32898" length="11" /><text>resveratrol</text></annotation><annotation id="473"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="33115" length="11" /><text>resveratrol</text></annotation><annotation id="474"><infon key="identifier">MESH:D012643</infon><infon key="type">Chemical</infon><location offset="33131" length="8" /><text>selenium</text></annotation><annotation id="475"><infon key="identifier">MESH:D005690</infon><infon key="type">Chemical</infon><location offset="33200" length="11" /><text>d-galactose</text></annotation><annotation id="476"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="32848" length="5" /><text>mouse</text></annotation><annotation id="477"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="32860" length="4" /><text>mice</text></annotation><annotation id="478"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="32989" length="4" /><text>mice</text></annotation><annotation id="479"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="33248" length="4" /><text>mice</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>33254</offset><text>In obese humans, Timmers et al. reported a variety of improvements after treatment with 150 mg per day of RSV for 30 days, including glycemic control and insulin sensitivity, along with a reduction in serum levels of inflammatory markers. Konings et al., on the other hand, focused on changes in adipose tissue morphology, showing a reduction in the size of abdominal subcutaneous adipocytes in subjects treated with RSV (150 mg per day) for 30 days (Table 2).</text><annotation id="480"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="33408" length="7" /><text>insulin</text></annotation><annotation id="481"><infon key="identifier">MESH:D009765</infon><infon key="type">Disease</infon><location offset="33257" length="5" /><text>obese</text></annotation><annotation id="482"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="33471" length="12" /><text>inflammatory</text></annotation><annotation id="483"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="33360" length="3" /><text>RSV</text></annotation><annotation id="484"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="33671" length="3" /><text>RSV</text></annotation><annotation id="485"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="33263" length="6" /><text>humans</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>33722</offset><text>Regarding its role in MCI prevention, as previously reported, Witte et al. proved its effectiveness in neuroprotection in normal subjects. The study analyzed the effect of 200 mg/d of RSV for 26 weeks in twenty-three healthy overweight older patients. Through the assessment of working memory, neuroimaging, serum parameters, anthropometric records, and vascular markers, the authors registered improvements in the integrity and functionality of the hippocampus, along with a reduction in body fat and in HbA1c.</text><annotation id="486"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="33744" length="3" /><text>MCI</text></annotation><annotation id="487"><infon key="identifier">MESH:D050177</infon><infon key="type">Disease</infon><location offset="33947" length="10" /><text>overweight</text></annotation><annotation id="488"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="33906" length="3" /><text>RSV</text></annotation><annotation id="489"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="33964" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>34239</offset><text>Experimental findings have proved RSV to be effective, to some extent, in both metabolism and neuroactivity pathways. Indeed, Gocmez and collaborators have demonstrated that resveratrol supplementation (20 mg/kg/day, intraperitoneally [i.p.]) for 4 weeks after induction of diabetes by streptozotocin in rat prevented cognitive decline, occurring in diabetes mice without resveratrol supplementation. In particular, their data demonstrated that resveratrol prevents memory deficit, endothelial dysfunction, increased oxidative stress and inflammation in a vascular dementia rat model. A similar result has been shown by Tian and colleagues, who demonstrated that resveratrol supplementation improved neuronal injury and cognitive performance by attenuating oxidative stress and inflammation as well as inhibiting synapse loss in diabetic rats.</text><annotation id="490"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="34513" length="8" /><text>diabetes</text></annotation><annotation id="491"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="34557" length="17" /><text>cognitive decline</text></annotation><annotation id="492"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="34589" length="8" /><text>diabetes</text></annotation><annotation id="493"><infon key="identifier">MESH:D008569</infon><infon key="type">Disease</infon><location offset="34705" length="14" /><text>memory deficit</text></annotation><annotation id="494"><infon key="identifier">MESH:D014652</infon><infon key="type">Disease</infon><location offset="34721" length="23" /><text>endothelial dysfunction</text></annotation><annotation id="495"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="34777" length="12" /><text>inflammation</text></annotation><annotation id="496"><infon key="identifier">MESH:D015140</infon><infon key="type">Disease</infon><location offset="34795" length="17" /><text>vascular dementia</text></annotation><annotation id="497"><infon key="identifier">MESH:D009410</infon><infon key="type">Disease</infon><location offset="34939" length="15" /><text>neuronal injury</text></annotation><annotation id="498"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="35017" length="12" /><text>inflammation</text></annotation><annotation id="499"><infon key="identifier">MESH:D016388</infon><infon key="type">Disease</infon><location offset="35052" length="12" /><text>synapse loss</text></annotation><annotation id="500"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="35068" length="8" /><text>diabetic</text></annotation><annotation id="501"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="34273" length="3" /><text>RSV</text></annotation><annotation id="502"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="34413" length="11" /><text>resveratrol</text></annotation><annotation id="503"><infon key="identifier">MESH:D013311</infon><infon key="type">Chemical</infon><location offset="34525" length="14" /><text>streptozotocin</text></annotation><annotation id="504"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="34611" length="11" /><text>resveratrol</text></annotation><annotation id="505"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="34684" length="11" /><text>resveratrol</text></annotation><annotation id="506"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="34902" length="11" /><text>resveratrol</text></annotation><annotation id="507"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="34543" length="3" /><text>rat</text></annotation><annotation id="508"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="34598" length="4" /><text>mice</text></annotation><annotation id="509"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="34813" length="3" /><text>rat</text></annotation><annotation id="510"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="35077" length="4" /><text>rats</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>35085</offset><text>Overall, this evidence demonstrated that resveratrol may be useful in MetS and MCI alone, but also to prevent cognitive decline in metabolic disease.</text><annotation id="511"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="35155" length="4" /><text>MetS</text></annotation><annotation id="512"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="35164" length="3" /><text>MCI</text></annotation><annotation id="513"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="35195" length="17" /><text>cognitive decline</text></annotation><annotation id="514"><infon key="identifier">MESH:D008659</infon><infon key="type">Disease</infon><location offset="35216" length="17" /><text>metabolic disease</text></annotation><annotation id="515"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="35126" length="11" /><text>resveratrol</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>35235</offset><text>The role of PUFAs on MetS</text><annotation id="516"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="35256" length="4" /><text>MetS</text></annotation><annotation id="517"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="35247" length="5" /><text>PUFAs</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>35261</offset><text>Dietary intake of polyunsaturated fatty acids (PUFAs) and omega-3-fatty acids has been shown to have positive cardiovascular effects. Major sources of PUFA are tofu, and some nuts and seeds such as walnuts and sunflower seeds, while omega-3-fatty acids, eicosapentaenoic acid (EPA, 20:5), and docosahexaenoic acid (DHA, 22:6), are mostly found in fish and other seafood. It is well known that dietary patterns enriched with these foods are associated with positive cardiometabolic outcomes. For this reason this supplement is largely used in clinical practice, as omega-3-fatty acids in particular are the first-line therapy for hypertriglyceridemia.</text><annotation id="518"><infon key="identifier">MESH:D015228</infon><infon key="type">Disease</infon><location offset="35890" length="20" /><text>hypertriglyceridemia</text></annotation><annotation id="519"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="35279" length="27" /><text>polyunsaturated fatty acids</text></annotation><annotation id="520"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="35308" length="5" /><text>PUFAs</text></annotation><annotation id="521"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="35319" length="19" /><text>omega-3-fatty acids</text></annotation><annotation id="522"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="35412" length="4" /><text>PUFA</text></annotation><annotation id="523"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="35494" length="19" /><text>omega-3-fatty acids</text></annotation><annotation id="524"><infon key="identifier">MESH:D015118</infon><infon key="type">Chemical</infon><location offset="35515" length="21" /><text>eicosapentaenoic acid</text></annotation><annotation id="525"><infon key="identifier">MESH:D004281</infon><infon key="type">Chemical</infon><location offset="35554" length="20" /><text>docosahexaenoic acid</text></annotation><annotation id="526"><infon key="identifier">MESH:C027493</infon><infon key="type">Chemical</infon><location offset="35576" length="3" /><text>DHA</text></annotation><annotation id="527"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="35825" length="19" /><text>omega-3-fatty acids</text></annotation><annotation id="528"><infon key="type">Species</infon><location offset="35421" length="4" /><text>tofu</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>35912</offset><text>A meta-analysis was run in 2023 on the effects of omega-3 PUFAs on the different features of MetS, such as total lipid profiles, blood pressure, and inflammatory markers. As a result, the authors confirmed a significant reduction in TG levels, with a linear relationship between the duration of omega-3 PUFAs intake and changes in TG. Interestingly, supplementation also had a favorable effect on blood pressure and inflammatory markers such as IL-6, tumor necrosis factor alpha (TNF-alpha), C-reactive protein (CRP), and IL-1 levels.</text><annotation id="529"><infon key="identifier">3569</infon><infon key="type">Gene</infon><location offset="36357" length="4" /><text>IL-6</text></annotation><annotation id="530"><infon key="identifier">7124</infon><infon key="type">Gene</infon><location offset="36363" length="27" /><text>tumor necrosis factor alpha</text></annotation><annotation id="531"><infon key="identifier">24835</infon><infon key="type">Gene</infon><location offset="36392" length="9" /><text>TNF-alpha</text></annotation><annotation id="532"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="36404" length="18" /><text>C-reactive protein</text></annotation><annotation id="533"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="36424" length="3" /><text>CRP</text></annotation><annotation id="534"><infon key="identifier">3552</infon><infon key="type">Gene</infon><location offset="36434" length="4" /><text>IL-1</text></annotation><annotation id="535"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="36005" length="4" /><text>MetS</text></annotation><annotation id="536"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="36061" length="12" /><text>inflammatory</text></annotation><annotation id="537"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="36328" length="12" /><text>inflammatory</text></annotation><annotation id="538"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="35962" length="13" /><text>omega-3 PUFAs</text></annotation><annotation id="539"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="36025" length="5" /><text>lipid</text></annotation><annotation id="540"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="36145" length="2" /><text>TG</text></annotation><annotation id="541"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="36207" length="13" /><text>omega-3 PUFAs</text></annotation><annotation id="542"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="36243" length="2" /><text>TG</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>36447</offset><text>A review by Brady et al. on the intake of very long chain PUFAs (VLC n-3 PUFA) in MetS subjects found similar effects on lipid profiles, but no impact on glucose metabolism and insulin action. Regarding the effect on glycemic metabolism, some studies highlighted a worsened glucose control in the intervention group, while others evidenced a protective role. A recent study suggested that use of n-3 PUFAs supplements may significantly decrease serum triglyceride levels and lower blood pressure in patients with MetS. In this study, n-3 PUFAs increased insulin sensitivity, leading the authors to hypothesize a role in the prevention of hyperglycaemia (Table 2).</text><annotation id="543"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="36624" length="7" /><text>insulin</text></annotation><annotation id="544"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="37001" length="7" /><text>insulin</text></annotation><annotation id="545"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="36529" length="4" /><text>MetS</text></annotation><annotation id="546"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="36960" length="5" /><text>MetS.</text></annotation><annotation id="547"><infon key="type">Disease</infon><location offset="37085" length="14" /><text>hyperglycaemia</text></annotation><annotation id="548"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="36505" length="5" /><text>PUFAs</text></annotation><annotation id="549"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="36512" length="3" /><text>VLC</text></annotation><annotation id="550"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="36516" length="8" /><text>n-3 PUFA</text></annotation><annotation id="551"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="36568" length="5" /><text>lipid</text></annotation><annotation id="552"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="36601" length="7" /><text>glucose</text></annotation><annotation id="553"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="36721" length="7" /><text>glucose</text></annotation><annotation id="554"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="36843" length="9" /><text>n-3 PUFAs</text></annotation><annotation id="555"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="36898" length="12" /><text>triglyceride</text></annotation><annotation id="556"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="36981" length="9" /><text>n-3 PUFAs</text></annotation><annotation id="557"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="36946" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>37113</offset><text>The role of PUFAs on MCI</text><annotation id="558"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="37134" length="3" /><text>MCI</text></annotation><annotation id="559"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="37125" length="5" /><text>PUFAs</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>37138</offset><text>The composition of the neuronal membrane is believed to be directly affected by diet; this idea has focused attention on the role of PUFA supplementation on brain health, including psychological distress and cognitive impairment. PUFAs influence cognitive function through several mechanisms, with effects on brain development, neurotransmission, modulation of ion channels, and moreover neuroprotection. Additionally, many of these functions are dependent on neuronal membrane fluidity; as rigidity increases during aging, PUFA are believed to be useful in maintaining the proper architecture of the membrane.</text><annotation id="560"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="37346" length="20" /><text>cognitive impairment</text></annotation><annotation id="561"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="37271" length="4" /><text>PUFA</text></annotation><annotation id="562"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="37368" length="5" /><text>PUFAs</text></annotation><annotation id="563"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="37662" length="4" /><text>PUFA</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>37749</offset><text>One of the interesting aspects of PUFAs is their ability to modulate the production of inflammatory cytokines, which are supposed to be active effectors of neurodegeneration, in different pathological conditions. Data from preclinical studies support the hypothesis that PUFAs can actively interfere with inflammatory pathways involved in neurological weakening by positively regulating the transcription of nuclear erythroid 2-related factor 2 (Nrf2), resulting in an upregulation of antioxidant proteins, and by converting the phenotype of microglial cells from macrophage M1 state to an M2 state.</text><annotation id="564"><infon key="identifier">4780</infon><infon key="type">Gene</infon><location offset="38195" length="4" /><text>Nrf2</text></annotation><annotation id="565"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="37905" length="17" /><text>neurodegeneration</text></annotation><annotation id="566"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="38054" length="12" /><text>inflammatory</text></annotation><annotation id="567"><infon key="identifier">MESH:D009461</infon><infon key="type">Disease</infon><location offset="38088" length="22" /><text>neurological weakening</text></annotation><annotation id="568"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="37783" length="5" /><text>PUFAs</text></annotation><annotation id="569"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="38020" length="5" /><text>PUFAs</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>38349</offset><text>Several RCTs have been conducted with the aim of proving that regular intake of these micronutrients can help the neurological system of subjects with MCI better cope with aging and its inflammatory pattern.</text><annotation id="570"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="38500" length="3" /><text>MCI</text></annotation><annotation id="571"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="38535" length="12" /><text>inflammatory</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>38557</offset><text>Freund Levy et al. performed an RCT analyzing the effect of six-month supplementation of omega-3 fatty acids (1.7 g of DHA and 0.6 g of EPA) in patients with mild to moderate AD and found no significant impact as measured using the mini-mental state examination (MMSE) or the cognitive portion of the AD assessment scale. Interestingly, the study of a subgroup of 32 patients with very mild AD (MMSE 27 points) revealed a statistically significant treatment effect in the MMSE scores over time between the 2 groups. The authors concluded that when the disease is clinically advanced, the neuropathological substrate is too developed to be attenuated by anti-inflammatory activity. As shown by this trial, there may be a critical period to halt this process, i.e., 2 years or more before the onset of dementia, during which inflammatory molecules likely mediate cognitive impairment and can be successfully targeted to restore cognitive function.</text><annotation id="572"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="38732" length="2" /><text>AD</text></annotation><annotation id="573"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="38858" length="2" /><text>AD</text></annotation><annotation id="574"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="38948" length="2" /><text>AD</text></annotation><annotation id="575"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="39215" length="12" /><text>inflammatory</text></annotation><annotation id="576"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="39357" length="8" /><text>dementia</text></annotation><annotation id="577"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="39380" length="12" /><text>inflammatory</text></annotation><annotation id="578"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="39418" length="20" /><text>cognitive impairment</text></annotation><annotation id="579"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="38646" length="19" /><text>omega-3 fatty acids</text></annotation><annotation id="580"><infon key="identifier">MESH:C027493</infon><infon key="type">Chemical</infon><location offset="38676" length="3" /><text>DHA</text></annotation><annotation id="581"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="38701" length="8" /><text>patients</text></annotation><annotation id="582"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="38924" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>39504</offset><text>To explore this possibility, Solfrizzi et al. conducted a prospective study on non-demented elderly subjects to evaluate the role of PUFA supplementation. Their data revealed that only high-dose PUFA supplementation showed a borderline, but non-significant, trend for a protective effect against the development of MCI.</text><annotation id="583"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="39819" length="3" /><text>MCI</text></annotation><annotation id="584"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="39637" length="4" /><text>PUFA</text></annotation><annotation id="585"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="39699" length="4" /><text>PUFA</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>39825</offset><text>In subjects with MCI, a 12-month period intervention with fish oil supplementation high in DHA (3 soft gelatin capsules each day, each containing 430 mg of DHA and 150 mg of EPA), showed a positive impact on almost every cognitive domain. This evidence supports the hypothesis that MCI is an intermediate phase in the cognitive decline spectrum, which can be reversed if properly treated. Promising results on cognitive domains have been observed in a cohort of 50 people aged over 65 with MCI randomized to receive a supplement rich in EPA (1.67 g EPA th 0.16 g DHA/d; n 17), DHA (1.55 g DHA th 0.40 g EPA/d; n 18), or the n-6 PUFA linoleic acid (LA; 2.2 g/d; n 15) for 6 months, although no significant effect was reported overall on depressive symptoms and quality of life. A meta-analysis by Mazereeuw et al. also reported a protective effect on certain cognitive domains in MCI subjects after supplementation with n-3 fatty acids.</text><annotation id="586"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="39842" length="3" /><text>MCI</text></annotation><annotation id="587"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="40107" length="3" /><text>MCI</text></annotation><annotation id="588"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="40143" length="17" /><text>cognitive decline</text></annotation><annotation id="589"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="40315" length="3" /><text>MCI</text></annotation><annotation id="590"><infon key="identifier">MESH:D003866</infon><infon key="type">Disease</infon><location offset="40561" length="19" /><text>depressive symptoms</text></annotation><annotation id="591"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="40704" length="3" /><text>MCI</text></annotation><annotation id="592"><infon key="identifier">MESH:C027493</infon><infon key="type">Chemical</infon><location offset="39916" length="3" /><text>DHA</text></annotation><annotation id="593"><infon key="identifier">MESH:C027493</infon><infon key="type">Chemical</infon><location offset="39981" length="3" /><text>DHA</text></annotation><annotation id="594"><infon key="identifier">MESH:C027493</infon><infon key="type">Chemical</infon><location offset="40388" length="3" /><text>DHA</text></annotation><annotation id="595"><infon key="identifier">MESH:C027493</infon><infon key="type">Chemical</infon><location offset="40402" length="3" /><text>DHA</text></annotation><annotation id="596"><infon key="identifier">MESH:C027493</infon><infon key="type">Chemical</infon><location offset="40414" length="3" /><text>DHA</text></annotation><annotation id="597"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="40449" length="8" /><text>n-6 PUFA</text></annotation><annotation id="598"><infon key="identifier">MESH:D019787</infon><infon key="type">Chemical</infon><location offset="40458" length="13" /><text>linoleic acid</text></annotation><annotation id="599"><infon key="identifier">MESH:D019787</infon><infon key="type">Chemical</infon><location offset="40473" length="2" /><text>LA</text></annotation><annotation id="600"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="40744" length="15" /><text>n-3 fatty acids</text></annotation><annotation id="601"><infon key="type">Species</infon><location offset="39883" length="8" /><text>fish oil</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>40769</offset><text>This benefit on selected neuropsychological spheres may be due to targeted modulation of synaptic plasticity in specific brain areas that are particularly susceptible to oxidative stress.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>40957</offset><text>Similar results were obtained in a case control study run in 2013 by Lee et al. in which PUFA intake was found to be positively correlated with cognitive function in patients with MCI. In this study, lipid peroxidation was used as a biomarker of oxidative damage as it is known to be higher in MCI patients compared with the normal aging population, and was found to be significantly decreased after regular administration of PUFAs compared to the control group (Table 2).</text><annotation id="602"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="41137" length="3" /><text>MCI</text></annotation><annotation id="603"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="41251" length="3" /><text>MCI</text></annotation><annotation id="604"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="41046" length="4" /><text>PUFA</text></annotation><annotation id="605"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="41157" length="5" /><text>lipid</text></annotation><annotation id="606"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="41383" length="5" /><text>PUFAs</text></annotation><annotation id="607"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="41123" length="8" /><text>patients</text></annotation><annotation id="608"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="41255" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>41433</offset><text>These studies do, however, have some limitations, for example, the length of the follow up, limited to up to six months, and the small size of the cohort analyzed. Moreover, considering the countless biological pathways involved in neuronal aging, it is difficult to decide which markers should be selected for this kind of research.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>41767</offset><text>Overall, in RCTs, PUFAs have proven to have some influence on neural development, neurological aging, neuroinflammation and neuroprotection in general, together with a high safety and tolerability profile. Therefore, the introduction of PUFAs supplementation is probably a promising alternative in the management of MCI.</text><annotation id="609"><infon key="identifier">MESH:D000090862</infon><infon key="type">Disease</infon><location offset="41869" length="17" /><text>neuroinflammation</text></annotation><annotation id="610"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="42083" length="3" /><text>MCI</text></annotation><annotation id="611"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="41785" length="5" /><text>PUFAs</text></annotation><annotation id="612"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="42004" length="5" /><text>PUFAs</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>42088</offset><text>The role of PUFAs in the prevention of MCI/MetS</text><annotation id="613"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="42127" length="3" /><text>MCI</text></annotation><annotation id="614"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="42131" length="4" /><text>MetS</text></annotation><annotation id="615"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="42100" length="5" /><text>PUFAs</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>42136</offset><text>PUFAs interventions in MCI in prediabetic, non-cognitively impaired animal models have shown protective effects on brain health. In fact, Guo et al. showed that brain aging models (induced by D-Gal administration), with metabolism-related disorders, benefited from dietary intake of PUFAs. Neurocognitive tests and biochemical essays to detect metabolism parameters and oxidant activity showed that PUFAs exerted two effects: a reduction in the levels of brain receptor for advanced 14 glycation end-product (marker of oxidative stress) and plasma TNF-alpha, and the attenuation of abnormal metabolic characteristics in the D-gal-treated aging rats.</text><annotation id="616"><infon key="identifier">24835</infon><infon key="type">Gene</infon><location offset="42684" length="9" /><text>TNF-alpha</text></annotation><annotation id="617"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="42159" length="3" /><text>MCI</text></annotation><annotation id="618"><infon key="identifier">MESH:D008659</infon><infon key="type">Disease</infon><location offset="42356" length="28" /><text>metabolism-related disorders</text></annotation><annotation id="619"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="42136" length="5" /><text>PUFAs</text></annotation><annotation id="620"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="42328" length="5" /><text>D-Gal</text></annotation><annotation id="621"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="42419" length="5" /><text>PUFAs</text></annotation><annotation id="622"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="42535" length="5" /><text>PUFAs</text></annotation><annotation id="623"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="42760" length="5" /><text>D-gal</text></annotation><annotation id="624"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="42780" length="4" /><text>rats</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>42786</offset><text>In humans, data from a meta-analysis investigating the impact of PUFAs on cognitive health, showed the lack of accountability across these studies due to several biases, such as the short intervention period and the authors ability to statistically detect the potential beneficial effect of PUFAs on cognitive function in a healthy aging population (Table 2). However, given the positive effects found in cognitively impaired patients, the potential of a protective role of PUFAs remains intriguing and should be further investigated with RCTs to fill this gap in the literature.</text><annotation id="625"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="43191" length="20" /><text>cognitively impaired</text></annotation><annotation id="626"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="42851" length="5" /><text>PUFAs</text></annotation><annotation id="627"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="43077" length="5" /><text>PUFAs</text></annotation><annotation id="628"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="43260" length="5" /><text>PUFAs</text></annotation><annotation id="629"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="42789" length="6" /><text>humans</text></annotation><annotation id="630"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="43212" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>43367</offset><text>Given the importance of the MetS in the genesis of CVD, and the pivotal role of hypolipidemic therapy in its prevention, it seemed reasonable to investigate the association of PUFA with the risk of coronary heart disease and major cardiovascular events. A meta-analysis published in 2017 examined ten trials with a total of 77,917 patients and found neither a positive nor a negative association between omega-3 fatty acid supplementation and cardiovascular events.</text><annotation id="631"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="43395" length="4" /><text>MetS</text></annotation><annotation id="632"><infon key="type">Disease</infon><location offset="43418" length="3" /><text>CVD</text></annotation><annotation id="633"><infon key="identifier">MESH:D003327</infon><infon key="type">Disease</infon><location offset="43565" length="22" /><text>coronary heart disease</text></annotation><annotation id="634"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="43543" length="4" /><text>PUFA</text></annotation><annotation id="635"><infon key="identifier">MESH:D015525</infon><infon key="type">Chemical</infon><location offset="43771" length="18" /><text>omega-3 fatty acid</text></annotation><annotation id="636"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="43698" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>43833</offset><text>Preclinical studies have highlighted a protective effect of PUFAs on brain tissue, due to the antioxidant/anti-inflammatory action on the chronic low grade inflammation substrate generated by MetS. However, studies on the preventative role of PUFAs on MCI and development of MetS are currently lacking.</text><annotation id="637"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="43944" length="12" /><text>inflammatory</text></annotation><annotation id="638"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="43989" length="12" /><text>inflammation</text></annotation><annotation id="639"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="44025" length="5" /><text>MetS.</text></annotation><annotation id="640"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="44085" length="3" /><text>MCI</text></annotation><annotation id="641"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="44108" length="4" /><text>MetS</text></annotation><annotation id="642"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="43893" length="5" /><text>PUFAs</text></annotation><annotation id="643"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="44076" length="5" /><text>PUFAs</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>44136</offset><text>The role of probiotics on MetS</text><annotation id="644"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="44162" length="4" /><text>MetS</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>44167</offset><text>Probiotics are live microorganisms that have demonstrated beneficial effects on human health, affecting multiples pathways and axes. Major sources of probiotics are yogurt and kefir. Due to strong evidence that probiotics have anti-inflammatory properties, they could emerge as valuable tool for ameliorating MetS outcomes.</text><annotation id="645"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="44399" length="12" /><text>inflammatory</text></annotation><annotation id="646"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="44476" length="4" /><text>MetS</text></annotation><annotation id="647"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="44247" length="5" /><text>human</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>44491</offset><text>Treatment with probiotics has been demonstrated to significantly reduce mean arterial pressure and fasting plasma glucose, proving effectiveness in every MetS domain. Moreover, subjects treated with probiotics showed a significant decrease in high-sensitivity C-reactive protein (hs-CRP) and TNF-alpha levels compared to the control group, strengthening the hypothesis that probiotics may also improve MetS due to their anti-inflammatory effects.</text><annotation id="648"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="44751" length="18" /><text>C-reactive protein</text></annotation><annotation id="649"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="44774" length="3" /><text>CRP</text></annotation><annotation id="650"><infon key="identifier">24835</infon><infon key="type">Gene</infon><location offset="44783" length="9" /><text>TNF-alpha</text></annotation><annotation id="651"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="44645" length="4" /><text>MetS</text></annotation><annotation id="652"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="44893" length="4" /><text>MetS</text></annotation><annotation id="653"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="44916" length="12" /><text>inflammatory</text></annotation><annotation id="654"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="44605" length="7" /><text>glucose</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>44938</offset><text>Some RCTs have been performed in elderly populations, more than ten of which, however, showed confounders in the selection of the population (for example: T2DM subjects, or non-standardized interventions, such as "Effects of kefir or milk supplementation").</text><annotation id="655"><infon key="identifier">MESH:D003924</infon><infon key="type">Disease</infon><location offset="45093" length="4" /><text>T2DM</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>45201</offset><text>Cicero et al. found a reduction in prevalence of MetS, cardiovascular risk factors and markers of IR in elderly patients through the 2-month period of treatment with a formula of Lactiplantibacillus plantarum PBS067, Lactobacillus acidophilus PBS066, and Lactobacillus reuteri PBS072 with active prebiotics. Specifically, the treatment group showed a statistically significant improvement in waist circumference and in fasting plasma insulin, total cholesterol, HDL cholesterol, non-HDL-C, TG, low-density lipoprotein (LDL)-C. The exclusive effect on the plasma lipid profile was analyzed in a meta-analysis of 13 RCTs conducted in patients with high, borderline and normal cholesterol. As a result, the use of probiotics appeared to significantly lower total cholesterol and LDL, although with no impact on HDL and TG. This effect was observed in all cohorts of subjects, and lipid profile at the baseline did not influence the results (Table 2). This finding is important as it may open a path for the possible use of probiotics in the prevention of hypercholesterolemia.</text><annotation id="656"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="45635" length="7" /><text>insulin</text></annotation><annotation id="657"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="45250" length="4" /><text>MetS</text></annotation><annotation id="658"><infon key="identifier">MESH:D007333</infon><infon key="type">Disease</infon><location offset="45299" length="2" /><text>IR</text></annotation><annotation id="659"><infon key="identifier">MESH:D006937</infon><infon key="type">Disease</infon><location offset="46253" length="20" /><text>hypercholesterolemia</text></annotation><annotation id="660"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="45650" length="11" /><text>cholesterol</text></annotation><annotation id="661"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="45667" length="11" /><text>cholesterol</text></annotation><annotation id="662"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="45684" length="5" /><text>HDL-C</text></annotation><annotation id="663"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="45691" length="2" /><text>TG</text></annotation><annotation id="664"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="45695" length="32" /><text>low-density lipoprotein (LDL)-C.</text></annotation><annotation id="665"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="45763" length="5" /><text>lipid</text></annotation><annotation id="666"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="45875" length="11" /><text>cholesterol</text></annotation><annotation id="667"><infon key="identifier">MESH:D002784</infon><infon key="type">Chemical</infon><location offset="45961" length="11" /><text>cholesterol</text></annotation><annotation id="668"><infon key="identifier">MESH:D014280</infon><infon key="type">Chemical</infon><location offset="46017" length="2" /><text>TG</text></annotation><annotation id="669"><infon key="identifier">MESH:D008055</infon><infon key="type">Chemical</infon><location offset="46078" length="5" /><text>lipid</text></annotation><annotation id="670"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="45313" length="8" /><text>patients</text></annotation><annotation id="671"><infon key="type">Species</infon><location offset="45380" length="36" /><text>Lactiplantibacillus plantarum PBS067</text></annotation><annotation id="672"><infon key="type">Species</infon><location offset="45418" length="32" /><text>Lactobacillus acidophilus PBS066</text></annotation><annotation id="673"><infon key="type">Species</infon><location offset="45456" length="28" /><text>Lactobacillus reuteri PBS072</text></annotation><annotation id="674"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="45833" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>46277</offset><text>The role of probiotics on MCI</text><annotation id="675"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="46303" length="3" /><text>MCI</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>46307</offset><text>Emerging clinical and experimental evidence has highlighted a bidirectional relationship between the gut microbiota and the brain, known as the microbiota-gut-brain axis (MGB). Countless of pathways are involved in this interconnection and a balanced composition of microbes is required for its optimal functioning. In fact, activation of gut inflammation, due to dysbiosis, is believed to be a cofactor in many pathological conditions; specifically, the microbiota has been proposed as a key player in the pathogenesis of both neurodegeneration and MetS. Therefore, restoring homeostasis of gut microbiota could be a reasonable goal for medical therapy in MCI, for which a medical therapy still needs to be codified.</text><annotation id="676"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="46646" length="16" /><text>gut inflammation</text></annotation><annotation id="677"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="46835" length="17" /><text>neurodegeneration</text></annotation><annotation id="678"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="46857" length="5" /><text>MetS.</text></annotation><annotation id="679"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="46964" length="3" /><text>MCI</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>47025</offset><text>To this end many efforts have been made to analyze the composition of microbiota in patients with neurodegenerative disorders. The most characteristic alterations in gut microbiota flora observed in patients with neurodegenerative disorders is the decrease in anti-inflammatory bacterial species such as Bifidobacterium breve strain A1 and increase in pro-inflammatory bacterial species such as Firmicutes and Bacteroidetes. Lactiplantibacillus plantarum has also been studied for its anti-inflammatory properties, due to its high IL-10-inducing activity in immune cells.</text><annotation id="680"><infon key="identifier">3586</infon><infon key="type">Gene</infon><location offset="47556" length="5" /><text>IL-10</text></annotation><annotation id="681"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="47123" length="27" /><text>neurodegenerative disorders</text></annotation><annotation id="682"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="47238" length="27" /><text>neurodegenerative disorders</text></annotation><annotation id="683"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="47290" length="12" /><text>inflammatory</text></annotation><annotation id="684"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="47381" length="12" /><text>inflammatory</text></annotation><annotation id="685"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="47515" length="12" /><text>inflammatory</text></annotation><annotation id="686"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="47109" length="8" /><text>patients</text></annotation><annotation id="687"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="47224" length="8" /><text>patients</text></annotation><annotation id="688"><infon key="type">Species</infon><location offset="47329" length="31" /><text>Bifidobacterium breve strain A1</text></annotation><annotation id="689"><infon key="type">Species</infon><location offset="47450" length="29" /><text>Lactiplantibacillus plantarum</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>47597</offset><text>Different studies with animal models, some RTCs, and an open label single arm study have explored the possibility of restoring a correct proportion of microbiota as a potential treatment for MCI, by administering probiotic B. breve strain A1 supplements in mice or patients diagnosed with MCI. These RCTs have tested similar amount of B. breve colony-forming unit (CFU) comparing this treatment to placebo for different time lapse, such as B. breve MCC1274, 2 x 1,010 CFU vs. placebo for 24 weeks, B. breve A1, 2 x 1,010 CFU vs. placebo for 16 weeks, B. breve MCC1274, 2 x 1,010 CFU) or placebo for 16 weeks, and two capsules daily approximately &gt;2.0 x 1,010 CFU B. breve A1 for 12 weeks vs. placebo.</text><annotation id="690"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="47788" length="3" /><text>MCI</text></annotation><annotation id="691"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="47886" length="3" /><text>MCI</text></annotation><annotation id="692"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="48046" length="7" /><text>MCC1274</text></annotation><annotation id="693"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="48157" length="7" /><text>MCC1274</text></annotation><annotation id="694"><infon key="type">Species</infon><location offset="47820" length="18" /><text>B. breve strain A1</text></annotation><annotation id="695"><infon key="identifier">10090</infon><infon key="type">Species</infon><location offset="47854" length="4" /><text>mice</text></annotation><annotation id="696"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="47862" length="8" /><text>patients</text></annotation><annotation id="697"><infon key="type">Species</infon><location offset="47932" length="8" /><text>B. breve</text></annotation><annotation id="698"><infon key="type">Species</infon><location offset="48037" length="8" /><text>B. breve</text></annotation><annotation id="699"><infon key="type">Species</infon><location offset="48095" length="11" /><text>B. breve A1</text></annotation><annotation id="700"><infon key="type">Species</infon><location offset="48148" length="8" /><text>B. breve</text></annotation><annotation id="701"><infon key="type">Species</infon><location offset="48260" length="11" /><text>B. breve A1</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>48321</offset><text>A meta-analysis run in 2020 by Den. et al. revealed a significant difference in cognitive improvement between subjects with MCI or AD with and without probiotic supplementation. Indeed, subjects treated with probiotics showed better cognitive function after supplementation. The authors hypothesized that probiotics exert their effects by decreasing the level of inflammatory and oxidative effectors, such as malondialdehyde (MDA) and hs-CRP, as these have been found to be significantly decreased in the probiotics versus control group (Table 2).</text><annotation id="702"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="48759" length="3" /><text>CRP</text></annotation><annotation id="703"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="48445" length="3" /><text>MCI</text></annotation><annotation id="704"><infon key="identifier">MESH:D000544</infon><infon key="type">Disease</infon><location offset="48452" length="2" /><text>AD</text></annotation><annotation id="705"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="48684" length="12" /><text>inflammatory</text></annotation><annotation id="706"><infon key="identifier">MESH:D008315</infon><infon key="type">Chemical</infon><location offset="48730" length="15" /><text>malondialdehyde</text></annotation><annotation id="707"><infon key="identifier">MESH:D008315</infon><infon key="type">Chemical</infon><location offset="48747" length="3" /><text>MDA</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>48871</offset><text>However, no significant differences were observed at the level of total GSH, NO and total antioxidant capacity (TAC). Although a relationship of causality needs to be demonstrated, it is reasonable to note that immune signaling may not only be just a consequence of neurodegeneration, but also a key player in its process. As a matter of fact, increasing evidence demonstrates the relevance of inflammation in the progression of neurodegeneration. It has been reported that individuals with higher levels of inflammatory proteins in the blood, decades before the typical age of dementia symptom onset, are at increased risk for developing neurodegenerative disease.</text><annotation id="708"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="49137" length="17" /><text>neurodegeneration</text></annotation><annotation id="709"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="49265" length="12" /><text>inflammation</text></annotation><annotation id="710"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="49300" length="17" /><text>neurodegeneration</text></annotation><annotation id="711"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="49379" length="21" /><text>inflammatory proteins</text></annotation><annotation id="712"><infon key="identifier">MESH:D003704</infon><infon key="type">Disease</infon><location offset="49449" length="8" /><text>dementia</text></annotation><annotation id="713"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="49510" length="25" /><text>neurodegenerative disease</text></annotation><annotation id="714"><infon key="identifier">MESH:D005978</infon><infon key="type">Chemical</infon><location offset="48943" length="3" /><text>GSH</text></annotation><annotation id="715"><infon key="identifier">MESH:D009569</infon><infon key="type">Chemical</infon><location offset="48948" length="2" /><text>NO</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>49537</offset><text>In studies on the effects of probiotics as a dietary supplement in subjects with MCI, results were consistent with an improvement in the composite score of attention and working/verbal memory. However, these studies present some limitations since the small population, the short observational period and the limited selection of cognitive domains assessed limit the reliability of their results. Therefore, increasing the sample size and improving the design of the trial could help clarify the effect of probiotics on general brain function.</text><annotation id="716"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="49618" length="3" /><text>MCI</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>50080</offset><text>The role of probiotics in the prevention of MCI/MetS</text><annotation id="717"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="50124" length="3" /><text>MCI</text></annotation><annotation id="718"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="50128" length="4" /><text>MetS</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>50133</offset><text>Regarding the role of probiotics in the prevention of MCI, an interesting example of in utero use of probiotics to ameliorate memory decline in later life was reported by Zhang et al. Using animal models of lead-induced spatial memory deficit, maternal supplementation with Lacticaseibacillus rhamnosus at a dose of 109 CFU/day has proven its potential to mitigate lead-induced memory deficits. Notably, this result was independent of lead-induced alterations, as lead levels were measured and were not significantly reduced after treatment. Furthermore, in vitro experiments have revealed that L. rhamnosus inhibits growth of Escherichia coli, a pathogen involved in memory decline. Further research is needed to elucidate the mechanisms underlying probiotic-mediated memory protection and its potential for broader application in cognitive impairment prevention.</text><annotation id="719"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="50187" length="3" /><text>MCI</text></annotation><annotation id="720"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="50259" length="14" /><text>memory decline</text></annotation><annotation id="721"><infon key="identifier">MESH:D008569</infon><infon key="type">Disease</infon><location offset="50361" length="14" /><text>memory deficit</text></annotation><annotation id="722"><infon key="identifier">MESH:D008569</infon><infon key="type">Disease</infon><location offset="50511" length="15" /><text>memory deficits</text></annotation><annotation id="723"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="50801" length="14" /><text>memory decline</text></annotation><annotation id="724"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="50965" length="20" /><text>cognitive impairment</text></annotation><annotation id="725"><infon key="identifier">MESH:D007854</infon><infon key="type">Chemical</infon><location offset="50340" length="4" /><text>lead</text></annotation><annotation id="726"><infon key="identifier">MESH:D007854</infon><infon key="type">Chemical</infon><location offset="50498" length="4" /><text>lead</text></annotation><annotation id="727"><infon key="identifier">MESH:D007854</infon><infon key="type">Chemical</infon><location offset="50568" length="4" /><text>lead</text></annotation><annotation id="728"><infon key="identifier">MESH:D007854</infon><infon key="type">Chemical</infon><location offset="50597" length="4" /><text>lead</text></annotation><annotation id="729"><infon key="type">Species</infon><location offset="50407" length="28" /><text>Lacticaseibacillus rhamnosus</text></annotation><annotation id="730"><infon key="identifier">47715</infon><infon key="type">Species</infon><location offset="50728" length="12" /><text>L. rhamnosus</text></annotation><annotation id="731"><infon key="identifier">562</infon><infon key="type">Species</infon><location offset="50760" length="16" /><text>Escherichia coli</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>51001</offset><text>Even with growing evidence from animal models supporting the use of therapies targeting gut microbiota before birth, to protect against the development of MetS, their effects on pregnant women are still unknown and these results require further research. However, animal models offer a valid example of how environmental factors during pregnancy and lactation exert an influence on adulthood development of MCI and MetS. With this awareness, various prevention strategies in early life have been explored: as an example, as reviewed by Hsu et al., supplementation with Lactobacillus casei during gestation in MetS induced rodent models, has been shown to benefit hypertension in adult progenies.</text><annotation id="732"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="51156" length="4" /><text>MetS</text></annotation><annotation id="733"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="51408" length="3" /><text>MCI</text></annotation><annotation id="734"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="51416" length="5" /><text>MetS.</text></annotation><annotation id="735"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="51610" length="4" /><text>MetS</text></annotation><annotation id="736"><infon key="identifier">MESH:D006973</infon><infon key="type">Disease</infon><location offset="51664" length="12" /><text>hypertension</text></annotation><annotation id="737"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="51188" length="5" /><text>women</text></annotation><annotation id="738"><infon key="identifier">1582</infon><infon key="type">Species</infon><location offset="51570" length="19" /><text>Lactobacillus casei</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>51698</offset><text>The use of probiotics in the prevention of cognitive decline and metabolic features was also studied by Davari et al., who aimed to evaluate the effect of probiotics on plasma glucose and insulin levels, behavioral tasks, and synaptic plasticity in a diabetic rat model. The probiotics solution was made by a mixture (each 334 mg) of L. acidophilus (American type culture collection [ATCC] 4356, 10 10 CFU/g), Bifidobacterium lactis (Dutch chemical company [DSM] 10140, 10 10 CFU/g), and Lactobacillus fermentum (ATCC 9338, 10 10 CFU/g) and was administered for 8 weeks. It was effective in mitigating oxidative stress and inflammation and alleviating diabetic complications. Indeed, results showed that supplementation with a probiotics solution (a mixture of L. acidophilus, B. lactis, and L. fermentum) significantly improved spatial memory and task learning capabilities in diabetic animals. Moreover, electrophysiological recordings revealed enhanced synaptic transmission compared to the control group; biochemical measurements showed mitigated oxidative stress, as proven by increased level of superoxide dismutase activity and reduced level of 8-hydroxydesoxyguanosin production. Interestingly, no significant effects were observed on behavior, synaptic plasticity, or biochemical markers in control rats, suggesting that the potential therapeutic role of probiotics is specifically on diabetes-related oxidative stress and neurodegeneration.</text><annotation id="739"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="51886" length="7" /><text>insulin</text></annotation><annotation id="740"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="51741" length="17" /><text>cognitive decline</text></annotation><annotation id="741"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="51949" length="8" /><text>diabetic</text></annotation><annotation id="742"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="52321" length="12" /><text>inflammation</text></annotation><annotation id="743"><infon key="identifier">MESH:D048909</infon><infon key="type">Disease</infon><location offset="52350" length="22" /><text>diabetic complications</text></annotation><annotation id="744"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="52576" length="8" /><text>diabetic</text></annotation><annotation id="745"><infon key="identifier">MESH:D003920</infon><infon key="type">Disease</infon><location offset="53092" length="8" /><text>diabetes</text></annotation><annotation id="746"><infon key="identifier">MESH:D019636</infon><infon key="type">Disease</infon><location offset="53130" length="17" /><text>neurodegeneration</text></annotation><annotation id="747"><infon key="identifier">MESH:D005947</infon><infon key="type">Chemical</infon><location offset="51874" length="7" /><text>glucose</text></annotation><annotation id="748"><infon key="identifier">-</infon><infon key="type">Chemical</infon><location offset="52850" length="23" /><text>8-hydroxydesoxyguanosin</text></annotation><annotation id="749"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="51958" length="3" /><text>rat</text></annotation><annotation id="750"><infon key="identifier">1579</infon><infon key="type">Species</infon><location offset="52032" length="14" /><text>L. acidophilus</text></annotation><annotation id="751"><infon key="identifier">302911</infon><infon key="type">Species</infon><location offset="52108" length="22" /><text>Bifidobacterium lactis</text></annotation><annotation id="752"><infon key="identifier">1613</infon><infon key="type">Species</infon><location offset="52186" length="23" /><text>Lactobacillus fermentum</text></annotation><annotation id="753"><infon key="type">Species</infon><location offset="52211" length="9" /><text>ATCC 9338</text></annotation><annotation id="754"><infon key="identifier">1579</infon><infon key="type">Species</infon><location offset="52459" length="14" /><text>L. acidophilus</text></annotation><annotation id="755"><infon key="identifier">1358</infon><infon key="type">Species</infon><location offset="52475" length="9" /><text>B. lactis</text></annotation><annotation id="756"><infon key="identifier">1613</infon><infon key="type">Species</infon><location offset="52490" length="12" /><text>L. fermentum</text></annotation><annotation id="757"><infon key="identifier">10116</infon><infon key="type">Species</infon><location offset="53006" length="4" /><text>rats</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>53159</offset><text>Mo et al. explored the effects of probiotic supplementation in overweight human subjects, showing how probiotics can positively influence some anthropometric parameters of MetS in borderline-healthy patients. Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 were administered orally for 12 weeks, resulting in a reduction in visceral fat mass and waist circumference, along with an increase in adiponectin levels. This positive impact could be triggered by a modulation of gut microbiota, presented here as a key determinant for activation of specific signaling pathways in obese humans. This RCT suggests how probiotics could be used as a promising strategy for the prevention of obesity and related metabolic disorders (Table 2).</text><annotation id="758"><infon key="identifier">9370</infon><infon key="type">Gene</infon><location offset="53569" length="11" /><text>adiponectin</text></annotation><annotation id="759"><infon key="identifier">MESH:D050177</infon><infon key="type">Disease</infon><location offset="53222" length="10" /><text>overweight</text></annotation><annotation id="760"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="53331" length="4" /><text>MetS</text></annotation><annotation id="761"><infon key="identifier">MESH:D009765</infon><infon key="type">Disease</infon><location offset="53749" length="5" /><text>obese</text></annotation><annotation id="762"><infon key="identifier">MESH:D009765</infon><infon key="type">Disease</infon><location offset="53856" length="7" /><text>obesity</text></annotation><annotation id="763"><infon key="identifier">MESH:D008659</infon><infon key="type">Disease</infon><location offset="53876" length="19" /><text>metabolic disorders</text></annotation><annotation id="764"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="53233" length="5" /><text>human</text></annotation><annotation id="765"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="53358" length="8" /><text>patients</text></annotation><annotation id="766"><infon key="type">Species</infon><location offset="53368" length="29" /><text>Lactobacillus curvatus HY7601</text></annotation><annotation id="767"><infon key="type">Species</infon><location offset="53402" length="30" /><text>Lactobacillus plantarum KY1032</text></annotation><annotation id="768"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="53755" length="6" /><text>humans</text></annotation></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>53910</offset><text>In conclusion, we can say that studies on the effect of probiotics MetS and MCI show contrasting results. However, given the lack of RCTs with standardized outcome in the literature, more research is needed in order to clarify whether these nutraceuticals can be validated as codified treatment for both MetS and MCI.</text><annotation id="769"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="53977" length="4" /><text>MetS</text></annotation><annotation id="770"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="53986" length="3" /><text>MCI</text></annotation><annotation id="771"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="54214" length="4" /><text>MetS</text></annotation><annotation id="772"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="54223" length="3" /><text>MCI</text></annotation></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>54228</offset><text>Conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>54240</offset><text>The study of nutraceuticals is an emerging field of growing interest due to the necessity for strategies in the prevention and treatment of MetS and MCI. These conditions are strongly connected, and both are a prelude to more severe outcomes. Since MetS and MCI share pathophysiological pathways, the keys of which are inflammation and oxidative stress, substances with antioxidant and anti-inflammatory properties have been explored in healthy and impaired models, with heterogeneous results. While there is sufficient literature on the biochemical effects of some nutraceuticals, there is still limited evidence for the positive effects of vitamin E, PUFAs, probiotics and resveratrol on subjects with impaired cognitive function or MetS and weak evidence supporting the intervention with these nutraceuticals as prevention. The literature lacks studies with standardized interventions, clear and codified cognitive and metabolic assessments, and specific pathognomonic biomarkers of MetS and MCI. Also, considering the long-term requirement of medications when it comes to MetS and MCI, longer trials and observational studies in this area are needed. In particular, we stress the need for RCTs with more rigorous endpoints and more specific markers that can provide reliable evidence to assess the adequacy of interventions with nutraceuticals.</text><annotation id="773"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="54380" length="4" /><text>MetS</text></annotation><annotation id="774"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="54389" length="3" /><text>MCI</text></annotation><annotation id="775"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="54489" length="4" /><text>MetS</text></annotation><annotation id="776"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="54498" length="3" /><text>MCI</text></annotation><annotation id="777"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="54559" length="12" /><text>inflammation</text></annotation><annotation id="778"><infon key="identifier">MESH:D007249</infon><infon key="type">Disease</infon><location offset="54631" length="12" /><text>inflammatory</text></annotation><annotation id="779"><infon key="identifier">MESH:D003072</infon><infon key="type">Disease</infon><location offset="54944" length="27" /><text>impaired cognitive function</text></annotation><annotation id="780"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="54975" length="4" /><text>MetS</text></annotation><annotation id="781"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="55226" length="4" /><text>MetS</text></annotation><annotation id="782"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="55235" length="3" /><text>MCI</text></annotation><annotation id="783"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="55316" length="4" /><text>MetS</text></annotation><annotation id="784"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="55325" length="3" /><text>MCI</text></annotation><annotation id="785"><infon key="identifier">MESH:D014810</infon><infon key="type">Chemical</infon><location offset="54882" length="9" /><text>vitamin E</text></annotation><annotation id="786"><infon key="identifier">MESH:D005231</infon><infon key="type">Chemical</infon><location offset="54893" length="5" /><text>PUFAs</text></annotation><annotation id="787"><infon key="identifier">MESH:D000077185</infon><infon key="type">Chemical</infon><location offset="54915" length="11" /><text>resveratrol</text></annotation></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>55589</offset><text>Limitations of the study</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>55614</offset><text>Firstly, the narrative character of this study represent itself a limitation. As a matter of fact, the unsystematic selection, lacked formal metanalytic method to derive the most trustable RCTs from the existing literature, could have produced a biased study selection. Secondary, we have not organized our review by mechanisms of actions or biological origin of components, which represents another flaw. Finally, the preclinical character of MCI and MetS represents an obstacle for rigorous identification of population and outcome, leading us to include a variety of studies that are often too different from each other to be reproducible.</text><annotation id="788"><infon key="identifier">MESH:D060825</infon><infon key="type">Disease</infon><location offset="56058" length="3" /><text>MCI</text></annotation><annotation id="789"><infon key="identifier">MESH:D024821</infon><infon key="type">Disease</infon><location offset="56066" length="4" /><text>MetS</text></annotation></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>56257</offset><text>Declaration of interests</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>56282</offset><text>The authors declare no competing interests.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>56326</offset><text>References</text></passage><passage><infon key="name_3">surname:Allam;given-names:S.</infon><infon key="name_2">surname:Zerdan;given-names:M.B.</infon><infon key="name_1">surname:Aoun;given-names:L.</infon><infon key="name_0">surname:Fahed;given-names:G.</infon><infon key="fpage">786</infon><infon key="pub-id_doi">10.3390/ijms23020786</infon><infon key="pub-id_pmid">35054972</infon><infon key="year">2022</infon><infon key="source">Int. J. Mol. Sci.</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="section_type">REF</infon><infon key="name_6">surname:Assi;given-names:H.I.</infon><infon key="name_5">surname:Bouferraa;given-names:Y.</infon><infon key="name_4">surname:Zerdan;given-names:M.B.</infon><offset>56337</offset><text>Metabolic Syndrome: Updates on Pathophysiology and Management in 2021</text></passage><passage><infon key="name_3">surname:Quero;given-names:G.</infon><infon key="name_2">surname:Cinti;given-names:F.</infon><infon key="name_1">surname:Cefalo;given-names:C.M.A.</infon><infon key="name_0">surname:Mezza;given-names:T.</infon><infon key="fpage">760</infon><infon key="pub-id_doi">10.1016/j.tem.2020.07.003</infon><infon key="pub-id_pmid">32830029</infon><infon key="year">2020</infon><infon key="source">Trends Endocrinol. Metab.</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Giaccari;given-names:A.</infon><infon key="lpage">772</infon><infon key="name_6">surname:Holst;given-names:J.J.</infon><infon key="name_5">surname:Alfieri;given-names:S.</infon><infon key="name_4">surname:Pontecorvi;given-names:A.</infon><offset>56407</offset><text>Endocrine and Metabolic Insights from Pancreatic Surgery</text></passage><passage><infon key="volume">23</infon><infon key="name_2">surname:Luchsinger;given-names:J.A.</infon><infon key="name_1">surname:Palta;given-names:P.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Tahmi;given-names:M.</infon><infon key="fpage">180</infon><infon key="pub-id_doi">10.1007/s11886-021-01615-y</infon><infon key="pub-id_pmid">34668083</infon><infon key="year">2021</infon><infon key="source">Curr. Cardiol. Rep.</infon><infon key="type">ref</infon><offset>56464</offset><text>Metabolic Syndrome and Cognitive Function</text></passage><passage><infon key="name_3">surname:Ding;given-names:G.</infon><infon key="name_2">surname:Tang;given-names:Z.</infon><infon key="name_1">surname:Ji;given-names:L.</infon><infon key="name_0">surname:Wang;given-names:X.</infon><infon key="fpage">40</infon><infon key="pub-id_doi">10.1186/s12902-021-00705-w</infon><infon key="pub-id_pmid">33663435</infon><infon key="year">2021</infon><infon key="source">BMC Endocr. Disord.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Li;given-names:D.</infon><infon key="lpage">48</infon><infon key="name_6">surname:Chen;given-names:Y.</infon><infon key="name_5">surname:Lv;given-names:J.</infon><infon key="name_4">surname:Chen;given-names:X.</infon><offset>56506</offset><text>The association of metabolic syndrome and cognitive impairment in Jidong of China: a cross-sectional study</text></passage><passage><infon key="name_3">surname:Liu;given-names:M.</infon><infon key="name_2">surname:Wang;given-names:D.</infon><infon key="name_1">surname:Wu;given-names:B.</infon><infon key="name_0">surname:Hao;given-names:Z.</infon><infon key="fpage">69</infon><infon key="pub-id_doi">10.1111/j.1601-5215.2011.00527.x</infon><infon key="pub-id_pmid">26952861</infon><infon key="year">2011</infon><infon key="source">Acta Neuropsychiatr.</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="section_type">REF</infon><infon key="lpage">74</infon><offset>56613</offset><text>Association between metabolic syndrome and cognitive decline: A systematic review of prospective population-based studies</text></passage><passage><infon key="name_3">surname:Imbimbo;given-names:B.P.</infon><infon key="name_2">surname:Capurso;given-names:C.</infon><infon key="name_1">surname:Frisardi;given-names:V.</infon><infon key="name_0">surname:Panza;given-names:F.</infon><infon key="fpage">691</infon><infon key="pub-id_doi">10.3233/JAD-2010-091669</infon><infon key="pub-id_pmid">20571214</infon><infon key="year">2010</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="name_10">surname:Solfrizzi;given-names:V.</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Pilotto;given-names:A.</infon><infon key="name_8">surname:Sancarlo;given-names:D.</infon><infon key="name_7">surname:Seripa;given-names:D.</infon><infon key="lpage">724</infon><infon key="name_6">surname:D'Onofrio;given-names:G.</infon><infon key="name_5">surname:Santamato;given-names:A.</infon><infon key="name_4">surname:Vendemiale;given-names:G.</infon><offset>56735</offset><text>Metabolic syndrome and cognitive impairment: Current epidemiology and possible underlying mechanisms</text></passage><passage><infon key="name_3">surname:Wu;given-names:C.J.</infon><infon key="name_2">surname:Lee;given-names:J.T.</infon><infon key="name_1">surname:Kao;given-names:T.W.</infon><infon key="name_0">surname:Tsai;given-names:C.K.</infon><infon key="pub-id_doi">10.1097/MD.0000000000004791</infon><infon key="year">2016</infon><infon key="source">Medicine</infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Chen;given-names:W.L.</infon><infon key="name_7">surname:Yang;given-names:F.C.</infon><infon key="name_6">surname:Wang;given-names:G.C.</infon><infon key="name_5">surname:Liang;given-names:C.S.</infon><infon key="name_4">surname:Hueng;given-names:D.Y.</infon><offset>56836</offset><text>Increased risk of cognitive impairment in patients with components of metabolic syndrome</text></passage><passage><infon key="name_3">surname:Capurso;given-names:C.</infon><infon key="name_2">surname:Seripa;given-names:D.</infon><infon key="name_1">surname:Solfrizzi;given-names:V.</infon><infon key="name_0">surname:Frisardi;given-names:V.</infon><infon key="fpage">399</infon><infon key="pub-id_doi">10.1016/j.arr.2010.04.007</infon><infon key="pub-id_pmid">20444434</infon><infon key="year">2010</infon><infon key="source">Ageing Res. Rev.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Panza;given-names:F.</infon><infon key="name_7">surname:Pilotto;given-names:A.</infon><infon key="lpage">417</infon><infon key="name_6">surname:Vendemiale;given-names:G.</infon><infon key="name_5">surname:Sancarlo;given-names:D.</infon><infon key="name_4">surname:Santamato;given-names:A.</infon><offset>56925</offset><text>Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease</text></passage><passage><infon key="name_3">surname:Catanzaro;given-names:G.</infon><infon key="name_2">surname:Romano;given-names:E.</infon><infon key="name_1">surname:Masciulli;given-names:F.</infon><infon key="name_0">surname:Ambroselli;given-names:D.</infon><infon key="pub-id_doi">10.3390/nu15030640</infon><infon key="year">2023</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Ritieni;given-names:A.</infon><infon key="name_8">surname:Izzo;given-names:L.</infon><infon key="name_7">surname:Migliaccio;given-names:S.</infon><infon key="name_6">surname:Ferretti;given-names:E.</infon><infon key="name_5">surname:Massari;given-names:M.C.</infon><infon key="name_4">surname:Besharat;given-names:Z.M.</infon><offset>57021</offset><text>New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food</text></passage><passage><infon key="volume">127</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Calder;given-names:P.C.</infon><infon key="fpage">1455</infon><infon key="pub-id_doi">10.1017/S0007114522000782</infon><infon key="pub-id_pmid">35260214</infon><infon key="year">2022</infon><infon key="source">Br. J. Nutr.</infon><infon key="type">ref</infon><infon key="lpage">1457</infon><offset>57113</offset><text>Dietary factors and low-grade inflammation in relation to overweight and obesity revisted</text></passage><passage><infon key="name_3">surname:Dubey;given-names:G.P.</infon><infon key="name_2">surname:Agrawal;given-names:A.</infon><infon key="name_1">surname:Agrawal;given-names:S.</infon><infon key="name_0">surname:Debnath;given-names:M.</infon><infon key="fpage">103</infon><infon key="pub-id_doi">10.1016/j.orcp.2015.10.012</infon><infon key="pub-id_pmid">26614484</infon><infon key="year">2016</infon><infon key="source">Obes. Res. Clin. Pract.</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="section_type">REF</infon><infon key="lpage">113</infon><offset>57203</offset><text>Metaflammatory responses during obesity: Pathomechanism and treatment</text></passage><passage><infon key="name_3">surname:Baroni;given-names:M.G.</infon><infon key="name_2">surname:Ciccarelli;given-names:G.</infon><infon key="name_1">surname:Cimini;given-names:F.A.</infon><infon key="name_0">surname:Barchetta;given-names:I.</infon><infon key="fpage">1257</infon><infon key="pub-id_doi">10.1007/s40618-019-01052-3</infon><infon key="pub-id_pmid">31073969</infon><infon key="year">2019</infon><infon key="source">J. Endocrinol. Invest.</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="section_type">REF</infon><infon key="lpage">1272</infon><infon key="name_4">surname:Cavallo;given-names:M.G.</infon><offset>57273</offset><text>Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation</text></passage><passage><infon key="name_3">surname:Imbimbo;given-names:B.P.</infon><infon key="name_2">surname:Capurso;given-names:C.</infon><infon key="name_1">surname:Solfrizzi;given-names:V.</infon><infon key="name_0">surname:Frisardi;given-names:V.</infon><infon key="fpage">57</infon><infon key="pub-id_doi">10.3233/JAD-2010-100015</infon><infon key="pub-id_pmid">20421697</infon><infon key="year">2010</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Panza;given-names:F.</infon><infon key="lpage">63</infon><infon key="name_6">surname:Pilotto;given-names:A.</infon><infon key="name_5">surname:Seripa;given-names:D.</infon><infon key="name_4">surname:Vendemiale;given-names:G.</infon><offset>57370</offset><text>Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?</text><annotation id="790"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="57373" length="7" /><text>insulin</text></annotation></passage><passage><infon key="name_3">surname:Patrick-Melin;given-names:A.J.</infon><infon key="name_2">surname:Solomon;given-names:T.P.J.</infon><infon key="name_1">surname:Haus;given-names:J.M.</infon><infon key="name_0">surname:Kelly;given-names:K.R.</infon><infon key="fpage">1089</infon><infon key="pub-id_doi">10.3945/jn.111.139964</infon><infon key="pub-id_pmid">21525252</infon><infon key="year">2011</infon><infon key="source">J. Nutr.</infon><infon key="type">ref</infon><infon key="volume">141</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Kirwan;given-names:J.P.</infon><infon key="lpage">1094</infon><infon key="name_6">surname:Barkoukis;given-names:H.</infon><infon key="name_5">surname:Rocco;given-names:M.</infon><infon key="name_4">surname:Cook;given-names:M.</infon><offset>57458</offset><text>A low-glycemic index diet and exercise intervention reduces TNFalpha in isolated mononuclear cells of older, obese adults</text></passage><passage><infon key="volume">40</infon><infon key="name_1">surname:Muccioli;given-names:G.G.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Guillemot-Legris;given-names:O.</infon><infon key="fpage">237</infon><infon key="pub-id_doi">10.1016/j.tins.2017.02.005</infon><infon key="pub-id_pmid">28318543</infon><infon key="year">2017</infon><infon key="source">Trends Neurosci.</infon><infon key="type">ref</infon><infon key="lpage">253</infon><offset>57580</offset><text>Obesity-Induced Neuroinflammation: Beyond the Hypothalamus</text></passage><passage><infon key="name_3">surname:Guyton;given-names:J.R.</infon><infon key="name_2">surname:Califf;given-names:R.M.</infon><infon key="name_1">surname:DeFronzo;given-names:R.A.</infon><infon key="name_0">surname:Miranda;given-names:P.J.</infon><infon key="fpage">33</infon><infon key="pub-id_doi">10.1016/j.ahj.2004.07.013</infon><infon key="pub-id_pmid">15660032</infon><infon key="year">2005</infon><infon key="source">Am. Heart J.</infon><infon key="type">ref</infon><infon key="volume">149</infon><infon key="section_type">REF</infon><infon key="lpage">45</infon><offset>57639</offset><text>Metabolic syndrome: Definition, pathophysiology, and mechanisms</text></passage><passage><infon key="volume">16</infon><infon key="name_2">surname:Al-Domi;given-names:H.A.</infon><infon key="name_1">surname:Ababneh;given-names:N.A.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Al Haj Ahmad;given-names:R.M.</infon><infon key="pub-id_doi">10.1016/j.dsx.2022.102468</infon><infon key="year">2022</infon><infon key="source">Diabetes Metab. Syndr.</infon><infon key="type">ref</infon><offset>57703</offset><text>Brain insulin resistance as a mechanistic mediator links peripheral metabolic disorders with declining cognition</text><annotation id="791"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="57709" length="7" /><text>insulin</text></annotation></passage><passage><infon key="name_3">surname:Lin;given-names:R.L.</infon><infon key="name_2">surname:Anderson;given-names:K.L.</infon><infon key="name_1">surname:Ghoweri;given-names:A.O.</infon><infon key="name_0">surname:Frazier;given-names:H.N.</infon><infon key="fpage">79</infon><infon key="pub-id_doi">10.1016/j.expneurol.2018.12.007</infon><infon key="pub-id_pmid">30576640</infon><infon key="year">2019</infon><infon key="source">Exp. Neurol.</infon><infon key="type">ref</infon><infon key="volume">313</infon><infon key="section_type">REF</infon><infon key="lpage">87</infon><infon key="name_5">surname:Thibault;given-names:O.</infon><infon key="name_4">surname:Porter;given-names:N.M.</infon><offset>57816</offset><text>Broadening the definition of brain insulin resistance in aging and Alzheimer's disease</text><annotation id="792"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="57851" length="7" /><text>insulin</text></annotation></passage><passage><infon key="volume">47</infon><infon key="name_1">surname:Feldman;given-names:E.L.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Kim;given-names:B.</infon><infon key="fpage">e149</infon><infon key="pub-id_doi">10.1038/EMM.2015.3</infon><infon key="pub-id_pmid">25766618</infon><infon key="year">2015</infon><infon key="source">Exp. Mol. Med.</infon><infon key="type">ref</infon><offset>57905</offset><text>Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome</text><annotation id="793"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="57905" length="7" /><text>Insulin</text></annotation></passage><passage><infon key="volume">10</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Holscher;given-names:C.</infon><infon key="fpage">47</infon><infon key="pub-id_doi">10.1016/j.jalz.2013.12.009</infon><infon key="year">2014</infon><infon key="source">Alzheimers Dement.</infon><infon key="type">ref</infon><infon key="lpage">54</infon><offset>58011</offset><text>The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease</text></passage><passage><infon key="name_3">surname:Auriemma;given-names:M.C.</infon><infon key="name_2">surname:Polito;given-names:R.</infon><infon key="name_1">surname:Di Meo;given-names:I.</infon><infon key="name_0">surname:Rizzo;given-names:M.R.</infon><infon key="pub-id_doi">10.1016/j.phrs.2022.106062</infon><infon key="year">2022</infon><infon key="source">Pharmacol. Res.</infon><infon key="type">ref</infon><infon key="volume">176</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Paolisso;given-names:G.</infon><infon key="name_6">surname:Capuano;given-names:A.</infon><infon key="name_5">surname:di Mauro;given-names:G.</infon><infon key="name_4">surname:Gambardella;given-names:A.</infon><offset>58166</offset><text>Cognitive impairment and type 2 diabetes mellitus: Focus of SGLT2 inhibitors treatment</text></passage><passage><infon key="name_3">surname:Moran;given-names:C.</infon><infon key="name_2">surname:Hill-Briggs;given-names:F.</infon><infon key="name_1">surname:Sinclair;given-names:A.J.</infon><infon key="name_0">surname:Srikanth;given-names:V.</infon><infon key="fpage">535</infon><infon key="pub-id_doi">10.1016/S2213-8587(20)30118-2</infon><infon key="pub-id_pmid">32445740</infon><infon key="year">2020</infon><infon key="source">Lancet Diabetes Endocrinol.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="section_type">REF</infon><infon key="lpage">545</infon><infon key="name_4">surname:Biessels;given-names:G.J.</infon><offset>58253</offset><text>Type 2 diabetes and cognitive dysfunction:towards effective management of both comorbidities</text></passage><passage><infon key="volume">24</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Anderson;given-names:N.D.</infon><infon key="fpage">78</infon><infon key="pub-id_doi">10.1017/S1092852918001347</infon><infon key="pub-id_pmid">30651152</infon><infon key="year">2019</infon><infon key="source">CNS Spectr.</infon><infon key="type">ref</infon><infon key="lpage">87</infon><offset>58348</offset><text>State of the science on mild cognitive impairment (MCI)</text></passage><passage><infon key="name_3">surname:Allegra;given-names:M.</infon><infon key="name_2">surname:Di Liberto;given-names:V.</infon><infon key="name_1">surname:Ricciardi;given-names:N.</infon><infon key="name_0">surname:Di Majo;given-names:D.</infon><infon key="pub-id_doi">10.1016/j.biopha.2024.117028</infon><infon key="year">2024</infon><infon key="source">Biomed. Pharmacother.</infon><infon key="type">ref</infon><infon key="volume">177</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Ferraro;given-names:G.</infon><infon key="name_8">surname:Mudo;given-names:G.</infon><infon key="name_7">surname:Massaro;given-names:A.</infon><infon key="name_6">surname:Scordino;given-names:M.</infon><infon key="name_5">surname:Urone;given-names:G.</infon><infon key="name_4">surname:Frinchi;given-names:M.</infon><offset>58404</offset><text>The remarkable impact of Opuntia Ficus Indica fruit administration on metabolic syndrome: Correlations between cognitive functions, oxidative stress and lipid dysmetabolism in the high-fat, diet-fed rat model</text></passage><passage><infon key="name_3">surname:Mader;given-names:K.S.</infon><infon key="name_2">surname:Kugelman;given-names:T.L.</infon><infon key="name_1">surname:Zuloaga;given-names:K.L.</infon><infon key="name_0">surname:Johnson;given-names:L.A.</infon><infon key="fpage">26</infon><infon key="pub-id_doi">10.1016/j.ebiom.2015.12.008</infon><infon key="pub-id_pmid">26870815</infon><infon key="year">2016</infon><infon key="source">EBioMedicine</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Button;given-names:D.</infon><infon key="name_8">surname:Mulford;given-names:A.</infon><infon key="name_7">surname:Marzulla;given-names:T.</infon><infon key="lpage">42</infon><infon key="name_6">surname:Weber;given-names:S.</infon><infon key="name_5">surname:Zuloaga;given-names:D.G.</infon><infon key="name_4">surname:Morre;given-names:J.T.</infon><offset>58613</offset><text>Amelioration of Metabolic Syndrome-Associated Cognitive Impairments in Mice via a Reduction in Dietary Fat Content or Infusion of Non-Diabetic Plasma</text></passage><passage><infon key="name_3">surname:Mannikko;given-names:R.</infon><infon key="name_2">surname:Savonen;given-names:K.</infon><infon key="name_1">surname:Tuomilehto;given-names:J.</infon><infon key="name_0">surname:Komulainen;given-names:P.</infon><infon key="fpage">1428</infon><infon key="pub-id_doi">10.1093/ajcn/nqab018</infon><infon key="pub-id_pmid">33742194</infon><infon key="year">2021</infon><infon key="source">Am. J. Clin. Nutr.</infon><infon key="type">ref</infon><infon key="volume">113</infon><infon key="name_10">surname:Rauramaa;given-names:R.</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Kivipelto;given-names:M.</infon><infon key="name_8">surname:Jacobs;given-names:D.R.</infon><infon key="name_7">surname:Kiviniemi;given-names:V.</infon><infon key="lpage">1439</infon><infon key="name_6">surname:Hanninen;given-names:T.</infon><infon key="name_5">surname:Lakka;given-names:T.A.</infon><infon key="name_4">surname:Hassinen;given-names:M.</infon><offset>58763</offset><text>Exercise, diet, and cognition in a 4-year randomized controlled trial: Dose-Responses to Exercise Training (DR's EXTRA)</text></passage><passage><infon key="name_3">surname:Imbimbo;given-names:B.P.</infon><infon key="name_2">surname:Seripa;given-names:D.</infon><infon key="name_1">surname:Panza;given-names:F.</infon><infon key="name_0">surname:Frisardi;given-names:V.</infon><infon key="fpage">715</infon><infon key="pub-id_doi">10.3233/JAD-2010-100942</infon><infon key="pub-id_pmid">20858954</infon><infon key="year">2010</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="section_type">REF</infon><infon key="lpage">740</infon><infon key="name_6">surname:Solfrizzi;given-names:V.</infon><infon key="name_5">surname:Pilotto;given-names:A.</infon><infon key="name_4">surname:Vendemiale;given-names:G.</infon><offset>58885</offset><text>Nutraceutical properties of mediterranean diet and cognitive decline: Possible underlying mechanisms</text></passage><passage><infon key="name_3">surname:Moffa;given-names:S.</infon><infon key="name_2">surname:Soldovieri;given-names:L.</infon><infon key="name_1">surname:Di Giuseppe;given-names:G.</infon><infon key="name_0">surname:Di Murro;given-names:E.</infon><infon key="fpage">4202</infon><infon key="pub-id_doi">10.3390/nu15194202</infon><infon key="pub-id_pmid">37836486</infon><infon key="year">2023</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Brunetti;given-names:M.</infon><infon key="name_8">surname:Ciccarelli;given-names:G.</infon><infon key="name_7">surname:Cinti;given-names:F.</infon><infon key="lpage">4216</infon><infon key="name_6">surname:Nista;given-names:E.C.</infon><infon key="name_5">surname:Capece;given-names:U.</infon><infon key="name_4">surname:Improta;given-names:I.</infon><offset>58986</offset><text>Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving beta-Cell Function</text></passage><passage><infon key="name_3">surname:Cinti;given-names:F.</infon><infon key="name_2">surname:Cefalo;given-names:C.M.</infon><infon key="name_1">surname:Ciccarelli;given-names:G.</infon><infon key="name_0">surname:DI Giuseppe;given-names:G.</infon><infon key="fpage">272</infon><infon key="pub-id_doi">10.23736/S2724-6507.21.03405-9</infon><infon key="year">2021</infon><infon key="source">Minerva Endocrinol.</infon><infon key="type">ref</infon><infon key="volume">46</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Mezza;given-names:T.</infon><infon key="name_8">surname:Giaccari;given-names:A.</infon><infon key="name_7">surname:Pontecorvi;given-names:A.</infon><infon key="lpage">292</infon><infon key="name_6">surname:Capece;given-names:U.</infon><infon key="name_5">surname:Impronta;given-names:F.</infon><infon key="name_4">surname:Moffa;given-names:S.</infon><offset>59094</offset><text>Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences</text></passage><passage><infon key="volume">11</infon><infon key="name_2">surname:Grover;given-names:B.</infon><infon key="name_1">surname:Shaheen;given-names:M.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Puri;given-names:S.</infon><infon key="fpage">1023907</infon><infon key="pub-id_doi">10.3389/fpubh.2023.1023907</infon><infon key="pub-id_pmid">37050953</infon><infon key="year">2023</infon><infon key="source">Front. Public Health</infon><infon key="type">ref</infon><offset>59216</offset><text>Nutrition and cognitive health: A life course approach</text></passage><passage><infon key="name_3">surname:Catanese;given-names:G.</infon><infon key="name_2">surname:Vernuccio;given-names:L.</infon><infon key="name_1">surname:Veronese;given-names:N.</infon><infon key="name_0">surname:Dominguez;given-names:L.J.</infon><infon key="fpage">4080</infon><infon key="pub-id_doi">10.3390/nu13114080</infon><infon key="pub-id_pmid">34836334</infon><infon key="year">2021</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="section_type">REF</infon><infon key="name_6">surname:Barbagallo;given-names:M.</infon><infon key="name_5">surname:Salemi;given-names:G.</infon><infon key="name_4">surname:Inzerillo;given-names:F.</infon><offset>59271</offset><text>Nutrition, physical activity, and other lifestyle factors in the prevention of cognitive decline and dementia</text></passage><passage><infon key="name_3">surname:Mezza;given-names:T.</infon><infon key="name_2">surname:Rocchetti;given-names:S.</infon><infon key="name_1">surname:Improta;given-names:I.</infon><infon key="name_0">surname:Moffa;given-names:S.</infon><infon key="fpage">1</infon><infon key="pub-id_doi">10.1016/j.nut.2018.04.010</infon><infon key="pub-id_pmid">30086435</infon><infon key="year">2019</infon><infon key="source">Nutrition</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="section_type">REF</infon><infon key="lpage">4</infon><infon key="name_4">surname:Giaccari;given-names:A.</infon><offset>59381</offset><text>Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: Two case reports</text><annotation id="794"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="59425" length="7" /><text>insulin</text></annotation></passage><passage><infon key="name_3">surname:Di Giuseppe;given-names:G.</infon><infon key="name_2">surname:Improta;given-names:I.</infon><infon key="name_1">surname:Moffa;given-names:S.</infon><infon key="name_0">surname:Capece;given-names:U.</infon><infon key="fpage">18</infon><infon key="pub-id_doi">10.3390/nu15010018</infon><infon key="pub-id_pmid">36615676</infon><infon key="year">2022</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="name_10">surname:Mezza;given-names:T.</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Giaccari;given-names:A.</infon><infon key="name_8">surname:Gasbarrini;given-names:A.</infon><infon key="name_7">surname:Pontecorvi;given-names:A.</infon><infon key="lpage">19</infon><infon key="name_6">surname:Cinti;given-names:F.</infon><infon key="name_5">surname:Cefalo;given-names:C.M.A.</infon><infon key="name_4">surname:Nista;given-names:E.C.</infon><offset>59493</offset><text>Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features</text></passage><passage><infon key="volume">12</infon><infon key="name_2">surname:Novellino;given-names:E.</infon><infon key="name_1">surname:Santini;given-names:A.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Daliu;given-names:P.</infon><infon key="fpage">1</infon><infon key="pub-id_doi">10.1080/17512433.2019.1552135</infon><infon key="pub-id_pmid">30484336</infon><infon key="year">2019</infon><infon key="source">Expert Rev. Clin. Pharmacol.</infon><infon key="type">ref</infon><infon key="lpage">7</infon><offset>59598</offset><text>From pharmaceuticals to nutraceuticals: bridging disease prevention and management</text></passage><passage><infon key="name_3">surname:Pallardo;given-names:F.V.</infon><infon key="name_2">surname:Mora;given-names:N.J.</infon><infon key="name_1">surname:Badia;given-names:M.C.</infon><infon key="name_0">surname:Lloret;given-names:A.</infon><infon key="fpage">143</infon><infon key="pub-id_doi">10.3233/JAD-2009-1033</infon><infon key="pub-id_pmid">19494439</infon><infon key="year">2009</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="section_type">REF</infon><infon key="lpage">149</infon><infon key="name_5">surname:Vina;given-names:J.</infon><infon key="name_4">surname:Alonso;given-names:M.D.</infon><offset>59681</offset><text>Vitamin e paradox in alzheimer's disease: It does not prevent loss of cognition and may even be detrimental</text></passage><passage><infon key="volume">15</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Engin;given-names:K.N.</infon><infon key="fpage">855</infon><infon key="pub-id_pmid">19390643</infon><infon key="year">2009</infon><infon key="source">Mol. Vis.</infon><infon key="type">ref</infon><infon key="lpage">860</infon><offset>59791</offset><text>Alpha-tocopherol: looking beyond an antioxidant</text></passage><passage><infon key="name_3">surname:Ahmad;given-names:F.</infon><infon key="name_2">surname:Suhaimi;given-names:F.H.</infon><infon key="name_1">surname:Chin;given-names:K.Y.</infon><infon key="name_0">surname:Wong;given-names:S.K.</infon><infon key="fpage">444</infon><infon key="pub-id_doi">10.3389/fphar.2017.00444</infon><infon key="pub-id_pmid">28725195</infon><infon key="year">2017</infon><infon key="source">Front. Pharmacol.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="section_type">REF</infon><infon key="lpage">512</infon><infon key="name_4">surname:Ima-Nirwana;given-names:S.</infon><offset>59839</offset><text>Vitamin E as a potential interventional treatment for metabolic syndrome: Evidence from animal and human studies</text></passage><passage><infon key="name_3">surname:Wang;given-names:W.</infon><infon key="name_2">surname:Fang;given-names:X.</infon><infon key="name_1">surname:Kang;given-names:I.</infon><infon key="name_0">surname:Zhao;given-names:L.</infon><infon key="fpage">438</infon><infon key="pub-id_doi">10.1038/ijo.2014.124</infon><infon key="year">2015</infon><infon key="source">Int. J. Obes.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Chung;given-names:S.</infon><infon key="lpage">446</infon><infon key="name_6">surname:Marshall;given-names:M.R.</infon><infon key="name_5">surname:Hollins;given-names:R.R.</infon><infon key="name_4">surname:Lee;given-names:M.A.</infon><offset>59952</offset><text>Gamma-tocotrienol attenuates high-fat diet-induced obesity and insulin resistance by inhibiting adipose inflammation and M1 macrophage recruitment</text><annotation id="795"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="60015" length="7" /><text>insulin</text></annotation></passage><passage><infon key="name_3">surname:Fukui;given-names:K.</infon><infon key="volume">27</infon><infon key="name_2">surname:Kiyose;given-names:C.</infon><infon key="name_1">surname:Aoki;given-names:Y.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Kato;given-names:Y.</infon><infon key="fpage">2188</infon><infon key="pub-id_doi">10.3390/molecules27072188</infon><infon key="pub-id_pmid">35408585</infon><infon key="year">2022</infon><infon key="source">Molecules</infon><infon key="type">ref</infon><offset>60099</offset><text>Tocotrienols attenuate white adipose tissue accumulation and improve serum cholesterol concentration in high-fat diet-treated mice</text></passage><passage><infon key="name_3">surname:Paolisso;given-names:G.</infon><infon key="name_2">surname:Ragno;given-names:E.</infon><infon key="name_1">surname:Barbieri;given-names:M.</infon><infon key="name_0">surname:Manzella;given-names:D.</infon><infon key="fpage">1052</infon><infon key="pub-id_doi">10.1093/ajcn/73.6.1052</infon><infon key="pub-id_pmid">11382659</infon><infon key="year">2001</infon><infon key="source">Am. J. Clin. Nutr.</infon><infon key="type">ref</infon><infon key="volume">73</infon><infon key="section_type">REF</infon><infon key="lpage">1057</infon><offset>60230</offset><text>Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes</text></passage><passage><infon key="name_3">surname:Cacciapuoti;given-names:F.</infon><infon key="name_2">surname:Galzerano;given-names:D.</infon><infon key="name_1">surname:Di Maro;given-names:G.</infon><infon key="name_0">surname:Paolisso;given-names:G.</infon><infon key="fpage">1291</infon><infon key="pub-id_doi">10.1093/ajcn/59.6.1291</infon><infon key="pub-id_pmid">8198053</infon><infon key="year">1994</infon><infon key="source">Am. J. Clin. Nutr.</infon><infon key="type">ref</infon><infon key="volume">59</infon><infon key="section_type">REF</infon><infon key="lpage">1296</infon><infon key="name_6">surname:D'Onofrio;given-names:F.</infon><infon key="name_5">surname:Varricchio;given-names:M.</infon><infon key="name_4">surname:Varricchio;given-names:G.</infon><offset>60368</offset><text>Pharmacological doses of vitamin E and insulin action in elderly subjects</text><annotation id="796"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="60407" length="7" /><text>insulin</text></annotation></passage><passage><infon key="volume">131</infon><infon key="name_1">surname:Burgess;given-names:J.R.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Pazdro;given-names:R.</infon><infon key="fpage">276</infon><infon key="pub-id_doi">10.1016/j.mad.2010.03.005</infon><infon key="pub-id_pmid">20307566</infon><infon key="year">2010</infon><infon key="source">Mech. Ageing Dev.</infon><infon key="type">ref</infon><infon key="lpage">286</infon><offset>60442</offset><text>The role of vitamin E and oxidative stress in diabetes complications</text></passage><passage><infon key="name_3">surname:Hu;given-names:J.</infon><infon key="name_2">surname:Martinez;given-names:R.</infon><infon key="name_1">surname:Shirakawa;given-names:J.</infon><infon key="name_0">surname:Mezza;given-names:T.</infon><infon key="fpage">21485</infon><infon key="pub-id_doi">10.1074/jbc.M116.735738</infon><infon key="pub-id_pmid">27535223</infon><infon key="year">2016</infon><infon key="source">J. Biol. Chem.</infon><infon key="type">ref</infon><infon key="volume">291</infon><infon key="section_type">REF</infon><infon key="lpage">21495</infon><infon key="name_5">surname:Kulkarni;given-names:R.N.</infon><infon key="name_4">surname:Giaccari;given-names:A.</infon><offset>60511</offset><text>Nuclear export of FoxO1 is associated with ERK signaling in beta-cells lacking insulin receptors</text><annotation id="797"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="60590" length="7" /><text>insulin</text></annotation></passage><passage><infon key="name_3">surname:Moffa;given-names:S.</infon><infon key="name_2">surname:Giuseppe;given-names:G.D.</infon><infon key="name_1">surname:Ferraro;given-names:P.M.</infon><infon key="name_0">surname:Mezza;given-names:T.</infon><infon key="fpage">e146788</infon><infon key="pub-id_doi">10.1172/JCI146788</infon><infon key="pub-id_pmid">33905373</infon><infon key="year">2021</infon><infon key="source">J. Clin. Invest.</infon><infon key="type">ref</infon><infon key="volume">131</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Pontecorvi;given-names:A.</infon><infon key="name_8">surname:Quero;given-names:G.</infon><infon key="name_7">surname:Capece;given-names:U.</infon><infon key="name_6">surname:Impronta;given-names:F.</infon><infon key="name_5">surname:Cinti;given-names:F.</infon><infon key="name_4">surname:Cefalo;given-names:C.M.A.</infon><offset>60608</offset><text>Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional beta cells in predicting diabetes</text></passage><passage><infon key="volume">107</infon><infon key="name_2">surname:Burr;given-names:I.M.</infon><infon key="name_1">surname:Kooy;given-names:N.W.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Asayama;given-names:K.</infon><infon key="fpage">459</infon><infon key="pub-id_pmid">3517203</infon><infon key="year">1986</infon><infon key="source">J. Lab. Clin. Med.</infon><infon key="type">ref</infon><infon key="lpage">464</infon><offset>60721</offset><text>Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase</text><annotation id="798"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="60779" length="7" /><text>insulin</text></annotation></passage><passage><infon key="name_3">surname:Mutalib;given-names:M.S.A.</infon><infon key="name_2">surname:Khaza'ai;given-names:H.</infon><infon key="name_1">surname:Siraj;given-names:H.H.</infon><infon key="name_0">surname:Mahdy;given-names:Z.A.</infon><infon key="fpage">104</infon><infon key="pub-id_doi">10.14712/18059694.2014.17</infon><infon key="year">2013</infon><infon key="source">Acta Med.</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="name_10">surname:Adeeb;given-names:N.</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Jamil;given-names:M.A.</infon><infon key="name_8">surname:Ismail;given-names:N.A.M.</infon><infon key="name_7">surname:Jaafar;given-names:R.</infon><infon key="lpage">109</infon><infon key="name_6">surname:Dali;given-names:A.Z.H.M.</infon><infon key="name_5">surname:Wahab;given-names:M.A.</infon><infon key="name_4">surname:Azwar;given-names:M.H.</infon><offset>60898</offset><text>Does palm oil vitamin E reduce the risk of pregnancy induced hypertension?</text></passage><passage><infon key="volume">7</infon><infon key="name_2">surname:Mahdy;given-names:Z.A.</infon><infon key="name_1">surname:Sutan;given-names:R.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Aminuddin;given-names:N.A.</infon><infon key="fpage">596405</infon><infon key="pub-id_doi">10.3389/fmed.2020.596405</infon><infon key="year">2020</infon><infon key="source">Front. Med.</infon><infon key="type">ref</infon><offset>60973</offset><text>Role of Palm Oil Vitamin E in Preventing Pre-eclampsia: A Secondary Analysis of a Randomized Clinical Trial Following ISSHP Reclassification</text></passage><passage><infon key="name_3">surname:Khan;given-names:F.A.</infon><infon key="name_2">surname:Salser;given-names:W.A.</infon><infon key="name_1">surname:Sami;given-names:S.A.</infon><infon key="name_0">surname:Qureshi;given-names:A.A.</infon><infon key="fpage">318</infon><infon key="pub-id_doi">10.1016/s0955-2863(01)00144-9</infon><infon key="pub-id_pmid">11516635</infon><infon key="year">2001</infon><infon key="source">J. Nutr. Biochem.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="section_type">REF</infon><infon key="lpage">329</infon><offset>61114</offset><text>Synergistic effect of tocotrienol-rich fraction (TRF(25)) of rice bran and lovastatin on lipid parameters in hypercholesterolemic humans</text></passage><passage><infon key="name_3">surname:Roncaglioni;given-names:M.C.</infon><infon key="name_2">surname:Alli;given-names:C.</infon><infon key="name_1">surname:Avanzini;given-names:F.</infon><infon key="name_0">surname:Palumbo;given-names:G.</infon><infon key="fpage">564</infon><infon key="pub-id_doi">10.1016/s0895-7061(00)00244-2</infon><infon key="pub-id_pmid">10826412</infon><infon key="year">2000</infon><infon key="source">Am. J. Hypertens.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="name_10">surname:Cavalera;given-names:C.</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Costantini;given-names:C.</infon><infon key="name_8">surname:Nosotti;given-names:L.</infon><infon key="name_7">surname:Rossi;given-names:S.</infon><infon key="lpage">567</infon><infon key="name_6">surname:Capra;given-names:A.</infon><infon key="name_5">surname:Cristofari;given-names:M.</infon><infon key="name_4">surname:Ronchi;given-names:E.</infon><offset>61251</offset><text>Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients</text></passage><passage><infon key="volume">18</infon><infon key="name_2">surname:Mazzon;given-names:E.</infon><infon key="name_1">surname:Bramanti;given-names:P.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Gugliandolo;given-names:A.</infon><infon key="pub-id_doi">10.3390/ijms18122504</infon><infon key="year">2017</infon><infon key="source">Int. J. Mol. Sci.</infon><infon key="type">ref</infon><offset>61345</offset><text>Role of vitamin e in the treatment of alzheimer's disease: Evidence from animal models</text></passage><passage><infon key="name_3">surname:Stoecklin;given-names:E.</infon><infon key="name_2">surname:Minihane;given-names:A.M.</infon><infon key="name_1">surname:Rimbach;given-names:G.</infon><infon key="name_0">surname:Rota;given-names:C.</infon><infon key="fpage">21</infon><infon key="pub-id_doi">10.1080/10284150400027123</infon><infon key="pub-id_pmid">15909764</infon><infon key="year">2005</infon><infon key="source">Nutr. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="section_type">REF</infon><infon key="lpage">29</infon><infon key="name_4">surname:Barella;given-names:L.</infon><offset>61434</offset><text>Dietary vitamin E modulates differential gene expression in the rat hippocampus: Potential implications for its neuroprotective properties</text></passage><passage><infon key="name_3">surname:Basran;given-names:J.</infon><infon key="name_2">surname:Hogan;given-names:D.B.</infon><infon key="name_1">surname:Hicks;given-names:M.S.</infon><infon key="name_0">surname:Maxwell;given-names:C.J.</infon><infon key="fpage">45</infon><infon key="pub-id_doi">10.1159/000085074</infon><infon key="pub-id_pmid">15832036</infon><infon key="year">2005</infon><infon key="source">Dement. Geriatr. Cogn. Disord</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="lpage">51</infon><infon key="name_4">surname:Ebly;given-names:E.M.</infon><offset>61573</offset><text>Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia</text></passage><passage><infon key="name_3">surname:Tangney;given-names:C.C.</infon><infon key="name_2">surname:Li;given-names:H.</infon><infon key="name_1">surname:Schneider;given-names:J.A.</infon><infon key="name_0">surname:Morris;given-names:M.C.</infon><infon key="fpage">32</infon><infon key="pub-id_doi">10.1016/j.jalz.2013.12.015</infon><infon key="pub-id_pmid">24589434</infon><infon key="year">2015</infon><infon key="source">Alzheimers Dement.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Barnes;given-names:L.L.</infon><infon key="lpage">39</infon><infon key="name_6">surname:Honer;given-names:W.G.</infon><infon key="name_5">surname:Bennett;given-names:D.A.</infon><infon key="name_4">surname:Nag;given-names:S.</infon><offset>61668</offset><text>Brain tocopherols related to Alzheimer's disease neuropathology in humans</text></passage><passage><infon key="name_3">surname:Buring;given-names:J.E.</infon><infon key="name_2">surname:Manson;given-names:J.A.</infon><infon key="name_1">surname:Cook;given-names:N.</infon><infon key="name_0">surname:Jae;given-names:H.K.</infon><infon key="fpage">2462</infon><infon key="pub-id_doi">10.1001/archinte.166.22.2462</infon><infon key="pub-id_pmid">17159011</infon><infon key="year">2006</infon><infon key="source">Arch. Intern. Med.</infon><infon key="type">ref</infon><infon key="volume">166</infon><infon key="section_type">REF</infon><infon key="lpage">2468</infon><infon key="name_4">surname:Grodstein;given-names:F.</infon><offset>61744</offset><text>A randomized trial of vitamin E supplementation and cognitive function in women</text></passage><passage><infon key="volume">1852</infon><infon key="name_1">surname:Szkudelska;given-names:K.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Szkudelski;given-names:T.</infon><infon key="fpage">1145</infon><infon key="pub-id_doi">10.1016/j.bbadis.2014.10.013</infon><infon key="pub-id_pmid">25445538</infon><infon key="year">2015</infon><infon key="source">Biochim. Biophys. Acta</infon><infon key="type">ref</infon><infon key="lpage">1154</infon><offset>61824</offset><text>Resveratrol and diabetes: From animal to human studies</text></passage><passage><infon key="name_3">surname:Hartzell;given-names:D.L.</infon><infon key="name_2">surname:Rayalam;given-names:S.</infon><infon key="name_1">surname:Yang;given-names:J.Y.</infon><infon key="name_0">surname:Baile;given-names:C.A.</infon><infon key="fpage">40</infon><infon key="pub-id_doi">10.1111/j.1749-6632.2010.05845.x</infon><infon key="pub-id_pmid">21261640</infon><infon key="year">2011</infon><infon key="source">Ann. N. Y. Acad. Sci.</infon><infon key="type">ref</infon><infon key="volume">1215</infon><infon key="section_type">REF</infon><infon key="lpage">47</infon><infon key="name_6">surname:Della-Fera;given-names:M.A.</infon><infon key="name_5">surname:Andersen;given-names:C.</infon><infon key="name_4">surname:Lai;given-names:C.Y.</infon><offset>61879</offset><text>Effect of resveratrol on fat mobilization</text></passage><passage><infon key="name_3">surname:Kim;given-names:Y.</infon><infon key="name_2">surname:Lim;given-names:J.H.</infon><infon key="name_1">surname:Kim;given-names:M.Y.</infon><infon key="name_0">surname:Kim;given-names:E.N.</infon><infon key="fpage">123</infon><infon key="pub-id_doi">10.1016/j.atherosclerosis.2018.01.043</infon><infon key="pub-id_pmid">29407880</infon><infon key="year">2018</infon><infon key="source">Atherosclerosis</infon><infon key="type">ref</infon><infon key="volume">270</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Choi;given-names:B.S.</infon><infon key="name_8">surname:Yoon;given-names:H.E.</infon><infon key="name_7">surname:Chang;given-names:Y.S.</infon><infon key="lpage">131</infon><infon key="name_6">surname:Kim;given-names:Y.S.</infon><infon key="name_5">surname:Park;given-names:C.W.</infon><infon key="name_4">surname:Shin;given-names:S.J.</infon><offset>61921</offset><text>The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system</text><annotation id="799"><infon key="identifier">5972</infon><infon key="type">Gene</infon><location offset="61997" length="5" /><text>renin</text></annotation></passage><passage><infon key="name_3">surname:Houtkooper;given-names:R.H.</infon><infon key="name_2">surname:Bilet;given-names:L.</infon><infon key="name_1">surname:Konings;given-names:E.</infon><infon key="name_0">surname:Timmers;given-names:S.</infon><infon key="fpage">612</infon><infon key="pub-id_doi">10.1016/j.cmet.2011.10.002</infon><infon key="pub-id_pmid">22055504</infon><infon key="year">2011</infon><infon key="source">Cell Metab.</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Kersten;given-names:S.</infon><infon key="name_8">surname:Ryu;given-names:D.</infon><infon key="name_7">surname:Van Der Krieken;given-names:S.</infon><infon key="lpage">622</infon><infon key="name_6">surname:Hoeks;given-names:J.</infon><infon key="name_5">surname:Goossens;given-names:G.H.</infon><infon key="name_4">surname:Van De Weijer;given-names:T.</infon><offset>62024</offset><text>Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans</text></passage><passage><infon key="name_3">surname:Naseri;given-names:R.</infon><infon key="name_2">surname:Momtaz;given-names:S.</infon><infon key="name_1">surname:Karimi;given-names:R.</infon><infon key="name_0">surname:Asgary;given-names:S.</infon><infon key="fpage">173</infon><infon key="pub-id_doi">10.1007/s11154-019-09494-z</infon><infon key="pub-id_pmid">31065943</infon><infon key="year">2019</infon><infon key="source">Rev. Endocr. Metab. Disord.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="lpage">186</infon><infon key="name_4">surname:Farzaei;given-names:M.H.</infon><offset>62159</offset><text>Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis</text></passage><passage><infon key="name_3">surname:Saimaiti;given-names:A.</infon><infon key="name_2">surname:Huang;given-names:S.Y.</infon><infon key="name_1">surname:Luo;given-names:M.</infon><infon key="name_0">surname:Zhou;given-names:D.D.</infon><infon key="pub-id_doi">10.1155/2021/9932218</infon><infon key="year">2021</infon><infon key="source">Oxid. Med. Cell. Longev.</infon><infon key="type">ref</infon><infon key="volume">2021</infon><infon key="section_type">REF</infon><infon key="name_6">surname:Li;given-names:H.B.</infon><infon key="name_5">surname:Gan;given-names:R.Y.</infon><infon key="name_4">surname:Shang;given-names:A.</infon><offset>62253</offset><text>Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases</text></passage><passage><infon key="name_3">surname:Duruksu;given-names:G.</infon><infon key="name_2">surname:Yazir;given-names:Y.</infon><infon key="name_1">surname:Sahin;given-names:T.D.</infon><infon key="name_0">surname:Gocmez;given-names:S.S.</infon><infon key="fpage">198</infon><infon key="pub-id_doi">10.1016/j.physbeh.2018.12.012</infon><infon key="pub-id_pmid">30550811</infon><infon key="year">2019</infon><infon key="source">Physiol. Behav.</infon><infon key="type">ref</infon><infon key="volume">201</infon><infon key="section_type">REF</infon><infon key="lpage">207</infon><infon key="name_6">surname:Utkan;given-names:T.</infon><infon key="name_5">surname:Polat;given-names:S.</infon><infon key="name_4">surname:Eraldemir;given-names:F.C.</infon><offset>62325</offset><text>Resveratrol prevents cognitive deficits by attenuating oxidative damage and inflammation in rat model of streptozotocin diabetes induced vascular dementia</text></passage><passage><infon key="volume">45</infon><infon key="name_2">surname:Wu;given-names:S.N.</infon><infon key="name_1">surname:Chen;given-names:S.A.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Li;given-names:H.F.</infon><infon key="fpage">1035</infon><infon key="pub-id_doi">10.1016/S0008-6363(99)00397-1</infon><infon key="pub-id_pmid">10728430</infon><infon key="year">2000</infon><infon key="source">Cardiovasc. Res.</infon><infon key="type">ref</infon><infon key="lpage">1045</infon><offset>62480</offset><text>Evidence for the stimulatory effect of resveratrol on Ca2+-activated K+ current in vascular endothelial cells</text></passage><passage><infon key="name_3">surname:Floel;given-names:A.</infon><infon key="name_2">surname:Margulies;given-names:D.S.</infon><infon key="name_1">surname:Kerti;given-names:L.</infon><infon key="name_0">surname:Witte;given-names:A.V.</infon><infon key="fpage">7862</infon><infon key="pub-id_doi">10.1523/JNEUROSCI.0385-14.2014</infon><infon key="pub-id_pmid">24899709</infon><infon key="year">2014</infon><infon key="source">J. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">34</infon><infon key="section_type">REF</infon><infon key="lpage">7870</infon><offset>62590</offset><text>Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults</text></passage><passage><infon key="name_3">surname:Su;given-names:Y.</infon><infon key="name_2">surname:Shehzad;given-names:Q.</infon><infon key="name_1">surname:Wang;given-names:Y.</infon><infon key="name_0">surname:Wang;given-names:Y.</infon><infon key="fpage">9455</infon><infon key="pub-id_doi">10.1080/10408398.2023.2212817</infon><infon key="pub-id_pmid">37222574</infon><infon key="year">2024</infon><infon key="source">Crit. Rev. Food Sci. Nutr.</infon><infon key="type">ref</infon><infon key="volume">64</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Wei;given-names:W.</infon><infon key="name_8">surname:Wu;given-names:G.</infon><infon key="name_7">surname:Fang;given-names:Z.</infon><infon key="lpage">9482</infon><infon key="name_6">surname:Zeng;given-names:W.</infon><infon key="name_5">surname:Yu;given-names:L.</infon><infon key="name_4">surname:Xu;given-names:L.</infon><offset>62720</offset><text>Does omega-3 PUFAs supplementation improve metabolic syndrome and related cardiovascular diseases? A systematic review and meta-analysis of randomized controlled trials</text></passage><passage><infon key="name_3">surname:Ma;given-names:W.Q.</infon><infon key="volume">12</infon><infon key="name_2">surname:Sun;given-names:J.H.</infon><infon key="name_1">surname:Yu;given-names:J.H.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Liu;given-names:Y.X.</infon><infon key="pub-id_doi">10.3390/foods12040725</infon><infon key="year">2023</infon><infon key="source">Foods</infon><infon key="type">ref</infon><infon key="name_5">surname:Sun;given-names:G.J.</infon><infon key="name_4">surname:Wang;given-names:J.J.</infon><offset>62889</offset><text>Effects of Omega-3 Fatty Acids Supplementation on Serum Lipid Profile and Blood Pressure in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials</text></passage><passage><infon key="name_3">surname:Chimin;given-names:P.</infon><infon key="name_2">surname:Magdalon;given-names:J.</infon><infon key="name_1">surname:Paschoal;given-names:V.A.</infon><infon key="name_0">surname:Belchior;given-names:T.</infon><infon key="fpage">957</infon><infon key="pub-id_doi">10.1002/mnfr.201400914</infon><infon key="pub-id_pmid">25641959</infon><infon key="year">2015</infon><infon key="source">Mol. Nutr. Food Res.</infon><infon key="type">ref</infon><infon key="volume">59</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Kang;given-names:J.X.</infon><infon key="name_8">surname:Miyamoto;given-names:S.</infon><infon key="name_7">surname:St-Pierre;given-names:P.</infon><infon key="lpage">967</infon><infon key="name_6">surname:Gorjao;given-names:R.</infon><infon key="name_5">surname:Chaves-Filho;given-names:A.B.</infon><infon key="name_4">surname:Farias;given-names:T.M.</infon><offset>63085</offset><text>Omega-3 fatty acids protect from diet-induced obesity, glucose intolerance, and adipose tissue inflammation through PPARgamma-dependent and PPARgamma-independent actions</text></passage><passage><infon key="name_3">surname:Yu;given-names:S.C.</infon><infon key="name_2">surname:Lo;given-names:Y.C.</infon><infon key="name_1">surname:Lee;given-names:H.C.</infon><infon key="name_0">surname:Guo;given-names:Y.R.</infon><infon key="fpage">2228</infon><infon key="pub-id_doi">10.1039/c8fo00074c</infon><infon key="pub-id_pmid">29552684</infon><infon key="year">2018</infon><infon key="source">Food Funct.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="section_type">REF</infon><infon key="lpage">2239</infon><infon key="name_4">surname:Huang;given-names:S.Y.</infon><offset>63255</offset><text>N-3 polyunsaturated fatty acids prevent d-galactose-induced cognitive deficits in prediabetic rats</text></passage><passage><infon key="name_3">surname:Dichi;given-names:J.B.</infon><infon key="name_2">surname:Lozovoy;given-names:M.A.B.</infon><infon key="name_1">surname:Godeny;given-names:P.</infon><infon key="name_0">surname:Simao;given-names:A.N.C.</infon><infon key="fpage">463</infon><infon key="pub-id_doi">10.1590/s0004-27302010000500006</infon><infon key="pub-id_pmid">20694407</infon><infon key="year">2010</infon><infon key="source">Arq. Bras. Endocrinol. Metabol.</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="section_type">REF</infon><infon key="lpage">469</infon><infon key="name_4">surname:Dichi;given-names:I.</infon><offset>63354</offset><text>[Effect of n-3 fatty acids in glycemic and lipid profiles, oxidative stress and total antioxidant capacity in patients with the metabolic syndrome]</text></passage><passage><infon key="name_3">surname:Watts;given-names:G.F.</infon><infon key="name_2">surname:Puddey;given-names:I.B.</infon><infon key="name_1">surname:Burke;given-names:V.</infon><infon key="name_0">surname:Mori;given-names:T.A.</infon><infon key="fpage">1085</infon><infon key="pub-id_doi">10.1093/ajcn/71.5.1085</infon><infon key="pub-id_pmid">10799369</infon><infon key="year">2000</infon><infon key="source">Am. J. Clin. Nutr.</infon><infon key="type">ref</infon><infon key="volume">71</infon><infon key="section_type">REF</infon><infon key="lpage">1094</infon><infon key="name_6">surname:Beilin;given-names:L.J.</infon><infon key="name_5">surname:Best;given-names:J.D.</infon><infon key="name_4">surname:O'Neal;given-names:D.N.</infon><offset>63502</offset><text>Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men</text><annotation id="800"><infon key="identifier">3630</infon><infon key="type">Gene</infon><location offset="63646" length="7" /><text>insulin</text></annotation></passage><passage><infon key="volume">13</infon><infon key="name_1">surname:Calviello;given-names:G.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Serini;given-names:S.</infon><infon key="fpage">123</infon><infon key="pub-id_doi">10.2174/1567205012666150921101147</infon><infon key="pub-id_pmid">26391044</infon><infon key="year">2016</infon><infon key="source">Curr. Alzheimer Res.</infon><infon key="type">ref</infon><infon key="lpage">134</infon><offset>63683</offset><text>Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer's Disease</text></passage><passage><infon key="name_3">surname:Basun;given-names:H.</infon><infon key="name_2">surname:Cederholm;given-names:T.</infon><infon key="name_1">surname:Eriksdotter-Jonhagen;given-names:M.</infon><infon key="name_0">surname:Freund-Levi;given-names:Y.</infon><infon key="fpage">1402</infon><infon key="pub-id_doi">10.1001/archneur.63.10.1402</infon><infon key="pub-id_pmid">17030655</infon><infon key="year">2006</infon><infon key="source">Arch. Neurol.</infon><infon key="type">ref</infon><infon key="volume">63</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Palmblad;given-names:J.</infon><infon key="name_8">surname:Wahlund;given-names:L.O.</infon><infon key="name_7">surname:Vessby;given-names:B.</infon><infon key="lpage">1408</infon><infon key="name_6">surname:Vedin;given-names:I.</infon><infon key="name_5">surname:Garlind;given-names:A.</infon><infon key="name_4">surname:Faxen-Irving;given-names:G.</infon><offset>63821</offset><text>omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study - A randomized double-blind trial</text></passage><passage><infon key="name_3">surname:Yusoff;given-names:N.A.M.</infon><infon key="name_2">surname:Chin;given-names:A.V.</infon><infon key="name_1">surname:Shahar;given-names:S.</infon><infon key="name_0">surname:Lee;given-names:L.K.</infon><infon key="fpage">605</infon><infon key="pub-id_doi">10.1007/s00213-012-2848-0</infon><infon key="pub-id_pmid">22932777</infon><infon key="year">2013</infon><infon key="source">Psychopharmacology (Berl)</infon><infon key="type">ref</infon><infon key="volume">225</infon><infon key="section_type">REF</infon><infon key="lpage">612</infon><offset>63954</offset><text>Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): A 12-month randomised, double-blind, placebo-controlled trial</text></passage><passage><infon key="name_3">surname:Buckley;given-names:J.D.</infon><infon key="name_2">surname:Street;given-names:S.J.</infon><infon key="name_1">surname:Milte;given-names:C.M.</infon><infon key="name_0">surname:Sinn;given-names:N.</infon><infon key="fpage">1682</infon><infon key="pub-id_doi">10.1017/S0007114511004788</infon><infon key="pub-id_pmid">21929835</infon><infon key="year">2012</infon><infon key="source">Br. J. Nutr.</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="section_type">REF</infon><infon key="lpage">1693</infon><infon key="name_6">surname:Howe;given-names:P.R.C.</infon><infon key="name_5">surname:Petkov;given-names:J.</infon><infon key="name_4">surname:Coates;given-names:A.M.</infon><offset>64125</offset><text>Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: A 6-month randomised controlled trial</text></passage><passage><infon key="name_3">surname:Swardfager;given-names:W.</infon><infon key="name_2">surname:Chau;given-names:S.A.</infon><infon key="name_1">surname:Lanctot;given-names:K.L.</infon><infon key="name_0">surname:Mazereeuw;given-names:G.</infon><infon key="fpage">1482.e17</infon><infon key="pub-id_doi">10.1016/j.neurobiolaging.2011.12.014</infon><infon key="year">2012</infon><infon key="source">Neurobiol. Aging</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="section_type">REF</infon><infon key="lpage">1482.e29</infon><infon key="name_4">surname:Herrmann;given-names:N.</infon><offset>64322</offset><text>Effects of omega-3 fatty acids on cognitive performance: A meta-analysis</text></passage><passage><infon key="name_3">surname:Capurso;given-names:C.</infon><infon key="name_2">surname:D'Introno;given-names:A.</infon><infon key="name_1">surname:Colacicco;given-names:A.M.</infon><infon key="name_0">surname:Solfrizzi;given-names:V.</infon><infon key="fpage">619</infon><infon key="pub-id_doi">10.1016/j.exger.2006.03.017</infon><infon key="pub-id_pmid">16697546</infon><infon key="year">2006</infon><infon key="source">Exp. Gerontol.</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Panza;given-names:F.</infon><infon key="name_7">surname:Capurso;given-names:A.</infon><infon key="lpage">627</infon><infon key="name_6">surname:Argentieri;given-names:G.</infon><infon key="name_5">surname:Capurso;given-names:S.A.</infon><infon key="name_4">surname:Del Parigi;given-names:A.</infon><offset>64395</offset><text>Dietary fatty acids intakes and rate of mild cognitive impairment. The Italian Longitudinal Study on Aging</text></passage><passage><infon key="name_3">surname:Giovannini;given-names:M.</infon><infon key="name_2">surname:Bove;given-names:M.</infon><infon key="name_1">surname:Fogacci;given-names:F.</infon><infon key="name_0">surname:Cicero;given-names:A.F.G.</infon><infon key="fpage">655</infon><infon key="pub-id_doi">10.1007/s00394-020-02271-8</infon><infon key="pub-id_pmid">32417946</infon><infon key="year">2021</infon><infon key="source">Eur. J. Nutr.</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="section_type">REF</infon><infon key="lpage">663</infon><infon key="name_4">surname:Borghi;given-names:C.</infon><offset>64502</offset><text>Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial</text></passage><passage><infon key="name_3">surname:Shen;given-names:Z.</infon><infon key="name_2">surname:Zhang;given-names:Q.X.</infon><infon key="name_1">surname:Liu;given-names:X.M.</infon><infon key="name_0">surname:Guo;given-names:Z.</infon><infon key="fpage">844</infon><infon key="pub-id_doi">10.1016/j.numecd.2011.04.008</infon><infon key="pub-id_pmid">21930366</infon><infon key="year">2011</infon><infon key="source">Nutr. Metab. Cardiovasc. Dis.</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Chen;given-names:W.</infon><infon key="name_7">surname:Zhang;given-names:H.P.</infon><infon key="lpage">850</infon><infon key="name_6">surname:Sun;given-names:Z.H.</infon><infon key="name_5">surname:Zhang;given-names:H.</infon><infon key="name_4">surname:Tian;given-names:F.W.</infon><offset>64667</offset><text>Influence of consumption of probiotics on the plasma lipid profile: A meta-analysis of randomised controlled trials</text></passage><passage><infon key="name_3">surname:Zou;given-names:Z.</infon><infon key="volume">12</infon><infon key="name_2">surname:Chen;given-names:M.</infon><infon key="name_1">surname:Dong;given-names:X.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Den;given-names:H.</infon><infon key="fpage">4010</infon><infon key="pub-id_pmid">32062613</infon><infon key="year">2020</infon><infon key="source">Aging (Albany NY)</infon><infon key="type">ref</infon><infon key="lpage">4039</infon><offset>64783</offset><text>Efficacy of probiotics on cognition, and biomarkers of inflammation</text></passage><passage><infon key="name_3">surname:Yanagisawa;given-names:N.</infon><infon key="name_2">surname:Takeda;given-names:T.</infon><infon key="name_1">surname:Xiao;given-names:J.</infon><infon key="name_0">surname:Asaoka;given-names:D.</infon><infon key="fpage">75</infon><infon key="pub-id_doi">10.3233/JAD-220148</infon><infon key="pub-id_pmid">35570493</infon><infon key="year">2022</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">88</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Kasanuki;given-names:K.</infon><infon key="name_8">surname:Higa;given-names:M.</infon><infon key="name_7">surname:Endo;given-names:N.</infon><infon key="lpage">95</infon><infon key="name_6">surname:Sugiyama;given-names:H.</infon><infon key="name_5">surname:Matsubara;given-names:Y.</infon><infon key="name_4">surname:Yamazaki;given-names:T.</infon><offset>64851</offset><text>Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial</text></passage><passage><infon key="name_3">surname:Ohno;given-names:K.</infon><infon key="name_2">surname:Bernier;given-names:F.</infon><infon key="name_1">surname:Katsumata;given-names:N.</infon><infon key="name_0">surname:Xiao;given-names:J.</infon><infon key="fpage">139</infon><infon key="pub-id_doi">10.3233/JAD-200488</infon><infon key="pub-id_pmid">32623402</infon><infon key="year">2020</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Kaneko;given-names:T.</infon><infon key="name_7">surname:Ito;given-names:K.</infon><infon key="lpage">147</infon><infon key="name_6">surname:Yoshikawa;given-names:K.</infon><infon key="name_5">surname:Odamaki;given-names:T.</infon><infon key="name_4">surname:Yamauchi;given-names:Y.</infon><offset>65086</offset><text>Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial</text></passage><passage><infon key="name_3">surname:Shimizu;given-names:T.</infon><infon key="name_2">surname:Katsumata;given-names:N.</infon><infon key="name_1">surname:Ohno;given-names:K.</infon><infon key="name_0">surname:Bernier;given-names:F.</infon><infon key="fpage">493</infon><infon key="pub-id_doi">10.3233/jad-201488</infon><infon key="pub-id_pmid">33814441</infon><infon key="year">2021</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">81</infon><infon key="section_type">REF</infon><infon key="lpage">497</infon><infon key="name_4">surname:Xiao;given-names:J.</infon><offset>65262</offset><text>Association of Plasma Hemoglobin A1c with Improvement of Cognitive Functions by Probiotic Bifidobacterium breve Supplementation in Healthy Adults with Mild Cognitive Impairment</text></passage><passage><infon key="name_3">surname:Anzai;given-names:S.</infon><infon key="name_2">surname:Okada;given-names:E.</infon><infon key="name_1">surname:Toshimitsu;given-names:T.</infon><infon key="name_0">surname:Sakurai;given-names:K.</infon><infon key="pub-id_doi">10.3390/nu14204300</infon><infon key="year">2022</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Hisatsune;given-names:T.</infon><infon key="name_7">surname:Sashihara;given-names:T.</infon><infon key="name_6">surname:Kobayashi;given-names:S.</infon><infon key="name_5">surname:Inamura;given-names:N.</infon><infon key="name_4">surname:Shiraishi;given-names:I.</infon><offset>65439</offset><text>Effects of Lactiplantibacillus plantarum OLL2712 on Memory Function in Older Adults with Declining Memory: A Randomized Placebo-Controlled Trial</text></passage><passage><infon key="name_3">surname:Yoshino;given-names:K.</infon><infon key="name_2">surname:Matsumoto;given-names:A.</infon><infon key="name_1">surname:Kinoshita;given-names:T.</infon><infon key="name_0">surname:Kobayashi;given-names:Y.</infon><infon key="fpage">70</infon><infon key="pub-id_doi">10.14283/jpad.2018.32</infon><infon key="pub-id_pmid">30569089</infon><infon key="year">2019</infon><infon key="source">J. Prev. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="section_type">REF</infon><infon key="lpage">75</infon><infon key="name_5">surname:Xiao;given-names:J.Z.</infon><infon key="name_4">surname:Saito;given-names:I.</infon><offset>65584</offset><text>Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study</text></passage><passage><infon key="name_3">surname:Magagna;given-names:A.</infon><infon key="name_2">surname:Ghiadoni;given-names:L.</infon><infon key="name_1">surname:Virdis;given-names:A.</infon><infon key="name_0">surname:Taddei;given-names:S.</infon><infon key="fpage">2222</infon><infon key="pub-id_doi">10.1161/01.CIR.97.22.2222</infon><infon key="pub-id_pmid">9631871</infon><infon key="year">1998</infon><infon key="source">Circulation</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="section_type">REF</infon><infon key="lpage">2229</infon><infon key="name_4">surname:Salvetti;given-names:A.</infon><offset>65732</offset><text>Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension</text></passage><passage><infon key="name_3">surname:Lefebvre;given-names:P.J.</infon><infon key="volume">81</infon><infon key="name_2">surname:Quatraro;given-names:A.</infon><infon key="name_1">surname:Giugliano;given-names:D.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Ceriello;given-names:A.</infon><infon key="fpage">739</infon><infon key="pub-id_doi">10.1042/cs0810739</infon><infon key="year">1991</infon><infon key="source">Clin. Sci.</infon><infon key="type">ref</infon><infon key="lpage">742</infon><offset>65847</offset><text>Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects</text></passage><passage><infon key="name_3">surname:Caballero;given-names:A.E.</infon><infon key="name_2">surname:Caselli;given-names:A.</infon><infon key="name_1">surname:Khaodhiar;given-names:L.</infon><infon key="name_0">surname:Economides;given-names:P.A.</infon><infon key="fpage">204</infon><infon key="pub-id_doi">10.2337/diabetes.54.1.204</infon><infon key="pub-id_pmid">15616030</infon><infon key="year">2005</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">54</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Veves;given-names:A.</infon><infon key="name_8">surname:Horton;given-names:E.S.</infon><infon key="name_7">surname:Johnstone;given-names:M.T.</infon><infon key="lpage">211</infon><infon key="name_6">surname:King;given-names:G.L.</infon><infon key="name_5">surname:Bursell;given-names:S.E.</infon><infon key="name_4">surname:Keenan;given-names:H.</infon><offset>65932</offset><text>The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients</text></passage><passage><infon key="name_3">surname:Tabet;given-names:N.</infon><infon key="volume">4</infon><infon key="name_2">surname:Isaac;given-names:M.G.E.K.N.</infon><infon key="name_1">surname:Llewellyn;given-names:D.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Farina;given-names:N.</infon><infon key="fpage">CD002854</infon><infon key="pub-id_doi">10.1002/14651858.CD002854.pub5</infon><infon key="pub-id_pmid">28418065</infon><infon key="year">2017</infon><infon key="source">Cochrane Database Syst. Rev.</infon><infon key="type">ref</infon><offset>66080</offset><text>Vitamin E for Alzheimer's dementia and mild cognitive impairment</text></passage><passage><infon key="name_3">surname:Beatty;given-names:F.B.</infon><infon key="volume">9</infon><infon key="name_2">surname:Batra;given-names:K.</infon><infon key="name_1">surname:Sharma;given-names:M.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Lakhan;given-names:R.</infon><infon key="fpage">1573</infon><infon key="pub-id_doi">10.3390/healthcare9111573</infon><infon key="pub-id_pmid">34828619</infon><infon key="year">2021</infon><infon key="source">Healthcare</infon><infon key="type">ref</infon><offset>66147</offset><text>The role of vitamin e in slowing down mild cognitive impairment: A narrative review</text></passage><passage><infon key="name_3">surname:Fukui;given-names:K.</infon><infon key="name_2">surname:Takatsu;given-names:H.</infon><infon key="name_1">surname:Arai;given-names:M.</infon><infon key="name_0">surname:Kaneai;given-names:N.</infon><infon key="fpage">183</infon><infon key="pub-id_doi">10.3233/JAD-2011-111133</infon><infon key="pub-id_pmid">21971407</infon><infon key="year">2012</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="section_type">REF</infon><infon key="lpage">189</infon><infon key="name_4">surname:Urano;given-names:S.</infon><offset>66231</offset><text>Vitamin e inhibits oxidative stress-induced denaturation of nerve terminal proteins involved in neurotransmission</text></passage><passage><infon key="volume">84</infon><infon key="name_1">surname:Manor;given-names:D.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Ulatowski;given-names:L.M.</infon><infon key="fpage">78</infon><infon key="pub-id_doi">10.1016/j.nbd.2015.04.002</infon><infon key="pub-id_pmid">25913028</infon><infon key="year">2015</infon><infon key="source">Neurobiol. Dis.</infon><infon key="type">ref</infon><infon key="lpage">83</infon><offset>66345</offset><text>Vitamin E and neurodegeneration</text></passage><passage><infon key="name_2">surname:Tabet;given-names:N.</infon><infon key="name_1">surname:Quinn;given-names:R.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Isaac;given-names:M.G.E.K.N.</infon><infon key="fpage">CD002854</infon><infon key="pub-id_doi">10.1002/14651858.CD002854.pub2</infon><infon key="pub-id_pmid">18646084</infon><infon key="year">2008</infon><infon key="source">Cochrane Database Syst. Rev.</infon><infon key="type">ref</infon><offset>66377</offset><text>Vitamin E for Alzheimer's disease and mild cognitive impairment</text></passage><passage><infon key="name_3">surname:Vina;given-names:J.</infon><infon key="name_2">surname:Fuchsberger;given-names:T.</infon><infon key="name_1">surname:Lloret;given-names:A.</infon><infon key="name_0">surname:Giraldo;given-names:E.</infon><infon key="fpage">873</infon><infon key="pub-id_doi">10.1016/j.redox.2014.03.002</infon><infon key="pub-id_pmid">25061569</infon><infon key="year">2014</infon><infon key="source">Redox Biol.</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="section_type">REF</infon><infon key="lpage">877</infon><offset>66443</offset><text>Abeta and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: Protective role of vitamin E</text><annotation id="801"><infon key="identifier">4137</infon><infon key="type">Gene</infon><location offset="66453" length="3" /><text>tau</text></annotation><annotation id="802"><infon key="identifier">351</infon><infon key="type">Gene</infon><location offset="66443" length="5" /><text>Abeta</text></annotation></passage><passage><infon key="volume">89</infon><infon key="name_1">surname:Barbagallo;given-names:M.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Dominguez;given-names:L.J.</infon><infon key="fpage">276</infon><infon key="pub-id_doi">10.23750/abm.v89i2.7401</infon><infon key="pub-id_pmid">29957766</infon><infon key="year">2018</infon><infon key="source">Acta Biomed.</infon><infon key="type">ref</infon><infon key="lpage">290</infon><offset>66568</offset><text>Nutritional prevention of cognitive decline and dementia</text></passage><passage><infon key="name_3">surname:Sabri;given-names:N.A.</infon><infon key="name_2">surname:Rahmo;given-names:R.M.</infon><infon key="name_1">surname:Tadros;given-names:M.G.</infon><infon key="name_0">surname:Nagib;given-names:M.M.</infon><infon key="fpage">451</infon><infon key="pub-id_doi">10.1007/s12640-018-9971-6</infon><infon key="pub-id_pmid">30374909</infon><infon key="year">2019</infon><infon key="source">Neurotox. Res.</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="section_type">REF</infon><infon key="lpage">462</infon><infon key="name_5">surname:Masoud;given-names:S.I.</infon><infon key="name_4">surname:Khalifa;given-names:A.E.</infon><offset>66625</offset><text>Ameliorative Effects of alpha-Tocopherol and/or Coenzyme Q10 on Phenytoin-Induced Cognitive Impairment in Rats: Role of VEGF and BDNF-TrkB-CREB Pathway</text></passage><passage><infon key="name_3">surname:Moranta;given-names:D.</infon><infon key="name_2">surname:Terrasa;given-names:J.L.</infon><infon key="name_1">surname:Sarubbo;given-names:F.</infon><infon key="name_0">surname:Ramis;given-names:M.R.</infon><infon key="fpage">159</infon><infon key="pub-id_doi">10.1089/rej.2015.1685</infon><infon key="pub-id_pmid">26414867</infon><infon key="year">2016</infon><infon key="source">Rejuvenation Res.</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="section_type">REF</infon><infon key="lpage">171</infon><infon key="name_6">surname:Esteban;given-names:S.</infon><infon key="name_5">surname:Miralles;given-names:A.</infon><infon key="name_4">surname:Aparicio;given-names:S.</infon><offset>66777</offset><text>Chronic alpha-Tocopherol Increases Central Monoamines Synthesis and Improves Cognitive and Motor Abilities in Old Rats</text></passage><passage><infon key="name_3">surname:Fang;given-names:C.</infon><infon key="name_2">surname:Li;given-names:Y.</infon><infon key="name_1">surname:Guo;given-names:J.</infon><infon key="name_0">surname:Qi;given-names:X.</infon><infon key="fpage">2592</infon><infon key="pub-id_doi">10.1038/s41598-024-52482-w</infon><infon key="pub-id_pmid">38296998</infon><infon key="year">2024</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="section_type">REF</infon><infon key="name_6">surname:Jia;given-names:J.</infon><infon key="name_5">surname:Chen;given-names:X.</infon><infon key="name_4">surname:Lin;given-names:J.</infon><offset>66896</offset><text>Vitamin E intake is inversely associated with NAFLD measured by liver ultrasound transient elastography</text></passage><passage><infon key="name_3">surname:Moffa;given-names:S.</infon><infon key="name_2">surname:Cinti;given-names:F.</infon><infon key="name_1">surname:Di Giuseppe;given-names:G.</infon><infon key="name_0">surname:Ciccarelli;given-names:G.</infon><infon key="fpage">e3668</infon><infon key="pub-id_doi">10.1002/dmrr.3668</infon><infon key="pub-id_pmid">37309298</infon><infon key="year">2023</infon><infon key="source">Diabetes. Metab. Res. Rev.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="section_type">REF</infon><infon key="name_5">surname:Giaccari;given-names:A.</infon><infon key="name_4">surname:Mezza;given-names:T.</infon><offset>67000</offset><text>Why do some glucose-lowering agents improve non-alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis</text></passage><passage><infon key="volume">21</infon><infon key="name_2">surname:Fukui;given-names:K.</infon><infon key="name_1">surname:Aoki;given-names:Y.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Kato;given-names:Y.</infon><infon key="fpage">4533</infon><infon key="pub-id_doi">10.3390/ijms21124533</infon><infon key="pub-id_pmid">32630592</infon><infon key="year">2020</infon><infon key="source">Int. J. Mol. Sci.</infon><infon key="type">ref</infon><offset>67155</offset><text>Tocotrienols influence body weight gain and brain protein expression in long-term high-fat diet-treated mice</text></passage><passage><infon key="name_3">surname:Kashiwaya;given-names:S.</infon><infon key="name_2">surname:Noto;given-names:A.</infon><infon key="name_1">surname:Ben;given-names:J.</infon><infon key="name_0">surname:Kato;given-names:Y.</infon><infon key="pub-id_doi">10.3390/ijms25063561</infon><infon key="year">2024</infon><infon key="source">Int. J. Mol. Sci.</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Fukui;given-names:K.</infon><infon key="name_7">surname:Miura;given-names:Y.</infon><infon key="name_6">surname:Tsumoto;given-names:H.</infon><infon key="name_5">surname:Watanabe;given-names:N.</infon><infon key="name_4">surname:Aoki;given-names:Y.</infon><offset>67264</offset><text>Tocotrienols Prevent the Decline of Learning Ability in High-Fat, High-Sucrose Diet-Fed C57BL/6 Mice</text></passage><passage><infon key="volume">16</infon><infon key="name_1">surname:Ghidoni;given-names:R.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Signorelli;given-names:P.</infon><infon key="fpage">449</infon><infon key="pub-id_doi">10.1016/j.jnutbio.2005.01.017</infon><infon key="pub-id_pmid">16043028</infon><infon key="year">2005</infon><infon key="source">J. Nutr. Biochem.</infon><infon key="type">ref</infon><infon key="lpage">466</infon><offset>67365</offset><text>Resveratrol as an anticancer nutrient: Molecular basis, open questions and promises</text></passage><passage><infon key="volume">411</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Dixon;given-names:R.A.</infon><infon key="fpage">843</infon><infon key="pub-id_doi">10.1038/35081178</infon><infon key="pub-id_pmid">11459067</infon><infon key="year">2001</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="lpage">847</infon><offset>67449</offset><text>Natural products and plant disease resistance</text></passage><passage><infon key="name_3">surname:Camara;given-names:M.</infon><infon key="volume">14</infon><infon key="name_2">surname:Fernandez-Ruiz;given-names:V.</infon><infon key="name_1">surname:Dominguez;given-names:L.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Lopez-Rodriguez;given-names:R.</infon><infon key="fpage">3194</infon><infon key="pub-id_doi">10.3390/nu14153194</infon><infon key="pub-id_pmid">35956370</infon><infon key="year">2022</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><offset>67495</offset><text>Extracts Rich in Nutrients as Novel Food Ingredients to Be Used in Food Supplements: A Proposal Classification</text></passage><passage><infon key="name_3">surname:Leonetti;given-names:F.</infon><infon key="name_2">surname:Ciccarelli;given-names:G.</infon><infon key="name_1">surname:Barchetta;given-names:I.</infon><infon key="name_0">surname:Cimini;given-names:F.A.</infon><infon key="fpage">e3358</infon><infon key="pub-id_doi">10.1002/dmrr.3358</infon><infon key="pub-id_pmid">32469428</infon><infon key="year">2021</infon><infon key="source">Diabetes. Metab. Res. Rev.</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Ceccarelli;given-names:V.</infon><infon key="name_8">surname:Bertoccini;given-names:L.</infon><infon key="name_7">surname:Capoccia;given-names:D.</infon><infon key="name_6">surname:Di Cristofano;given-names:C.</infon><infon key="name_5">surname:Chiappetta;given-names:C.</infon><infon key="name_4">surname:Silecchia;given-names:G.</infon><offset>67606</offset><text>Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease</text></passage><passage><infon key="name_3">surname:Oka;given-names:T.</infon><infon key="name_2">surname:Pereira;given-names:T.J.</infon><infon key="name_1">surname:Chakrabarti;given-names:S.</infon><infon key="name_0">surname:Dolinsky;given-names:V.W.</infon><infon key="fpage">1723</infon><infon key="pub-id_doi">10.1016/j.bbadis.2013.05.018</infon><infon key="pub-id_pmid">23707558</infon><infon key="year">2013</infon><infon key="source">Biochim. Biophys. Acta</infon><infon key="type">ref</infon><infon key="volume">1832</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Lopaschuk;given-names:G.D.</infon><infon key="name_8">surname:Nagendran;given-names:J.</infon><infon key="name_7">surname:Morton;given-names:J.S.</infon><infon key="lpage">1733</infon><infon key="name_6">surname:Zordoky;given-names:B.N.</infon><infon key="name_5">surname:Beker;given-names:D.</infon><infon key="name_4">surname:Levasseur;given-names:J.</infon><offset>67716</offset><text>Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice</text></passage><passage><infon key="name_3">surname:Guiguer;given-names:E.L.</infon><infon key="name_2">surname:Laurindo;given-names:L.F.</infon><infon key="name_1">surname:Marton;given-names:L.T.</infon><infon key="name_0">surname:Buglio;given-names:D.S.</infon><infon key="fpage">797</infon><infon key="pub-id_doi">10.1089/jmf.2021.0084</infon><infon key="pub-id_pmid">35353606</infon><infon key="year">2022</infon><infon key="source">J. Med. Food</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="section_type">REF</infon><infon key="name_8">surname:Barbalho;given-names:S.M.</infon><infon key="name_7">surname:Rubira;given-names:C.J.</infon><infon key="lpage">806</infon><infon key="name_6">surname:Goulart;given-names:R.d.A.</infon><infon key="name_5">surname:Buchaim;given-names:R.L.</infon><infon key="name_4">surname:Araujo;given-names:A.C.</infon><offset>67804</offset><text>The Role of Resveratrol in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review</text></passage><passage><infon key="name_3">surname:Tesky;given-names:V.A.</infon><infon key="name_2">surname:Schnelle;given-names:A.</infon><infon key="name_1">surname:Witte;given-names:A.V.</infon><infon key="name_0">surname:Kobe;given-names:T.</infon><infon key="fpage">1</infon><infon key="pub-id_doi">10.3389/fnins.2017.00105</infon><infon key="pub-id_pmid">28154520</infon><infon key="year">2017</infon><infon key="source">Front. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Floel;given-names:A.</infon><infon key="name_8">surname:Grittner;given-names:U.</infon><infon key="name_7">surname:Bohlken;given-names:J.</infon><infon key="lpage">11</infon><infon key="name_6">surname:Hahn;given-names:A.</infon><infon key="name_5">surname:Schuchardt;given-names:J.P.</infon><infon key="name_4">surname:Pantel;given-names:J.</infon><offset>67904</offset><text>Impact of resveratrol on glucose control, hippocampal structure and connectivity, and memory performance in patients with mild cognitive impairment</text></passage><passage><infon key="name_3">surname:Gacar;given-names:G.</infon><infon key="name_2">surname:Utkan;given-names:T.</infon><infon key="name_1">surname:Gacar;given-names:N.</infon><infon key="name_0">surname:Gocmez;given-names:S.S.</infon><infon key="fpage">131</infon><infon key="pub-id_doi">10.1016/j.nlm.2016.03.022</infon><infon key="pub-id_pmid">27040098</infon><infon key="year">2016</infon><infon key="source">Neurobiol. Learn. Mem.</infon><infon key="type">ref</infon><infon key="volume">131</infon><infon key="section_type">REF</infon><infon key="lpage">136</infon><infon key="name_5">surname:Tumer;given-names:N.</infon><infon key="name_4">surname:Scarpace;given-names:P.J.</infon><offset>68052</offset><text>Protective effects of resveratrol on aging-induced cognitive impairment in rats</text></passage><passage><infon key="name_3">surname:Camins;given-names:A.</infon><infon key="name_2">surname:Ferrer;given-names:I.</infon><infon key="name_1">surname:Grinan-Ferre;given-names:C.</infon><infon key="name_0">surname:Porquet;given-names:D.</infon><infon key="fpage">1209</infon><infon key="pub-id_doi">10.3233/JAD-140444</infon><infon key="pub-id_pmid">25024312</infon><infon key="year">2014</infon><infon key="source">J. Alzheimer's Dis.</infon><infon key="type">ref</infon><infon key="volume">42</infon><infon key="section_type">REF</infon><infon key="lpage">1220</infon><infon key="name_6">surname:Pallas;given-names:M.</infon><infon key="name_5">surname:Del Valle;given-names:J.</infon><infon key="name_4">surname:Sanfeliu;given-names:C.</infon><offset>68132</offset><text>Neuroprotective role of trans-resveratrol in a murine model of familial alzheimer's disease</text></passage><passage><infon key="name_3">surname:Davidge;given-names:S.T.</infon><infon key="name_2">surname:Morton;given-names:J.S.</infon><infon key="name_1">surname:Rueda-Clausen;given-names:C.F.</infon><infon key="name_0">surname:Dolinsky;given-names:V.W.</infon><infon key="fpage">2274</infon><infon key="pub-id_doi">10.2337/db11-0374</infon><infon key="pub-id_pmid">21810598</infon><infon key="year">2011</infon><infon key="source">Diabetes</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="section_type">REF</infon><infon key="lpage">2284</infon><infon key="name_4">surname:Dyck;given-names:J.R.B.</infon><offset>68226</offset><text>Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted</text></passage><passage><infon key="name_3">surname:Canudas;given-names:A.M.</infon><infon key="name_2">surname:Lopez-Ruiz;given-names:S.</infon><infon key="name_1">surname:Palomera-Avalos;given-names:V.</infon><infon key="name_0">surname:Izquierdo;given-names:V.</infon><infon key="fpage">1134</infon><infon key="pub-id_doi">10.3390/ijms20051134</infon><infon key="pub-id_pmid">30845644</infon><infon key="year">2019</infon><infon key="source">Int. J. Mol. Sci.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="section_type">REF</infon><infon key="name_5">surname:Grinan-Ferre;given-names:C.</infon><infon key="name_4">surname:Pallas;given-names:M.</infon><offset>68357</offset><text>Maternal resveratrol supplementation prevents cognitive decline in senescent mice offspring</text></passage><passage><infon key="name_3">surname:Zeng;given-names:X.</infon><infon key="name_2">surname:Pan;given-names:D.</infon><infon key="name_1">surname:Chen;given-names:T.</infon><infon key="name_0">surname:Wu;given-names:Z.</infon><infon key="fpage">1318</infon><infon key="pub-id_doi">10.1039/d0fo02029j</infon><infon key="pub-id_pmid">33443506</infon><infon key="year">2021</infon><infon key="source">Food Funct.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="section_type">REF</infon><infon key="lpage">1326</infon><infon key="name_5">surname:Zhao;given-names:G.</infon><infon key="name_4">surname:Guo;given-names:Y.</infon><offset>68449</offset><text>Resveratrol and organic selenium-rich fermented milk reduces D-galactose-induced cognitive dysfunction in mice</text></passage><passage><infon key="name_3">surname:Goossens;given-names:G.H.</infon><infon key="name_2">surname:Boekschoten;given-names:M.V.</infon><infon key="name_1">surname:Timmers;given-names:S.</infon><infon key="name_0">surname:Konings;given-names:E.</infon><infon key="fpage">470</infon><infon key="pub-id_doi">10.1038/ijo.2013.155</infon><infon key="year">2014</infon><infon key="source">Int. J. Obes.</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Blaak;given-names:E.E.</infon><infon key="name_8">surname:Mariman;given-names:E.C.</infon><infon key="name_7">surname:Schrauwen;given-names:P.</infon><infon key="lpage">473</infon><infon key="name_6">surname:Muller;given-names:M.</infon><infon key="name_5">surname:Afman;given-names:L.A.</infon><infon key="name_4">surname:Jocken;given-names:J.W.</infon><offset>68560</offset><text>The effects of 30 days resveratrol supplementation on adipose tissue morphology and gene expression patterns in obese men</text></passage><passage><infon key="name_3">surname:Yin;given-names:L.</infon><infon key="name_2">surname:Ren;given-names:G.</infon><infon key="name_1">surname:Liu;given-names:Y.</infon><infon key="name_0">surname:Tian;given-names:X.</infon><infon key="fpage">1</infon><infon key="pub-id_doi">10.1016/j.brainres.2016.08.032</infon><infon key="pub-id_pmid">27566063</infon><infon key="year">2016</infon><infon key="source">Brain Res.</infon><infon key="type">ref</infon><infon key="volume">1650</infon><infon key="section_type">REF</infon><infon key="name_7">surname:An;given-names:R.</infon><infon key="lpage">9</infon><infon key="name_6">surname:Dang;given-names:H.</infon><infon key="name_5">surname:Geng;given-names:T.</infon><infon key="name_4">surname:Liang;given-names:X.</infon><offset>68683</offset><text>Resveratrol limits diabetes-associated cognitive decline in rats by preventing oxidative stress and inflammation and modulating hippocampal structural synaptic plasticity</text></passage><passage><infon key="name_3">surname:Blackman;given-names:M.R.</infon><infon key="name_2">surname:Anawalt;given-names:B.</infon><infon key="name_1">surname:Feingold;given-names:K.R.</infon><infon key="name_0">surname:Feingold;given-names:K.R.</infon><infon key="year">2000</infon><infon key="source">The Effect of Diet on Cardiovascular Disease and Lipid and Lipoprotein Levels</infon><infon key="type">ref</infon><infon key="name_10">surname:Hofland;given-names:J.</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Dungan;given-names:K.</infon><infon key="name_8">surname:Dhatariya;given-names:K.</infon><infon key="name_7">surname:de Herder;given-names:W.W.</infon><infon key="name_6">surname:Corpas;given-names:E.</infon><infon key="name_5">surname:Chrousos;given-names:G.</infon><infon key="name_4">surname:Boyce;given-names:A.</infon><offset>68854</offset></passage><passage><infon key="name_3">surname:Sakane;given-names:N.</infon><infon key="name_2">surname:Kotani;given-names:K.</infon><infon key="name_1">surname:Shimatsu;given-names:A.</infon><infon key="name_0">surname:Satoh;given-names:N.</infon><infon key="fpage">144</infon><infon key="pub-id_doi">10.2337/dc06-1179</infon><infon key="pub-id_pmid">17192349</infon><infon key="year">2007</infon><infon key="source">Diabetes Care</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Ogawa;given-names:Y.</infon><infon key="lpage">146</infon><infon key="name_6">surname:Kuzuya;given-names:H.</infon><infon key="name_5">surname:Suganami;given-names:T.</infon><infon key="name_4">surname:Yamada;given-names:K.</infon><offset>68855</offset><text>Purified eicosapentaenoic acid reduces small dense LDL, remnant lipoprotein particles, and C-reactive protein in metabolic syndrome</text><annotation id="803"><infon key="identifier">1401</infon><infon key="type">Gene</infon><location offset="68946" length="18" /><text>C-reactive protein</text></annotation></passage><passage><infon key="volume">63</infon><infon key="name_2">surname:Lovegrove;given-names:J.A.</infon><infon key="name_1">surname:Williams;given-names:C.M.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Brady;given-names:L.M.</infon><infon key="fpage">115</infon><infon key="pub-id_doi">10.1079/pns2003318</infon><infon key="pub-id_pmid">15099409</infon><infon key="year">2004</infon><infon key="source">Proc. Nutr. Soc.</infon><infon key="type">ref</infon><infon key="lpage">125</infon><offset>68987</offset><text>Dietary PUFA and the metabolic syndrome in Indian Asians living in the UK</text></passage><passage><infon key="name_3">surname:Puddey;given-names:I.B.</infon><infon key="name_2">surname:Burke;given-names:V.</infon><infon key="name_1">surname:Mori;given-names:T.A.</infon><infon key="name_0">surname:Woodman;given-names:R.J.</infon><infon key="fpage">1007</infon><infon key="pub-id_doi">10.1093/ajcn/76.5.1007</infon><infon key="pub-id_pmid">12399272</infon><infon key="year">2002</infon><infon key="source">Am. J. Clin. Nutr.</infon><infon key="type">ref</infon><infon key="volume">76</infon><infon key="section_type">REF</infon><infon key="lpage">1015</infon><infon key="name_5">surname:Beilin;given-names:L.J.</infon><infon key="name_4">surname:Watts;given-names:G.F.</infon><offset>69061</offset><text>Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension</text></passage><passage><infon key="name_3">surname:Takeuchi;given-names:H.</infon><infon key="name_2">surname:Aoyama;given-names:T.</infon><infon key="name_1">surname:Suzuki;given-names:Y.</infon><infon key="name_0">surname:Ogawa;given-names:A.</infon><infon key="fpage">355</infon><infon key="pub-id_doi">10.5650/jos.58.355</infon><infon key="pub-id_pmid">19491530</infon><infon key="year">2009</infon><infon key="source">J. Oleo Sci.</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="section_type">REF</infon><infon key="lpage">360</infon><offset>69232</offset><text>Dietary alpha-linolenic acid inhibits angiotensin-converting enzyme activity and mRNA expression levels in the aorta of spontaneously hypertensive rats</text></passage><passage><infon key="name_3">surname:Hoey;given-names:L.</infon><infon key="name_2">surname:Ward;given-names:M.</infon><infon key="name_1">surname:Hughes;given-names:C.F.</infon><infon key="name_0">surname:Moore;given-names:K.</infon><infon key="fpage">152</infon><infon key="pub-id_doi">10.1017/S0029665117004177</infon><infon key="pub-id_pmid">29316987</infon><infon key="year">2018</infon><infon key="source">Proc. Nutr. Soc.</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="section_type">REF</infon><infon key="lpage">163</infon><infon key="name_4">surname:McNulty;given-names:H.</infon><offset>69384</offset><text>Diet, nutrition and the ageing brain: Current evidence and new directions</text></passage><passage><infon key="name_3">surname:Malaguarnera;given-names:M.</infon><infon key="name_2">surname:Marventano;given-names:S.</infon><infon key="name_1">surname:Galvano;given-names:F.</infon><infon key="name_0">surname:Grosso;given-names:G.</infon><infon key="pub-id_doi">10.1155/2014/313570</infon><infon key="year">2014</infon><infon key="source">Oxid. Med. Cell. Longev.</infon><infon key="type">ref</infon><infon key="volume">2014</infon><infon key="section_type">REF</infon><infon key="name_6">surname:Caraci;given-names:F.</infon><infon key="name_5">surname:Drago;given-names:F.</infon><infon key="name_4">surname:Bucolo;given-names:C.</infon><offset>69458</offset><text>Omega-3 fatty acids and depression: Scientific evidence and biological mechanisms</text></passage><passage><infon key="volume">31</infon><infon key="name_2">surname:Weber;given-names:P.</infon><infon key="name_1">surname:Troesch;given-names:B.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Mohajeri;given-names:M.H.</infon><infon key="fpage">261</infon><infon key="pub-id_doi">10.1016/j.nut.2014.06.016</infon><infon key="pub-id_pmid">25592004</infon><infon key="year">2015</infon><infon key="source">Nutrition</infon><infon key="type">ref</infon><infon key="lpage">275</infon><offset>69540</offset><text>Inadequate supply of vitamins and DHA in the elderly: Implications for brain aging and Alzheimer-type dementia</text></passage><passage><infon key="volume">29</infon><infon key="name_2">surname:Bandarra;given-names:N.M.</infon><infon key="name_1">surname:Afonso;given-names:C.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Cardoso;given-names:C.</infon><infon key="fpage">281</infon><infon key="pub-id_doi">10.1017/S0954422416000184</infon><infon key="pub-id_pmid">27866493</infon><infon key="year">2016</infon><infon key="source">Nutr. Res. Rev.</infon><infon key="type">ref</infon><infon key="lpage">294</infon><offset>69651</offset><text>Dietary DHA and health: Cognitive function ageing</text></passage><passage><infon key="name_3">surname:Mostofsky;given-names:D.I.</infon><infon key="name_2">surname:Carasso;given-names:R.L.</infon><infon key="name_1">surname:Rabinovitz;given-names:S.</infon><infon key="name_0">surname:Yehuda;given-names:S.</infon><infon key="fpage">843</infon><infon key="pub-id_doi">10.1016/s0197-4580(02)00074-x</infon><infon key="pub-id_pmid">12392789</infon><infon key="year">2002</infon><infon key="source">Neurobiol. Aging</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="section_type">REF</infon><infon key="lpage">853</infon><offset>69701</offset><text>The role of polyunsaturated fatty acids in restoring the aging neuronal membrane</text></passage><passage><infon key="name_3">surname:Matsukawa;given-names:N.</infon><infon key="name_2">surname:Warashina;given-names:S.</infon><infon key="name_1">surname:Sakaguchi;given-names:E.</infon><infon key="name_0">surname:Kotani;given-names:S.</infon><infon key="fpage">159</infon><infon key="pub-id_doi">10.1016/j.neures.2006.06.010</infon><infon key="pub-id_pmid">16905216</infon><infon key="year">2006</infon><infon key="source">Neurosci. Res.</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Yamashima;given-names:T.</infon><infon key="name_8">surname:Guo;given-names:J.</infon><infon key="name_7">surname:Yoshimoto;given-names:T.</infon><infon key="lpage">164</infon><infon key="name_6">surname:Sakakibara;given-names:M.</infon><infon key="name_5">surname:Kiso;given-names:Y.</infon><infon key="name_4">surname:Ishikura;given-names:Y.</infon><offset>69782</offset><text>Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction</text></passage><passage><infon key="name_3">surname:Chee;given-names:M.W.L.</infon><infon key="name_2">surname:Sim;given-names:S.K.Y.</infon><infon key="name_1">surname:Chuah;given-names:L.Y.M.</infon><infon key="name_0">surname:Chen;given-names:K.H.M.</infon><infon key="fpage">400</infon><infon key="pub-id_doi">10.1016/j.bandc.2009.11.007</infon><infon key="pub-id_pmid">20044193</infon><infon key="year">2010</infon><infon key="source">Brain Cogn.</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="section_type">REF</infon><infon key="lpage">407</infon><offset>69878</offset><text>Hippocampal region-specific contributions to memory performance in normal elderly</text></passage><passage><infon key="name_3">surname:Yusoff;given-names:N.A.M.</infon><infon key="name_2">surname:Rajab;given-names:N.</infon><infon key="name_1">surname:Shahar;given-names:S.</infon><infon key="name_0">surname:Lee;given-names:L.K.</infon><infon key="fpage">803</infon><infon key="pub-id_doi">10.1016/j.jnutbio.2012.04.014</infon><infon key="pub-id_pmid">22898566</infon><infon key="year">2013</infon><infon key="source">J. Nutr. Biochem.</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="section_type">REF</infon><infon key="lpage">808</infon><infon key="name_5">surname:Then;given-names:S.M.</infon><infon key="name_4">surname:Jamal;given-names:R.A.</infon><offset>69960</offset><text>The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case-control study</text></passage><passage><infon key="volume">53</infon><infon key="name_1">surname:Kiliaan;given-names:A.J.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Janssen;given-names:C.I.F.</infon><infon key="fpage">1</infon><infon key="pub-id_doi">10.1016/j.plipres.2013.10.002</infon><infon key="pub-id_pmid">24334113</infon><infon key="year">2014</infon><infon key="source">Prog. Lipid Res.</infon><infon key="type">ref</infon><infon key="lpage">17</infon><offset>70126</offset><text>Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration</text></passage><passage><infon key="name_3">surname:Fasey;given-names:N.</infon><infon key="name_2">surname:Elbourne;given-names:D.</infon><infon key="name_1">surname:Allen;given-names:E.</infon><infon key="name_0">surname:Dangour;given-names:A.D.</infon><infon key="fpage">1725</infon><infon key="pub-id_doi">10.3945/ajcn.2009.29121</infon><infon key="pub-id_pmid">20410089</infon><infon key="year">2010</infon><infon key="source">Am. J. Clin. Nutr.</infon><infon key="type">ref</infon><infon key="volume">91</infon><infon key="name_10">surname:Uauy;given-names:R.</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Richards;given-names:M.</infon><infon key="name_8">surname:Letley;given-names:L.</infon><infon key="name_7">surname:Knight;given-names:R.</infon><infon key="lpage">1732</infon><infon key="name_6">surname:Holder;given-names:G.E.</infon><infon key="name_5">surname:Hardy;given-names:P.</infon><infon key="name_4">surname:Fletcher;given-names:A.E.</infon><offset>70278</offset><text>Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial</text></passage><passage><infon key="name_3">surname:Chung;given-names:H.Y.</infon><infon key="name_2">surname:Caldarella;given-names:S.M.</infon><infon key="name_1">surname:McDonald;given-names:K.</infon><infon key="name_0">surname:Johnson;given-names:E.J.</infon><infon key="fpage">75</infon><infon key="pub-id_doi">10.1179/147683008X301450</infon><infon key="pub-id_pmid">18510807</infon><infon key="year">2008</infon><infon key="source">Nutr. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="lpage">83</infon><infon key="name_5">surname:Snodderly;given-names:D.M.</infon><infon key="name_4">surname:Troen;given-names:A.M.</infon><offset>70434</offset><text>Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women</text></passage><passage><infon key="name_3">surname:Van Staveren;given-names:W.A.</infon><infon key="name_2">surname:Kok;given-names:F.J.</infon><infon key="name_1">surname:Geleijnse;given-names:J.M.</infon><infon key="name_0">surname:Van De Rest;given-names:O.</infon><infon key="fpage">430</infon><infon key="pub-id_doi">10.1212/01.wnl.0000324268.45138.86</infon><infon key="pub-id_pmid">18678826</infon><infon key="year">2008</infon><infon key="source">Neurology</infon><infon key="type">ref</infon><infon key="volume">71</infon><infon key="section_type">REF</infon><infon key="name_7">surname:De Groot;given-names:C.P.G.M.</infon><infon key="lpage">438</infon><infon key="name_6">surname:Beekman;given-names:A.T.F.</infon><infon key="name_5">surname:OldeRikkert;given-names:M.G.M.</infon><infon key="name_4">surname:Dullemeijer;given-names:C.</infon><offset>70543</offset><text>Effect of fish oil on cognitive performance in older subjects: A randomized, controlled trial</text></passage><passage><infon key="name_3">surname:Gerstein;given-names:H.C.</infon><infon key="name_2">surname:Kromhout;given-names:D.</infon><infon key="name_1">surname:Halsey;given-names:J.</infon><infon key="name_0">surname:Aung;given-names:T.</infon><infon key="fpage">225</infon><infon key="pub-id_doi">10.1001/jamacardio.2017.5205</infon><infon key="pub-id_pmid">29387889</infon><infon key="year">2018</infon><infon key="source">JAMA Cardiol.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Galan;given-names:P.</infon><infon key="name_8">surname:Ness;given-names:A.</infon><infon key="name_7">surname:Rauch;given-names:B.</infon><infon key="lpage">234</infon><infon key="name_6">surname:Geleijnse;given-names:J.M.</infon><infon key="name_5">surname:Tavazzi;given-names:L.</infon><infon key="name_4">surname:Marchioli;given-names:R.</infon><offset>70637</offset><text>Associations of omega-3 fatty acid supplement use with cardiovascular disease risks meta-analysis of 10 trials involving 77 917 individuals</text></passage><passage><infon key="name_3">surname:Amini;given-names:M.</infon><infon key="name_2">surname:Aminorroaya;given-names:A.</infon><infon key="name_1">surname:Feizi;given-names:A.</infon><infon key="name_0">surname:Kassaian;given-names:N.</infon><infon key="fpage">2991</infon><infon key="pub-id_doi">10.1016/j.dsx.2018.07.016</infon><infon key="pub-id_pmid">30076087</infon><infon key="year">2019</infon><infon key="source">Diabetes Metab. Syndr.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="section_type">REF</infon><infon key="lpage">2996</infon><offset>70777</offset><text>Probiotic and synbiotic supplementation could improve metabolic syndrome in prediabetic adults: A randomized controlled trial</text></passage><passage><infon key="volume">77</infon><infon key="name_1">surname:Park;given-names:D.C.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Bischof;given-names:G.N.</infon><infon key="fpage">697</infon><infon key="pub-id_doi">10.1097/PSY.0000000000000212</infon><infon key="pub-id_pmid">26107577</infon><infon key="year">2015</infon><infon key="source">Psychosom. Med.</infon><infon key="type">ref</infon><infon key="lpage">709</infon><offset>70903</offset><text>Obesity and Aging: Consequences for Cognition, Brain Structure, and Brain Function</text></passage><passage><infon key="name_3">surname:Bizjak;given-names:M.C.</infon><infon key="name_2">surname:Vardjan;given-names:T.</infon><infon key="name_1">surname:Kenig;given-names:S.</infon><infon key="name_0">surname:Praznikar;given-names:Z.J.</infon><infon key="fpage">3961</infon><infon key="pub-id_doi">10.3168/jds.2019-17696</infon><infon key="pub-id_pmid">32171508</infon><infon key="year">2020</infon><infon key="source">J. Dairy Sci.</infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="section_type">REF</infon><infon key="lpage">3970</infon><infon key="name_4">surname:Petelin;given-names:A.</infon><offset>70986</offset><text>Effects of kefir or milk supplementation on zonulin in overweight subjects</text></passage><passage><infon key="name_3">surname:Singh;given-names:M.</infon><infon key="name_2">surname:Subramani;given-names:Y.</infon><infon key="name_1">surname:Millo;given-names:C.S.C.</infon><infon key="name_0">surname:Papadakis;given-names:G.Z.</infon><infon key="fpage">139</infon><infon key="pub-id_doi">10.1016/j.clinthera.2015.04.002.Gut-microbiota-brain</infon><infon key="year">2011</infon><infon key="source">Physiol. Behav.</infon><infon key="type">ref</infon><infon key="volume">176</infon><infon key="section_type">REF</infon><infon key="lpage">148</infon><infon key="name_6">surname:A Malhotra;given-names:F.C.</infon><infon key="name_5">surname:Kushida;given-names:A.</infon><infon key="name_4">surname:Wong;given-names:J.</infon><offset>71061</offset><text>       HHS Public Access</text></passage><passage><infon key="name_3">surname:Rijkers;given-names:G.T.</infon><infon key="name_2">surname:Van Overveld;given-names:F.J.</infon><infon key="name_1">surname:Jafri;given-names:I.</infon><infon key="name_0">surname:Bekkering;given-names:P.</infon><infon key="fpage">1031</infon><infon key="pub-id_doi">10.1586/1744666X.2013.848793</infon><infon key="pub-id_pmid">24138599</infon><infon key="year">2013</infon><infon key="source">Expert Rev. Clin. Immunol.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="section_type">REF</infon><infon key="lpage">1041</infon><offset>71098</offset><text>The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes</text></passage><passage><infon key="volume">127</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Bostanciklioglu;given-names:M.</infon><infon key="fpage">954</infon><infon key="pub-id_doi">10.1111/jam.14264</infon><infon key="pub-id_pmid">30920075</infon><infon key="year">2019</infon><infon key="source">J. Appl. Microbiol.</infon><infon key="type">ref</infon><infon key="lpage">967</infon><offset>71201</offset><text>The role of gut microbiota in pathogenesis of Alzheimer's disease</text></passage><passage><infon key="name_3">surname:Chae;given-names:S.W.</infon><infon key="name_2">surname:Paik;given-names:J.W.</infon><infon key="name_1">surname:Park;given-names:S.</infon><infon key="name_0">surname:Hwang;given-names:Y.H.</infon><infon key="pub-id_doi">10.3390/nu11020305</infon><infon key="year">2019</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Park;given-names:S.H.</infon><infon key="name_8">surname:Hong;given-names:G.</infon><infon key="name_7">surname:Kim;given-names:M.</infon><infon key="name_6">surname:Ha;given-names:E.</infon><infon key="name_5">surname:Jeong;given-names:D.G.</infon><infon key="name_4">surname:Kim;given-names:D.H.</infon><offset>71269</offset><text>Efficacy and safety of lactobacillus plantarum C29-fermented soybean (DW2009) in individuals with mild cognitive impairment: A 12-week, multi-center, randomized, double-blind, placebo-controlled clinical trial</text></passage><passage><infon key="name_3">surname:Michikawa;given-names:M.</infon><infon key="volume">14</infon><infon key="name_2">surname:Jung;given-names:C.G.</infon><infon key="name_1">surname:Zhou;given-names:C.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Abdelhamid;given-names:M.</infon><infon key="pub-id_doi">10.3390/nu14122543</infon><infon key="year">2022</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><offset>71479</offset><text>Probiotic Bifidobacterium breve MCC1274 Mitigates Alzheimer's Disease-Related Pathologies in Wild-Type Mice</text></passage><passage><infon key="name_3">surname:Chen;given-names:W.</infon><infon key="volume">13</infon><infon key="name_2">surname:Zhang;given-names:H.</infon><infon key="name_1">surname:Zhao;given-names:J.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Zhu;given-names:G.</infon><infon key="pub-id_doi">10.3390/nu13051602</infon><infon key="year">2021</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="name_4">surname:Wang;given-names:G.</infon><offset>71589</offset><text>Administration of bifidobacterium breve improves the brain function of abeta1-42-treated mice via the modulation of the gut microbiome</text></passage><passage><infon key="name_3">surname:Xiao;given-names:J.Z.</infon><infon key="name_2">surname:Oki;given-names:M.</infon><infon key="name_1">surname:Kuhara;given-names:T.</infon><infon key="name_0">surname:Kobayashi;given-names:Y.</infon><infon key="fpage">511</infon><infon key="pub-id_doi">10.3920/BM2018.0170</infon><infon key="pub-id_pmid">31090457</infon><infon key="year">2019</infon><infon key="source">Benef. Microbes</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="section_type">REF</infon><infon key="lpage">520</infon><offset>71724</offset><text>Effects of bifidobacterium breve a1 on the cognitive function of older adults with memory complaints: A randomised, double-blind, placebo-controlled trial</text></passage><passage><infon key="volume">75</infon><infon key="name_2">surname:Vellas;given-names:B.</infon><infon key="name_1">surname:Secher;given-names:M.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Gillette-Guyonnet;given-names:S.</infon><infon key="fpage">738</infon><infon key="pub-id_doi">10.1111/bcp.12058</infon><infon key="pub-id_pmid">23384081</infon><infon key="year">2013</infon><infon key="source">Br. J. Clin. Pharmacol.</infon><infon key="type">ref</infon><infon key="lpage">755</infon><offset>71879</offset><text>Nutrition and neurodegeneration: Epidemiological evidence and challenges for future research</text></passage><passage><infon key="name_3">surname:Leisgang;given-names:A.M.</infon><infon key="name_2">surname:Murtishaw;given-names:A.S.</infon><infon key="name_1">surname:Bemiller;given-names:S.M.</infon><infon key="name_0">surname:Kinney;given-names:J.W.</infon><infon key="fpage">575</infon><infon key="pub-id_doi">10.1016/j.trci.2018.06.014</infon><infon key="year">2018</infon><infon key="source">Alzheimers Dement.</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="section_type">REF</infon><infon key="lpage">590</infon><infon key="name_5">surname:Lamb;given-names:B.T.</infon><infon key="name_4">surname:Salazar;given-names:A.M.</infon><offset>71972</offset><text>Inflammation as a central mechanism in Alzheimer's disease</text></passage><passage><infon key="volume">50</infon><infon key="name_2">surname:Stevens;given-names:B.</infon><infon key="name_1">surname:Marsh;given-names:S.E.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Hammond;given-names:T.R.</infon><infon key="fpage">955</infon><infon key="pub-id_doi">10.1016/j.immuni.2019.03.016</infon><infon key="pub-id_pmid">30995509</infon><infon key="year">2019</infon><infon key="source">Immunity</infon><infon key="type">ref</infon><infon key="lpage">974</infon><offset>72033</offset><text>Immune Signaling in Neurodegeneration</text></passage><passage><infon key="name_3">surname:Xia;given-names:H.</infon><infon key="volume">8</infon><infon key="name_2">surname:Mao;given-names:Q.</infon><infon key="name_1">surname:Xiao;given-names:D.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Zhang;given-names:W.</infon><infon key="fpage">267</infon><infon key="pub-id_doi">10.1038/s41392-023-01486-5</infon><infon key="pub-id_pmid">37433768</infon><infon key="year">2023</infon><infon key="source">Signal Transduct. Target. Ther.</infon><infon key="type">ref</infon><offset>72071</offset><text>Role of neuroinflammation in neurodegeneration development</text></passage><passage><infon key="name_3">surname:Li;given-names:H.</infon><infon key="name_2">surname:Liu;given-names:L.</infon><infon key="name_1">surname:He;given-names:Z.</infon><infon key="name_0">surname:Zhang;given-names:J.</infon><infon key="pub-id_doi">10.3389/fnint.2023.1090294</infon><infon key="year">2023</infon><infon key="source">Front. Integr. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Xu;given-names:Y.</infon><infon key="name_8">surname:Ning;given-names:Y.</infon><infon key="name_7">surname:Zhu;given-names:D.</infon><infon key="name_6">surname:Wang;given-names:Y.</infon><infon key="name_5">surname:Zhu;given-names:X.</infon><infon key="name_4">surname:Wang;given-names:T.</infon><offset>72130</offset><text>Probiotic has prophylactic effect on spatial memory deficits by modulating gut microbiota characterized by the inhibitory growth of Escherichia coli</text></passage><passage><infon key="name_3">surname:Katagiri;given-names:R.</infon><infon key="name_2">surname:Yamaji;given-names:T.</infon><infon key="name_1">surname:Kanehara;given-names:R.</infon><infon key="name_0">surname:Iwasaki;given-names:M.</infon><infon key="fpage">277</infon><infon key="pub-id_doi">10.1111/cas.15196</infon><infon key="pub-id_pmid">34779109</infon><infon key="year">2022</infon><infon key="source">Cancer Sci.</infon><infon key="type">ref</infon><infon key="volume">113</infon><infon key="section_type">REF</infon><infon key="name_9">surname:Kakugawa;given-names:Y.</infon><infon key="name_8">surname:Hosomi;given-names:K.</infon><infon key="name_7">surname:Watanabe;given-names:K.</infon><infon key="lpage">286</infon><infon key="name_6">surname:Sato;given-names:M.</infon><infon key="name_5">surname:Tsunematsu;given-names:Y.</infon><infon key="name_4">surname:Mutoh;given-names:M.</infon><offset>72279</offset><text>Association of Escherichia coli containing polyketide synthase in the gut microbiota with colorectal neoplasia in Japan</text></passage><passage><infon key="volume">23</infon><infon key="name_2">surname:Hsu;given-names:C.N.</infon><infon key="name_1">surname:Tain;given-names:Y.L.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Huang;given-names:Y.H.</infon><infon key="pub-id_doi">10.3390/ijms231710173</infon><infon key="year">2022</infon><infon key="source">Int. J. Mol. Sci.</infon><infon key="type">ref</infon><offset>72399</offset><text>Maternal Supplementation of Probiotics, Prebiotics or Postbiotics to Prevent Offspring Metabolic Syndrome: The Gap between Preclinical Results and Clinical Translation</text></passage><passage><infon key="name_3">surname:Tain;given-names:Y.L.</infon><infon key="volume">22</infon><infon key="name_2">surname:Hsu;given-names:W.H.</infon><infon key="name_1">surname:Hou;given-names:C.Y.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Hsu;given-names:C.N.</infon><infon key="pub-id_doi">10.3390/ijms222111872</infon><infon key="year">2021</infon><infon key="source">Int. J. Mol. Sci.</infon><infon key="type">ref</infon><offset>72567</offset><text>Early-life origins of metabolic syndrome: Mechanisms and preventive aspects</text></passage><passage><infon key="name_3">surname:Tain;given-names:Y.L.</infon><infon key="volume">13</infon><infon key="name_2">surname:Hsu;given-names:W.H.</infon><infon key="name_1">surname:Hou;given-names:C.Y.</infon><infon key="section_type">REF</infon><infon key="name_0">surname:Hsu;given-names:C.N.</infon><infon key="pub-id_doi">10.3390/nu13072290</infon><infon key="year">2021</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><offset>72643</offset><text>Cardiovascular diseases of developmental origins: Preventive aspects of gut microbiota-targeted therapy</text></passage><passage><infon key="name_3">surname:Salami;given-names:M.</infon><infon key="name_2">surname:Alaei;given-names:H.</infon><infon key="name_1">surname:Talaei;given-names:S.A.</infon><infon key="name_0">surname:Davari;given-names:S.</infon><infon key="fpage">287</infon><infon key="pub-id_doi">10.1016/j.neuroscience.2013.02.055</infon><infon key="pub-id_pmid">23500100</infon><infon key="year">2013</infon><infon key="source">Neuroscience</infon><infon key="type">ref</infon><infon key="volume">240</infon><infon key="section_type">REF</infon><infon key="lpage">296</infon><offset>72747</offset><text>Probiotics treatment improves diabetes-induced impairment of synaptic activity and cognitive function: Behavioral and electrophysiological proofs for microbiome-gut-brain axis</text></passage><passage><infon key="name_3">surname:Hong;given-names:D.K.</infon><infon key="name_2">surname:Hong;given-names:H.J.</infon><infon key="name_1">surname:Lee;given-names:K.</infon><infon key="name_0">surname:Mo;given-names:S.J.</infon><infon key="pub-id_doi">10.3390/nu14122484</infon><infon key="year">2022</infon><infon key="source">Nutrients</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="section_type">REF</infon><infon key="name_7">surname:Lee;given-names:J.L.</infon><infon key="name_6">surname:Shim;given-names:J.J.</infon><infon key="name_5">surname:Park;given-names:S.D.</infon><infon key="name_4">surname:Jung;given-names:S.H.</infon><offset>72923</offset><text>Effects of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on Overweight and the Gut Microbiota in Humans: Randomized, Double-Blinded, Placebo-Controlled Clinical Trial</text></passage></document>
</collection>